TW491848B - Pyridone carboxylic acid derivatives and the synthetic intermediate thereof - Google Patents
Pyridone carboxylic acid derivatives and the synthetic intermediate thereof Download PDFInfo
- Publication number
- TW491848B TW491848B TW086112167A TW86112167A TW491848B TW 491848 B TW491848 B TW 491848B TW 086112167 A TW086112167 A TW 086112167A TW 86112167 A TW86112167 A TW 86112167A TW 491848 B TW491848 B TW 491848B
- Authority
- TW
- Taiwan
- Prior art keywords
- compound
- group
- ministry
- amine
- alkyl
- Prior art date
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
491848 A7 B7 五、發明説明(,) 技術領域 本發明為有醑可當作抗醣劑之新穎毗啶酮羧酸衍生物 及其新穎合成中間體。 背景技術 已知種種抗菌性吡啶酮羧酸衍生物,例如在曰本特開 平6-239857號(對應EP-A-6G3887)掲示如下式(A)化合物491848 A7 B7 V. Description of the invention (,) TECHNICAL FIELD The present invention is a novel pyridinonecarboxylic acid derivative and a novel synthetic intermediate thereof which can be used as an anti-sugar agent. BACKGROUND ART Various antibacterial pyridonecarboxylic acid derivatives are known, for example, in Japanese Patent Application Laid-Open No. 6-239857 (corresponding to EP-A-6G3887), compounds of the following formula (A) are shown:
COOR (A) 請 先 聞 背 面 之 注 意 事 項 再 填 寫 本 頁 經濟部中央標準局員工消費合作社印製 式中 X 1 9 X 2為齒素, Ri為可有取代基之胺基等, 113及114為H,烷基等, Y為Ο, N或亞甲基等, Z為0 , U或亞甲基等, a, η為0〜2之整數,其和為2或3, 口,9,1*為0〜3之整數,其和為()〜3, Α為Ν或C-X(X為Η或鹵素等)。 R為Η等。 在此式(Α)化合物中7位取代基二琛胺基乃由含Ν &胃一 環及含0等之第二環而成,但第一瓌上之取代®與&@ 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X297公釐) 491848 (a 1) (a 2) (a 3) A7 B7 五、發明説明(> ) 式(I)本發明化合物不同。在前述特公平6- 2 3 98 5 7號具龌 記載之前式(A)化合物中7位二環胺基僅掲示如下3種·· h〇Cn- 或 Η ς»- 另在特公平6-192262號(對應ΕΡ-Α-589318)掲示如下 式(Β )化合物 (請先閲讀背面之注意事項㈣填寫本頁) 裝· 寫太 訂COOR (A) Please read the notes on the back before filling out this page. In the printed format of the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs, X 1 9 X 2 is the tooth element, Ri is the amine group which may have substituents, etc. 113 and 114 Are H, alkyl, etc., Y is 0, N, or methylene, etc., Z is 0, U, or methylene, etc., a, η are integers from 0 to 2, and the sum is 2 or 3; 1 * is an integer of 0 ~ 3, and the sum is () ~ 3, Α is N or CX (X is Η or halogen, etc.). R is Η and so on. In the compound of the formula (Α), the 7-position dienylamino group is formed from a ring containing N & stomach and a second ring containing 0, etc., but the substitutions ® and & @ on the first sheet Applicable to Chinese National Standard (CNS) A4 specification (210X297 mm) 491848 (a 1) (a 2) (a 3) A7 B7 V. Description of the invention (>) Formula (I) The compounds of the present invention are different. In the aforementioned special fair 6- 2 3 98 5 No. 7, the bicyclic amine group at the 7-position in the compound of formula (A) before the description only shows the following three types: · h〇Cn- or Η »-Also in special fair 6- No. 192262 (corresponding to EP-Α-589318), which shows the compound of the following formula (B) (please read the precautions on the back first and fill in this page)
X 1為齒素或硝基, X 2為Η ,胺基等, 經濟部中央標準局員工消費合作社印製X 1 is tooth element or nitro, X 2 is thallium, amine, etc., printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs
Ri為烷基,璟烷基等, R 2為Η等, Α為Ν或C-R5 (R5為η,鹵素等), Z為如下式基: 本紙張尺度適用中國國家標準(CNS ) A4規格 2 η N,v鱗) 491848 A7 B7五、發明説明(4 ) R3' R4Ri is an alkyl group, fluorenyl group, etc., R 2 is fluorene, etc., A is N or C-R5 (R5 is η, halogen, etc.), and Z is based on the following formula: This paper size applies to China National Standard (CNS) A4 specifications 2 η N, v scale) 491848 A7 B7 V. Description of the invention (4) R3 'R4
(b 1) (b 2) (b 3) 其中R2, R4為H,甲基等, 但此化合物之7位取代基之二琛胺基(Ζ)為含Ν之第一 環及含0之第二瓖之稠合形式與本發明化合物不同。 發明之掲示 本發明提供如下式(I)新穎吡啶酮羧酸衍生物(以下有 時稱本發明化合物(I),其酯及其鹽, (請先閲讀背面之注意事項寫本頁) -裝- 、1Τ 經濟部中央標準局員工消費合作社印繁 Ο(b 1) (b 2) (b 3) where R2, R4 are H, methyl, etc., but the dichenyl group (Z) of the 7-position substituent of this compound is the first ring containing N and the ring containing 0 The second fused form differs from the compounds of the invention. Presentation of the invention The present invention provides novel pyridonecarboxylic acid derivatives of the following formula (I) (hereinafter sometimes referred to as the compound (I) of the present invention, its esters and salts thereof, (please read the precautions on the back to write this page)- -、 1fan Yinfan, a consumer cooperative of the Central Standards Bureau of the Ministry of Economic Affairs
本纸張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 491848 A7 B7五、發明説明(4 ) 式中 R為低烷基,低烯基或低環烷基(這些基有時可有鹵 素取代),或苯基(此基有時可取代著可有低烷基取代之 胺基及/或鹵素), X為H,鹵素,羥基,低烷基,低烷氣基或可被保護 之胺基, Y為Η或鹵素, Α為Ν或C-Z , Z為H,鹵素或氰基,或低烷氣基,低烷基,低烷硫 基,低烯基或低炔基(這些基有時可有鹵素取代),或與 8共形成- 0- CH2 -CH(CH3 )-之架橋, R i及R 2相同或'相異,各為H,低烷基或胺基保護基, R 3為Η或低烷基, R4〜R9相同或相異,各為Η,齒素或低烷基, a為0或1 , η及P相同或相異,各為0或1。 本發明又提供可當作上述吡啶_羧酸衍生物之合成中 間物之如下式(II)新穎二璟胺化合物及其鹽 (請先閱讀背面之注意事項^^寫本頁) 0. 裝· 訂 -線· 經濟部中央標準局員工消費合作社印製This paper size applies Chinese National Standard (CNS) A4 specification (210X 297 mm) 491848 A7 B7 V. Description of the invention (4) where R is low alkyl, low alkenyl or low cycloalkyl (these groups are sometimes May be substituted with halogen), or phenyl (this group may sometimes be substituted with amine and / or halogen which may be substituted with a low alkyl group), X is H, halogen, hydroxyl, low alkyl, low alkane or Protected amine group, Y is fluorene or halogen, A is N or CZ, Z is H, halogen or cyano, or low alkyl gas group, low alkyl group, low alkylthio group, low alkenyl group or low alkynyl group ( These groups may sometimes be substituted by halogens), or co-form with 8 to form a bridge of -0-CH2-CH (CH3)-, R i and R 2 are the same or different, each being H, lower alkyl or amine protected R 3 is fluorene or lower alkyl, R4 to R9 are the same or different, each is fluorene, dentin or low alkyl, a is 0 or 1, η and P are the same or different, and each is 0 or 1. The present invention also provides novel dihydramine compounds and their salts of the following formula (II) which can be used as synthetic intermediates of the above-mentioned pyridine-carboxylic acid derivatives (please read the notes on the back ^^ write this page) 0. 装 · Order-line · Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs
本紙張尺度適用中國國家標準(CNS ) Α4規格(210 X 297公釐) 491848 A7 B7 五、發明説明(JT ) (式中Ri〜R9 , *,n及P同前)。 本發明化合物(I)之構造上特徴為特定吡啶酮羧酸之 7位或7位相當位置鍵結如下式從未知之二環胺基:This paper size applies Chinese National Standard (CNS) A4 specification (210 X 297 mm) 491848 A7 B7 V. Description of invention (JT) (where Ri ~ R9, *, n and P are the same as above). The structure of the compound (I) of the present invention is specifically a 7-position or 7-position equivalent position of a specific pyridone carboxylic acid, and the unidentified bicyclic amine group is as follows:
式中Ri〜R9 ,祖,η及p 。 以如上構造為特徽之本發明化合物(I)具有抗菌活性 , 尤其對革蘭陽性薗之抗菌活性優異,可當作抗菌劑〇 以下就本發明化合物詳細説明。 本文中「鹵素」可為如氟,氯或溴等,「低J除S行 規定外,乃指C 〇 經濟部中央標準局員工消費合作社印製 「低烷基」乃指直或分枝之烷基,如甲基,乙 基,丙基,異丙基,丁基,第三丁基,戊基等。「低 烷氧基」乃指低烷基部分同上之低烷氣基,例如甲氣基 ,乙氣基,丙氣基,異丙氣基,丁氣基等。「低烯基J 乃指C2-7直或分枝烯基,如乙烯基,烯丙基,1-丙烯 基,異丙烯基等。「低炔基」,可為乙炔基,1-丙炔基 「低環烷基」包括C3_7環烷基,如環丙基,環丁基, 琛戊基,環己基等。「低烷硫基」可為甲硫基,乙硫基 等〇 各紙飧尺度遑用中國國家標準(CNS ) A4規格(210X297公釐) 491848 A7 _B7____ 五、發明説明() R所定義之低烷基,低烯基及低環烷基,有時可有1 〜數傾鹵素取代•鹵素取代之上述基之例可為氟甲基, 請 先 閱 讀 背 之 注 意 事 項 再 二氟甲基,三氟甲基,2-氟乙基,2-氯乙基,2, 2-二氟 乙基,2-氟乙烯基,卜氟乙烯基,2,2-二氟乙烯基,2-氟環丙基,2-氯環丙基等。Z所定義之低焼氣基,低 烷基,低烷硫基,低烯基及低炔基亦有時可有1〜數値 鹵素取代。鹵素取代之上述基可為前逑R所述鹵素取代 之低烷基及低烯基之外有氟甲氣基,二氟甲氣基,三氟 甲氣基,2-氟乙氣基,2,2-二氟乙氣基,2,2, 2-三氟乙 氧基,二氟甲硫基,三氟甲硫基,氟乙炔基,三氟丙炔 基等。 「苯基(此基有時可取代著可有低烷基之胺基及/或 鹵素)」可為2,4-二氟苯基,3-胺基-4,6-二氟苯基,4-氣-2-氟苯基,2-氛-4-氟苯基,3-胺基-4-氟苯基,4,6-二氟-3-甲胺苯基等。 「胺基保護基」或「可被保護胺基」中保護只要可由 水解或氫解等一般脱保護基反應就可對其他構造部分無 實質影饗而易脱離者均可使用。 經濟部中央標準局員工消費合作社印製 易由水解來脱離之胺基保護基(易水解性胺基保護基) 之例有如乙氣羰基,簡稱Boc之第三丁氧羰基,苄氧羰 基,對甲氣苄氣羰基,乙烯氣羰基,對甲苯横醯基) 乙氣羰基等氣羰基;如甲醯基,乙醛基,三氟乙醛基等 醯基;如三甲基矽烷基,第三丁基二甲基矽烷基等砂院 基;四氫吡喃基,鄰硝苯次磺醯基,二苯次磷醯基等。 -8 一 本紙張尺度適用中國國家標準(CNS ) Α4規格(210Χ297公釐) 491848 A7 B7 ..-- - 五、發明説明(7 ) 易由氫解來脱離之胺基保護基(易氫解性胺基保護基) 可為如對甲苯磺醯基等芳磺醯基;如苄基,三苯甲基, 节氣甲基等苯基或苄氣基取代之甲基;如苄氣羰基,鄰 甲氣苄氣羰基等芳甲氣羰棊;如办,泠,/?-三氯乙氧羰 棊,>5-碘乙氣羰基等鹵乙氣羰基等。 本發明化合物(I)之酯適為可由化學手段或酵素手段 來在活體内或外脱離而轉換成本發明化合物(I)者。 可由如水解等化學手段轉變成對應之游離羧酸之酯可 為如甲酯,乙酯等低烷酯。不僅化學手段,酵素手段亦 可轉換為對應游離羧酸之酯除如乙醯氣甲酯,1-乙醛氣 基瞅 羰f 氣(1 乙 2 - 1X , 如 '酯 ; 乙 酯胺 烷甲 低二 氣 2 醯如 烷 ; 低酯 等烷 酯低 甲基 氣羰 醛氧 戊烷 特低 ,等 酯酯 乙乙 基酯 啶甲 酯 乙 酯 酞 外 之-2 等基 酯甲 - 乙 5 胺ί 等丨 可 氣 啶等 毗酯 , 甲 酯丨 醯 乳7 基茂 丁 2Γ 3 二 為- 3 基 物 合 化 明 發 本 乙 氟 三 如 與 鹽 許 容 i 理 生 適 尤 鹽 之 磺 甲 酸二 丁 酸 乳 , , ,酸酸 酸糖鹽 乙萄如 ,葡與 酸如; 酸鹽 胺之 麩酸 或機 酸無 胺等 冬酸 天磷 ,鹽 酸之 二酸 丙機 ,有 酸等 來酸, 馬基鈉 ,胺與 酸等; 鉀 鋅Where Ri ~ R9, ancestors, η and p. The compound (I) of the present invention having the above-mentioned special emblem has antibacterial activity, and is particularly excellent in antibacterial activity against Gram-positive salamander, and can be used as an antibacterial agent. Hereinafter, the compound of the present invention will be described in detail. In this article, "halogen" can be fluorine, chlorine or bromine, etc. "Low-J, except for the provisions of S, refers to CO printed by the Consumers Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs." Low-alkyl "refers to straight or branched Alkyl, such as methyl, ethyl, propyl, isopropyl, butyl, tertiary butyl, pentyl and the like. "Low alkoxy" refers to a low alkanoyl group having the same alkyl group as above, such as methylamino, ethylamino, propane, isopropyl, butane, and the like. "Lower alkenyl J refers to C2-7 straight or branched alkenyl, such as vinyl, allyl, 1-propenyl, isopropenyl, etc." Low alkynyl "may be ethynyl, 1-propynyl The group "lower cycloalkyl" includes C3_7 cycloalkyl, such as cyclopropyl, cyclobutyl, octyl, cyclohexyl and the like. "Low alkylthio" can be methylthio, ethylthio, etc. Chinese paper standard (CNS) A4 (210X297 mm) for each paper size 491848 A7 _B7____ 5. Description of the invention () Low alkyl Group, low alkenyl group and low cycloalkyl group, which may have 1 to several halogen substitutions. Examples of the above-mentioned halogen substituted groups may be fluoromethyl groups. Please read the precautions before proceeding with difluoromethyl groups and trifluoro groups. Methyl, 2-fluoroethyl, 2-chloroethyl, 2, 2-difluoroethyl, 2-fluorovinyl, fluorovinyl, 2,2-difluorovinyl, 2-fluorocyclopropyl , 2-chlorocyclopropyl and the like. The low fluorene group, low alkyl group, low alkylthio group, low alkenyl group and low alkynyl group defined by Z may also be substituted with 1 to several halogens. The above-mentioned halogen-substituted group may be a fluoromethyl group, a difluoromethyl group, a trifluoromethyl group, a 2-fluoroethyl group other than the halogen-substituted low alkyl group and the alkene group described in the above-mentioned R. 2 2,2-difluoroethoxy, 2,2,2-trifluoroethoxy, difluoromethylthio, trifluoromethylthio, fluoroethynyl, trifluoropropynyl and the like. "Phenyl (this group may sometimes be substituted with amine and / or halogen which may have a lower alkyl group)" may be 2,4-difluorophenyl, 3-amino-4,6-difluorophenyl, 4-Gas-2-fluorophenyl, 2-Amo-4-fluorophenyl, 3-amino-4-fluorophenyl, 4,6-difluoro-3-methylaminephenyl and the like. "Amine-protecting groups" or "protectable amine groups" can be used as long as they can be easily detached without substantial influence on other structural parts as long as they can be reacted by general deprotection groups such as hydrolysis or hydrogenolysis. Examples of amine-protecting groups (easy-hydrolyzable amine-protecting groups) printed by the employees' cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs, such as ethyl carbonyl, the third butoxycarbonyl group of Boc, benzyloxycarbonyl, P-methyl benzyl carbonyl, ethylene carbonyl, p-toluene fluorenyl) ethane carbonyl and other gas carbonyl groups; such as methyl fluorenyl, acetaldehyde, trifluoroacetaldehyde and other fluorenyl groups; such as trimethylsilyl, p. Tributyl dimethylsilyl and other sand bases; tetrahydropyranyl, o-nitrophenylsulfenyl, diphenylphosphinofluorene and the like. -8 A paper size applies the Chinese National Standard (CNS) A4 specification (210 × 297 mm) 491848 A7 B7 .. --- 5. Description of the invention (7) Amine-protecting group (easy to hydrogen) Hydrolyzable amino-protecting group) can be arylsulfonyl groups such as p-toluenesulfonyl; such as benzyl, trityl, and thylyl methyl or substituted benzyl groups; such as benzylcarbonyl , Aromatic methyl carbonyl fluorene such as o-methylbenzyl carbonyl; etc., such as trichloroethoxycarbonyl fluorene, < The ester of the compound (I) of the present invention is suitably one which can be converted into the compound (I) of the present invention by chemical or enzymatic means for detachment in vivo or in vivo. The esters which can be converted into the corresponding free carboxylic acid by chemical means such as hydrolysis can be lower alkyl esters such as methyl esters and ethyl esters. Not only chemical means, but also enzymatic means can be converted to the corresponding free carboxylic acid esters, such as methyl ethyl acetone, 1-acetaldehyde methyl carbonyl f gas (1 ethyl 2-1X, such as' esters; ethyl amine alkyl methyl Low digas 2 Alkyl alkane; Alkyl esters such as low esters Low methyl gas Carboxaldehyde oxopentane, very low esters Ethyl esters Ethyl esters Ethyl pyridyl methyl esters Ethyl phthalate-2 Ethyl esters Ethyl-5 amine ί etc. 丨 Pyridoxine and other methyl esters, methyl esters, 醯 milk 7 Chirobutene 2Γ 3 Di is-3 base compound Mingfa Benfafluorotriol and salt Xu Rong i Physiochemical salt of sulfonic acid dibutyric acid Milk,,, acid, acid, sugar, salt, such as glucose and acid; acid amine, glutamic acid or organic acid without amine, such as aspartic acid, phosphorus acid, hydrochloric acid, diacid propionate, acid, etc. , Amines and acids; potassium zinc
等 艮 I 經濟部中央標準局員工消費合作社印製 胺 甲 三 如 與 ·, 鹽 銨 〇 ;鹽 鹽之 之鎊 屬機 金有 胺 乙 三 等 啉 嗎 基 甲 酸甲 硫, ,酸 酸乙 發氟 如三 與 , 為酸 可乙 發 , 之酸酸 I)甲之 (I如酸 物舆機 合 •,有 化鹽等 胺成酸 璟加磺 二酸苯 之之甲 明酸對 發機 , 本無酸 等磺 鹽 成 加 物 合 化 胺 環二 及 \t*/ I /V 物 生 衍 酸 羧 酮 啶 吼 之 明 發 本 本紙張用中國*家櫺率(cNS ) A4規格(210X297公釐) 491848 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明() 有時可以水合物或媒合物存在。本發明化合物又可以光 學活性饅,立體異構物(順,反型)或這些之混合物之形 態存在。這些化合物皆包括在本發明。 本發明化合物(I)中,適宜化合物乃前式(I)中η為1 者,其中更佳者乃前式(I)中 (i) R為環丙基,2 -氟環丙基等時,可被鹵素取代之 低璟烷基,或2,4-二氟苯基,3-胺基-4, 6-二氟苯基等 有鹵素及/或胺基取代之苯基, (ii) X為H,如甲基等低烷基,羥基或胺基, (iii) Y 為氟, (iv) A為N或C-Z,其中Z為H;如F, C1等鹵素,氣 基;甲氣基,二氟甲氣基,乙氣基,2_氟乙氣基等可由 鹵素取代之低烷氣基;如甲基等低烷基;如甲硫等低烷 硫基;如乙嫌基等低嫌基;或如乙炔基等低炔基; (viRiSR2相同或相異,各為甲基等低烷基, (v i ) R 3 為 Η , (vii)R4〜R9相同或相異,各為η或如甲基等低烷 基。 更佳之本發明化合物為前式(I)中,r為璟丙基,2-氟瓖丙基,2,4-二氟苯基或3-胺基M,6-二氟苯基,χ 為Η,甲基,羥基或胺基,Υ為氟,Α為Ν或C-Z,其中 ZgH, F, C1,甲氣基,二氟甲氣基,乙氣基,2_氟乙 氧基,甲基,甲硫基,乙烯基,乙炔基或氰基,Ri及 R2相同或相異,各為H或甲基,為H, R4〜R9相 -10- 本紙張尺度適用中國國家摞準(CNS ) Α4規格(210x297公釐) (請先閲讀背面之注意事項再填寫本頁) β裝· 7再填寫木 訂 491848 A7 B7 • 0〕辛-6-基)-卜第 五、發明説明(9 同或相異,各為Η或甲基,η為1者。更具體而言,如 後述實施例之化合物。 除後述實施例之化合物之外,本發明化合物(I)之代 表例如下。以下命名中,雖未待定宜立體構造,但下列 化學名之化合物包括所有種種立體構造。 7- (8-胺基-2-鸣-6-吖雙環〔 三丁基-6-氟-1,4-二氫-4-氧-1,8-暸啶-3-羧酸 7-(8 -胺基-2-鴨-6-B丫雙璟〔3·3·0〕辛-6-基)-1-第 三丁基_6_氟-1,4-二氫-8-甲氣基-4-氣B奎啉-3-羧酸 7-(8 -胺基-2-吗-6-B丫雙環〔3.3.0〕辛-6-基)-6,8-二氟-1-(2-氟乙基)-1,4 -二氫-4-氣β啉-3-羧酸 7-(8-胺基-2-ΒΙ-6-吖雙環〔3.3.0〕辛-6-基)-6-氟 -1,4-二氫-8-甲氧基-4-氣-1-乙烯B奎啉-3-羧酸 7-(4-胺基吖雙環〔3·2·0〕庚-2-基)-1-璟 丙基-6-氟-1,4-二氫-8-甲氣基-4-氣β咐-3-錢酸 7 -(8-胺基-8-甲基-2-鸣-6-吖雙環〔3.3.0〕辛-6-基) -1-環丙基-6-氟-1,4 -二氫-8-甲氣基-4-氣Itt咐-3-錢酸 7-(8 -胺基-4-氟-2-鸣-6-吖雙環〔3·3·0〕辛-6-基) 請 kj 閱 讀 背 之 注 意 事 項 再 經濟部中央標準局員工消費合作社印製 氟 氫二 »|- 2 - 氟二- 4 4 Τ基 基胺 丙8-環Τ - 環 基雙 氣ίγ 甲 6 啉 if 氣 >酸 基羧 基 丙 環 氟 氫二 基 氣 甲 環基 雙氣 吖甲 I I 6 8 I 應 鸣氫2-一一 I I 4* 基 , 1Χ 甲 -4 氟 I 垂 6 基-胺基 8-丙 Τ璟 啉 url 氣 0 6 . 基酸 羧76-羧 I- 啉 FI 0 氣 辛 辛 本纸張尺度適用中國國家標準(CNS “叹蜷(2丨0> 29*7公釐) 491848 A7 B7 五、發明説明(~ ) 7-(8-胺基-2-^-6-吖雙環〔3.3.0〕辛-6-基)-卜環 丙基-6-氟-1,4 -二氫-5-經基-8-甲基-4-氣挖琳-3-錢酸 1-(3-胺基-4,6-二氟苯基)-7-(8-胺基-2-丨§ - 6-吖雙 環〔3.3.0〕辛-6-基)-8 -氩-6-氟-1,4 -二氫-4-氣I奎咐 -3-羧酸 5 -胺基-1-(3 -胺基-4 ,6-二氟苯基)-7-(8•胺基-2-(| - 6_ 吖雙環〔3.3.0〕辛-6-基)-6-氟-1,4-二氫-4-氣-1, 8-暸啶-3-羧酸 7-(9-胺基-4,4-二氟-2-if-7-吖雙環〔4·3·0〕壬-7-基)-1-環丙基-6-氟-1,4-二氫-8-甲氣基-4-氧If淋- 3-羧酸 7-(8-胺甲基-2-1等-6-吖雙環〔3.3.0〕辛-6-基)-1-環丙基-6-氟-1,4 -二氣-8-甲氣基-4-氧If咐-3-錢酸 5-胺基-7-(8-胺基-2-ΙΠΙ-6-吖雙環〔3·3·0〕辛-6-基) -1-環丙基-6-氟-1,4 -二氫-8-甲基-4-氣睹啉-3-羧酸 卜環丙基-6-氟-1,4-二氫-8-甲基-7-(8-甲胺基-2-鸣 -6-吖雙環〔3.3.0〕辛-6-基)-4-氣β啉-3-羧酸 5-胺基-1-環丙基-6-氣-1,4 -二氫-8-甲基- 7- (8 -甲胺 基-2-丨等-6-B丫雙環〔3.3.0〕辛-6-基)-4 -氧睹林-3-錢酸 5·胺基-1-(4,6 -二氟-3-甲胺苯基)-6 -氟-1,4 -二氫- 7-(8-甲胺基-2-鸣-6-吖雙環〔3.3.0〕辛-6-基)-4-氣歧 啉-3-羧酸 1-環丙基乙氣基-6-氟-1,4-二氫- 7- (8-甲肢基- 2-鸣-6-吖雙環〔3·3·0〕辛-6-基)-4-氣丨奎啉-3-羧酸 -12- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 請 先 閱 讀 背 之 注 意 事Deng I. Printing of carbamoyl chloride by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs, salt ammonium 〇; The salt of the salt is organic amine triethyl morpholinoformyl methyl sulfide, acetic acid ethyl fluoride For example, the three and the acid can be oxidized, the acid acid I) a (I such as acid and organic compounds, amines and other amines to form acid, plus sulfonic acid benzene, methanoic acid on the machine, this Acid-free sulfonates and adducts combined with amine ring two and \ t * / I / V bio-derived carboxylic acid ketones and ketones. This paper uses China * furniture ratio (cNS) A4 size (210X297 mm). 491848 A7 B7 printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 5. Description of the invention () Sometimes it can exist as a hydrate or a vehicle. The compounds of the present invention can also be optically active tritium, stereoisomers (cis, trans) or These mixtures exist in the form. These compounds are included in the present invention. Among the compounds (I) of the present invention, suitable compounds are those in which η is 1 in the foregoing formula (I), and the more preferable ones are in (i) in the foregoing formula (I). ) When R is cyclopropyl, 2-fluorocyclopropyl, etc., it may be substituted by halogen Haloalkyl, or 2,4-difluorophenyl, 3-amino-4, 6-difluorophenyl and other phenyl substituted with halogen and / or amine group, (ii) X is H, such as methyl Equal lower alkyl, hydroxyl or amine groups, (iii) Y is fluorine, (iv) A is N or CZ, where Z is H; halogens such as F, C1, gas groups; methylamino, difluoromethylamino Low alkyl alkanoyl groups which can be substituted by halogen, such as ethyl, 2-fluoroethane, etc .; low alkyl groups such as methyl; low alkylthio groups such as methylsulfide; low alkyl groups such as ethylthio; or acetylene Low alkynyl groups such as (viRiSR2 are the same or different, each is a low alkyl such as methyl, (vi) R 3 is Η, (vii) R4 ~ R9 are the same or different, each η or low as methyl Alkyl. More preferred compounds of the present invention are in formula (I) above, where r is fluorenyl, 2-fluorofluorenyl, 2,4-difluorophenyl or 3-aminoM, 6-difluorophenyl. , Χ is Η, methyl, hydroxyl or amine, Υ is fluorine, A is N or CZ, of which ZgH, F, C1, methylamino, difluoromethyl, ethyl, and 2-fluoroethoxy , Methyl, methylthio, vinyl, ethynyl or cyano, Ri and R2 are the same or different, each H or methyl, H, R4 ~ R9 phase National Standards (CNS) Α4 size (210x297 mm) (Please read the notes on the back before filling out this page) β Pack · 7 and then fill in the wood order 491848 A7 B7 • 0] Xin-6-base)-Bu fifth 2. Description of the invention (9 Identical or different, each of fluorene or methyl, η is 1. More specifically, the compounds of the examples described below. In addition to the compounds of the examples described below, the compounds of the present invention (I) Examples are as follows. In the following names, although three-dimensional structures are not yet determined, the compounds of the following chemical names include all kinds of three-dimensional structures. 7- (8-Amino-2-Ming-6-Azabicyclo [tributyl-6-fluoro-1,4-dihydro-4-oxo-1,8-pyridine-3-carboxylic acid 7- ( 8-Amino-2-Duck-6-B-Yamidine [3 · 3 · 0] oct-6-yl) -1-Third-butyl-6-fluoro-1,4-dihydro-8-methyl Gasoline-4-Gas-B-quinoline-3-carboxylic acid 7- (8-Amino-2-morpho-6-Bammabicyclo [3.3.0] oct-6-yl) -6,8-difluoro- 1- (2-fluoroethyl) -1,4-dihydro-4-gas β morpholine-3-carboxylic acid 7- (8-amino-2-BI-6-azinebicyclo [3.3.0] octyl- 6-yl) -6-fluoro-1,4-dihydro-8-methoxy-4-gas-1-ethylene B quinoline-3-carboxylic acid 7- (4-aminoazinebicyclo [3.2 · 0] heptan-2-yl) -1-fluorenyl-6-fluoro-1,4-dihydro-8-methylamino-4-gas β3-3-carboxylic acid 7- (8-amino -8-Methyl-2-Ming-6-acylbicyclo [3.3.0] oct-6-yl) -1-cyclopropyl-6-fluoro-1,4-dihydro-8-methylamino-4 -Ga Itt instructs 3-carboxylic acid 7- (8-amino-4-fluoro-2-ming-6-acylbicyclo [3 · 3 · 0] oct-6-yl) Please read the notes on the back again Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs of the Consumer Cooperative Co., Ltd. ||-2-Fluorodi- 4 4 Tylaminopropyl 8-ring T-Cyclic Digas γ 6 Phosphine if Gas > Acid Carboxyl Propane Fluorohydrodiylcyclomethyl II 6 8 I should be hydrogen 2-one-II 4 * group, 1 × methyl-4 fluoro I p- 6-amino- 8-propaneline url gas 0 6. Carboxylic acid 76-carboxylic acid I-line FI 0 The size of the paper is applicable to the Chinese national standard (CNS "Sigh (2 丨 0 > 29 * 7mm) 491848 A7 B7 V. Description of the invention (~) 7- (8-amino-2-^-6 -Acridinebicyclo [3.3.0] octyl-6-yl) -bucyclopropyl-6-fluoro-1,4-dihydro-5-Cycyl-8-methyl-4-air Acid 1- (3-amino-4,6-difluorophenyl) -7- (8-amino-2- 丨 §-6-azinebicyclo [3.3.0] oct-6-yl) -8- Argon-6-fluoro-1,4-dihydro-4-gas I quinol-3-carboxylic acid 5-amino-1- (3-amino-4,6-difluorophenyl) -7- ( 8 • Amino-2- (|-6_ azinebicyclo [3.3.0] oct-6-yl) -6-fluoro-1,4-dihydro-4-gas-1,8-hexadin-3-carboxyl Acid 7- (9-amino-4,4-difluoro-2-if-7-acylbicyclo [4 · 3 · 0] non-7-yl) -1-cyclopropyl-6-fluoro-1, 4-dihydro-8-methylamino-4-oxo If leaching 3- 3-carboxylic acid 7- (8-aminomethyl-2-1, etc.-6-azinebicyclo [3.3.0] oct-6-yl) -1-Cyclopropyl-6-fluoro-1,4-digas-8-methylamino-4-oxo If 3--3-carboxylic acid 5-amino-7- (8-amino-2-IIII -6-Acridine bicyclo [3 · 3 · 0] oct-6-yl) -1-ring Methyl-6-fluoro-1,4-dihydro-8-methyl-4-ketoline-3-carboxylic acid bucyclopropyl-6-fluoro-1,4-dihydro-8-methyl-7 -(8-Methylamino-2-Ming-6-azinebicyclo [3.3.0] octane-6-yl) -4-gas β-line-3-carboxylic acid 5-amino-1-cyclopropyl-6 -Ga-1,4-dihydro-8-methyl-7- (8-methylamino-2- 丨 etc.-6-B yambicyclo [3.3.0] oct-6-yl) -4 -oxo Lin-3-carboxylic acid 5-amino-1- (4,6-difluoro-3-methylaminephenyl) -6-fluoro-1,4-dihydro-7- (8-methylamino-2 -Ming-6-azinebicyclo [3.3.0] octyl-6-yl) -4-aziridin-3-carboxylic acid 1-cyclopropylethylamino-6-fluoro-1,4-dihydro-7 -(8-Acrolimyl- 2-Ming-6-acylbicyclo [3 · 3 · 0] oct-6-yl) -4-qi 丨 quinoline-3-carboxylic acid-12- This paper is applicable to China Standard (CNS) A4 specification (210X 297 mm) Please read the notes of the back first
t 經濟部中央標準局員工消費合作社印製 491848 A7 B7 五、發明説明(〇 ) 5-胺基-1-環丙基-8-乙氣基-6-氟-1,4-二氫- 7- (8 -甲 胺基-2-1§ - 6-(丫雙環〔3.3.0〕辛-6-基)-4 -氣 I® 咐- 3-羧酸 1-環丙基-6-氟- 8- (2-氟乙氣基)-1,4 -二氣-7-(8 -甲 胺基-2H-6-吖雙環〔3.3.0〕辛-6-基)-4-氣丨奎啉-3-羧酸 5-胺基-1-環丙基-6-氟- 8-(2-氟乙氣基)-1,4-二氫- 7-(8-甲胺基- 2-1琴-6-吖雙環〔3.3.0〕辛-6-基)-4-氣睹 啉-3-羧酸 本發明之二環胺化合物(II)中宜為對應上述吡啶酮羧 酸衍生物之7位取代基之化合物。 本發明化合物(I)可例如由胺基化反應或閉環反應來 製造。以下就代表性製法之胺基化反應說明。 本發明化合物(I),其酯及鹽可由如下(III)化合物, 其酯或鹽 X 0t Printed by the Employees' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 491848 A7 B7 V. Description of the Invention (〇) 5-Amino-1-cyclopropyl-8-ethoxy-6-fluoro-1,4-dihydro-7 -(8 -Methylamino-2-1§-6- (Yabicyclo [3.3.0] oct-6-yl) -4 -GaI®-3-carboxylic acid 1-cyclopropyl-6-fluoro -8- (2-fluoroethoxy) -1,4 -digas-7- (8-methylamino-2H-6-azinebicyclo [3.3.0] oct-6-yl) -4-gas 丨Quinoline-3-carboxylic acid 5-amino-1-cyclopropyl-6-fluoro-8- (2-fluoroethylamino) -1,4-dihydro-7- (8-methylamino-2 -1qin-6-acylbicyclo [3.3.0] oct-6-yl) -4-ketoline-3-carboxylic acid The bicyclic amine compound (II) of the present invention is preferably derived from the corresponding pyridonecarboxylic acid A compound having a substituent at the 7-position of the compound. The compound (I) of the present invention can be produced, for example, by an amination reaction or a ring-closing reaction. The following describes a typical amination reaction. The compound (I) of the present invention, its ester and The salt may be a compound of the following (III), its ester or salt X 0
JL XOOH (請先閲讀背面之注意事填寫本頁) -裝· 訂JL XOOH (Please read the notes on the back and fill in this page)
經濟部中央標準局員工消費合作社印製Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs
X 前 * 同鍵 A 合應 及螯反 Y 硼物 成合 形化 R,間胺 ,之環 基基二 離些 η 為這(I L 在式 中可下 式基如 氧與 及 基 羧 之 中 式 上 尺 張 -紙 本 CN /V 準 標 家 國 j國 一中 用 一適 491848 A7 B7X before * with the bond A and chelation Y boron compound to form R, m-amine, the ring group of the two groups η is this (IL in the formula can be represented by the formula such as oxygen and carboxyl in the formula above Ruler-paper CN / V quasi-standard home country j country one middle school use one suitable 491848 A7 B7
五、發明説明( II) 式中R 1 若在生成物中有硼螯合部之存在時,將此水解即可製造。 式(III)中離基L,可為鹵素,低烷氣基,低烷硫基, 低烷磺醛基,低烷亞磺醯基,低烷磺醱氣基,芳磺醯氣 基等,其中宜如F, C1等鹵素。 化合物(II)與(III)之反應一般宜在惰性溶劑,約10 〜180%,宜約20〜130°C,攪拌約10分〜7日,宜約30分 〜3日來進行。所用惰性溶劑可為如水,甲醇,乙醇, 乙腈,氣仿,吡啶,Ν,Ν-二甲基甲醯胺,二甲亞硪,1-甲基-2端略丨淀酮等。這些溶劑可單獨或混合使用。 本反應可在酸受體之存在下,將化合物(II)對化合物 (III) 一般用當量或稍過量,但亦可用過量化合物(II) 兼當酸受體,酸受體可為如1,8-二吖雙環〔5·4·0〕-7-十一磺烯(DBU),三乙胺,吡啶,Κ啉,甲基吡啶等有 機齡,或如NaOH, Κ0Η,碩酸鉀,硪酸鈉,磺酸氫鈉, 碩酸氫鉀等無機齡。這些酸受體通常可對化合物(II)用 約1〜3倍莫耳。 化合物(III)為已知,或仿已知方法製造。二環胺化 -14- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 請 先 閲 讀 背 面 之 注 意 事 項 再 t 經濟部中央標準局員工消費合作社印製 491848 A7 _____JB7_ 五、發明説明(Η ) 合物(Π)均為新穎,瘇些製法如後述。 可由前逑胺基化反應製造之本發明化合物(I)中,若 有胺基保護基存在時及/或本發明化合物(1)以酯形獲 得時,這些胺基保護基及/或酯可随所望而脱離或轉換 ,結果得自由態時,應其霈要而轉換成鹽,或若得鹽時 可轉換成自由態。酯至自由態之轉換可由水解來實行。 胺基保護基之脱離可隨保護基之種類而水解或氫解來施 行,藉此導至該胺基保護基轉換成Η之本發明化合物(1> 。玆說明水解及氫解反應如下。 水解反應可由本發明化合物(I)之酯及/或具有易水 解性胺基保護基之本發明化合物(I)與水在適當溶劑中 接觸來實施。本反應為促進反應,通常在酸或齡之存在 下進行。可用之酸如馥酸,氫溴酸,硫酸,磷酸等無機 酸,如乙酸,三氟乙酸,甲酸,對甲苯磺酸等有機酸。 鹼可為如HaOH,氫氣化鋇等金颶氫氣化物;如硪酸納 ,碩酸鉀等碩酸鹽;乙酸鈉等。 經濟部中央標準局員工消費合作社印製 溶劑通常可用水。然依前逑化合物之性質可與乙醇, 乙二醇二甲醚,二哼烷等水混溶性有機溶劑與水一起使 用〇反應溫度一般為約0〜150eC,宜約30〜10ITC。 本反應在如前述酸之存在下將前述化合物直接加熱後 ,加水來實施。 由氫解之胺基保護基之脫離反應可在溶劑中有觸媒之 存在下有易氫解性胺基保護基之本發明化合物(I)以氫 處理即可實施。可用於本反應之觸媒為鉑,阮來錁等氫 -15-本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 491848 Α7 Β7 經濟部中央標準局員工消費合作社印製 五、發明説明(a ) 解觸媒。溶劑可用乙二醇,二丨等烷,Ν,Ν -二甲基甲醯胺 ,乙醇,乙酸,水等。本反應可在約60 eC以下。一般在 室溫實施。 若易氫解性胺基保護基為苄基,三苯甲基,苄氣羰基 ,對甲苯磺醯基等時,這種保護基可在液氨中約-50〜 -2 (TC以金屬鈉處理亦可脱離。 由前逑胺基化反應製造之本發明化合物(I)可依常法 單離精製。這些化合物依單離精製之條件而以鹽,自由 態或水合物之形獲得,但這些可依目的而互相轉換,可 導i所求形態之本發明化合物。 本發明化合物(I)之立體異構物可依常法,如分步結 晶,層析法等來分離,光學活性體可用習知之光學分割 法來單離。 所得本發明化合物(I)及其盥均為新穎化合物,具有 優異之抗菌活性,可當作抗菌劑。本發明化合物(1)及 其鹽可當作人及人以外之動物用蕖,或可當作農藥,食 品等之保存劑等。 本發明化合物(I)之酯可為本發明化合物(1)之合成原 料,若酷本身在活體易轉變成本發明化合物(I)時 亦 可當作前藥,與本發明化合物(I) 一樣可當作抗菌劑。 在前逑胺基化反應中當作原料之化合物(11)可例如令 如下式(IV)化合物之胺基保護基Rl〇脱離而轉換成Η來 製造: 一 1 6 - (請先閲讀背面之注意事項再填寫本頁) -裝· 、1Τ5. Description of the invention (II) In the formula, if R 1 has a boron chelating moiety in the product, this hydrolysis can be used for production. The ionic group L in formula (III) may be halogen, lower alkylthio, lower alkylthio, lower alkylsulfonyl, lower alkylsulfinyl, lower alkylsulfonyl, aromatic sulfonyl, etc. Among them, halogens such as F and C1 are preferred. The reaction of the compounds (II) and (III) is generally carried out in an inert solvent, about 10 to 180%, preferably about 20 to 130 ° C, and stirred for about 10 minutes to 7 days, preferably about 30 minutes to 3 days. The inert solvent used may be, for example, water, methanol, ethanol, acetonitrile, aeroform, pyridine, N, N-dimethylformamide, dimethyl sulfene, 1-methyl-2 terminal ketone, and the like. These solvents can be used alone or in combination. In the present reaction, the compound (II) is generally used in an equivalent amount or a slight excess to the compound (III) in the presence of an acid acceptor, but an excess of the compound (II) can also be used as an acid acceptor. The acid acceptor may be 1, 8-Diacylbicyclo [5 · 4 · 0] -7-undecene (DBU), triethylamine, pyridine, Kline, methylpyridine and other organic ages, or such as NaOH, K0Η, potassium sulphate, 硪Inorganic age such as sodium, sodium hydrogen sulfonate, potassium hydrogen sulphate. These acid acceptors are usually used at about 1 to 3 times moles for compound (II). The compound (III) is known, or can be produced following a known method. Bicyclic amination-14- This paper size is applicable to Chinese National Standard (CNS) A4 (210X 297 mm) Please read the notes on the back before t Printed by the Employees' Cooperative of the Central Standards Bureau of the Ministry of Economy 491848 A7 _____JB7_ V. Invention It is explained that (ii) compound (Π) is novel, and some preparation methods are described later. In the compound (I) of the present invention which can be produced by the amidation reaction of a precursor, if an amine protecting group is present and / or the compound (1) of the present invention is obtained in the form of an ester, these amine protecting groups and / or esters may be Detach or switch as you want, and when you get a free state, you can convert it to salt if you want it, or you can switch to a free state if you get salt. The conversion of the ester to the free state can be effected by hydrolysis. The detachment of the amine-protecting group can be carried out by hydrolysis or hydrogenolysis according to the type of the protective group, thereby leading to the conversion of the amine-protecting group into a compound of the present invention (1). The hydrolysis and hydrogenolysis reactions are described below. The hydrolysis reaction can be carried out by contacting the ester of the compound (I) of the present invention and / or the compound (I) of the present invention having an easily hydrolyzable amine protecting group with water in a suitable solvent. This reaction is to promote the reaction, and is usually carried out at an acid or age. It is carried out in the presence of. Available acids such as osmic acid, hydrobromic acid, sulfuric acid, phosphoric acid and other inorganic acids, such as acetic acid, trifluoroacetic acid, formic acid, p-toluenesulfonic acid and other organic acids. The base may be, for example, HaOH, barium hydrogen etc. Golden hurricane hydrochloride; such as sodium gallate, potassium ferrate, etc .; sodium acetate, etc. The solvent printed by the Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs can usually use water. However, the properties of the former compounds can be used with ethanol, ethylene Water-miscible organic solvents such as dimethyl ether and dihenane are used together with water. The reaction temperature is generally about 0 ~ 150eC, preferably about 30 ~ 10ITC. In this reaction, the aforementioned compound is directly heated in the presence of the aforementioned acid, Add water to fruit The dissociation reaction of the hydrogenolytic amine protecting group can be carried out by hydrogenating the compound (I) of the present invention which has an easily hydrogenolytic amine protecting group in the presence of a catalyst in a solvent. It can be used in this reaction The catalyst is platinum, Ruan Laihuan and other hydrogen. 15- This paper size is applicable to the Chinese National Standard (CNS) A4 specification (210X297 mm) 491848 Α7 Β7 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 5. Description of the invention (a) Solvent catalyst. Ethylene glycol, dioxane, N, N-dimethylformamide, ethanol, acetic acid, water, etc. can be used as the solvent. The reaction can be below about 60 eC. It is generally carried out at room temperature. When the hydrogenolytic amino protecting group is benzyl, trityl, benzyl carbonyl, p-toluenesulfonyl, etc., this protecting group can be about -50 ~ -2 in liquid ammonia (TC treated with metal sodium also It can be detached. The compound (I) of the present invention produced by the amidation reaction can be isolated and purified according to a conventional method. These compounds are obtained in the form of a salt, a free state or a hydrate according to the conditions of the isolation and purification, but these The compounds of the present invention can be converted to each other according to the purpose, and can lead to the desired form of the compound. The stereoisomers of compound (I) can be separated by conventional methods, such as stepwise crystallization, chromatography, etc., and the optically active species can be isolated by conventional optical segmentation methods. The obtained compound (I) of the present invention and its homogenate It is a novel compound with excellent antibacterial activity and can be used as an antibacterial agent. The compound (1) and its salt of the present invention can be used as a mandarin for animals other than humans, or can be used as a preservation agent for pesticides, foods, and the like. The ester of the compound (I) of the present invention can be a synthetic raw material of the compound (1) of the present invention. If the compound itself is easily converted into the compound of the present invention (I) in vivo, it can also be used as a prodrug, as well as the compound of the present invention (I). It is used as an antibacterial agent. The compound (11), which is used as a raw material in the amidation reaction of the precursor, can be produced by converting the amine protecting group R10 of the compound of the following formula (IV) into hydrazone, for example:-1 6- (Please read the precautions on the back before filling out this page)-Install · 1T
JI. 本紙#ΧΛ 4用家鏢牟(CNS ) Α4規格(210X297公釐) 491848 A7 B7 五、發明説明(JI. 本 纸 # ΧΛ 4 User darts (CNS) Α4 specifications (210X297 mm) 491848 A7 B7 V. Description of the invention (
R N-(CH2)mR N- (CH2) m
(請先閱讀背面之注意事項再填寫本頁) (IV) 式中Rio為胺基保護基,Ri〜R9 , »,η及p同前。 胺基保護基Rid可為如前述易氫解性胺基保護基或易 水解性胺基保護基。 化合物(IV)中1^及/或112為胺基保護基時,Rid之 胺基保護基Rii/或R2之胺基保護基雖可採用不同性 質者,但宜選擇適合其後反應者,例如若R1及/或R2 之胺基保護基為如第三丁氧羰基等易水解性胺基保護基 時,R1〇宜選擇如苄基,三苯甲基等易氫解性胺基保護 基。 胺基保護基1110之脱離反應可將化合物(IV)由如前逑 氫解或水解反應來實施。 經濟部中央標準局員工消費合作社印製 本脱離反應所得化合物中Ri及/或R2為胺基保護基 時,視所望而同樣脱離,轉變成H,結果若得自由態時, 視需要而依常法轉換成鹽,若得鹽時可轉變成自由態。 所得本發明化合物(II)之立體異構物可依常法,例如 分步結晶,層析法等來分離。光學活性體可用習知之光 學分割法來單離。 化合物(IV)亦新穎者,可依如下反應流程1〜9之方法 或仿此方法來製造。 -17-本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 491848 A7 B7 五、發明説明(4 ) 反窸流程(Please read the notes on the back before filling this page) (IV) In the formula, Rio is an amine protecting group, Ri ~ R9, », η and p are the same as above. The amine-protecting group Rid may be the easily-hydrolyzable amine-protecting group or the easily-hydrolyzable amine-protecting group as described above. When 1 ^ and / or 112 in the compound (IV) is an amine-protecting group, although the amino-protecting group of Rid and / or the amine-protecting group of R2 can adopt different properties, it is preferable to select one suitable for the subsequent reaction, for example If the amine-protecting group of R1 and / or R2 is an easily hydrolyzable amine-protecting group such as a third butoxycarbonyl group, R10 should preferably select an easily-hydrolyzable amine-protecting group such as benzyl, trityl and the like. The deprotection reaction of the amine protecting group 1110 can be carried out by subjecting the compound (IV) to a hydrogenolysis or hydrolysis reaction as described above. When Ri and / or R2 in the compound obtained from the disengagement reaction printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs is an amine-protecting group, it is also separated as desired and converted to H. If the result is a free state, it may be as needed. It is converted into salt according to the usual method, and if it is obtained, it can be converted into a free state. The obtained stereoisomers of the compound (II) of the present invention can be separated by ordinary methods, such as fractional crystallization, chromatography and the like. The optically active substance can be isolated by the conventional optical division method. The compound (IV) is also novel and can be produced according to the following reaction schemes 1 to 9 or by following this method. -17- This paper size applies to Chinese National Standard (CNS) A4 specification (210X297 mm) 491848 A7 B7 V. Description of the invention (4) Reverse process
(CH2)q-OR12 Ο T n-ri〇 (CH2)q.〇H 3 、(CH2) q-OR12 〇 T n-ri〇 (CH2) q.〇H 3,
HO, :N~R1。 (CH2)q-OH 6HO,: N ~ R1. (CH2) q-OH 6
(請先閲讀背面之注意事項再填寫本頁) 裝·(Please read the notes on the back before filling this page)
、1T HOm 經濟部中央標準局員工消費合作社印製 91T HOm Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 9
P N-R10 (CH2)q R/HN 反應流程2 PN3、、 ^-Ri (CH2)q 10 Rif N/P N-R10 (CH2) q R / HN Reaction Scheme 2 PN3, ^ -Ri (CH2) q 10 Rif N /
H2NH2N
N-Ri 11 (CH2)q 斤1。 (CH2)q (CH2)q 12 13 -18- 本紙張尺度適用中國國家標準(c、、: Α4_螓(210X297公釐) 491848N-Ri 11 (CH2) q kg 1. (CH2) q (CH2) q 12 13 -18- This paper size applies to Chinese national standards (c, :: Α4_ 螓 (210X297 mm) 491848
L A7 B7 五、發明説明(V7 ) 反應流程3 經濟部中央標準局員工消費合作社印製L A7 B7 V. Description of Invention (V7) Reaction Process 3 Printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs
(請先閱讀背面之注意事項再填寫本頁) 裝_ 訂 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 491848 A7 B7 五、發明説明(β ) 反慝流程6(Please read the precautions on the back before filling this page) Binding _ Order This paper size applies to Chinese National Standard (CNS) A4 (210X297 mm) 491848 A7 B7 V. Description of Invention (β) Reverse Process 6
反*流程7 (請先閲讀背面之注意事項再填寫本頁)Anti * Process 7 (Please read the notes on the back before filling this page)
反應流程8 經濟部中央標準局員工消費合作社印製Reaction Process 8 Printed by the Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs
HO R3·— 1 N-R, (CH2)q 35HO R3 · — 1 N-R, (CH2) q 35
33 R^HN R3^ N-R10 (CH2)q 36 .20·33 R ^ HN R3 ^ N-R10 (CH2) q 36 .20 ·
本紙張尺度適用中國國家標準(CNS ) A4規格(21〇X:N,v f 491848This paper size applies to China National Standard (CNS) A4 (21〇X: N, v f 491848
AT 一 B7 、發明説明(V?) 經濟部中央標準局員工消費合作社印製 反應流程9AT-1 B7, Invention Description (V?) Printed by the Consumers' Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs Response Process 9
-21- (請先閲讀背面之注意事項再填寫本頁) 1ΛΙ I . _裝· 訂 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 491848 經濟部中央標準局員工消費合作社印製 A7 ___^___B7__五、發明説明(w ) 式中Rio同前, R11為如第Η 丁基二甲基矽烷基,乙醯基,四氫吡喃 基等酵保護基, Rl2為低烷磺醯基,鹵低烷磺醛基,或芳磺酵基, 尺13為Η或低院基, R 1 ’為胺基保護基, R 2,及H 3,各為低烷基, Χι,及χ3各為齒素· q為1〜3之整數, r為0或1。 上述流程1〜9簡單說明如下。 〔反應流程1〕 將已知化合物1或2予以臭氣氣化後,還原而得化合 物3(q =1或2)。化合物3 (q=3)可將化合物1予以硼 氫化反應而得。化合物3之末端醇部分經磺醛化而生成 化合物4後,脫離醇保護基RlJL而成化合物5,閉環而得 化合物7。另将化合物3之醇保護基Ru脱離生成化合物 6,將此在鹼之存在下與磺酵化試藥反應,亦可得化合 物7。化合物7之羥基經化合物8而反轉,得化合物9。 〔反應流程2〕 如上所得化合物9之羥基予以磺醛化後,以叠氮基取 代成化合物10後,還原而得化合物11。將化合物11之胺 基保護而得包括在化合物(IV)之目的物12。將此化合物 12烷化,或將胺基保護基Ri ’還原成低烷基1{2 導入 -22- (請先閱讀背面之注意事項再填寫本頁) +1 -裝--21- (Please read the notes on the back before filling in this page) 1ΛΙ I. _Binds and bounds are in accordance with the Chinese National Standard (CNS) A4 size (210X297 mm) 491848 Printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs Preparation of A7 ___ ^ ___ B7__ 5. Description of the invention (w) In the formula, Rio is the same as above, R11 is a fermenting protective group such as thallium butyldimethylsilyl, acetamyl, tetrahydropyranyl, and Rl2 is a low alkane Sulfofluorenyl, haloalkanesulfonyl, or aromatic sulfonyl, stilbene is fluorene or low alkyl, R 1 ′ is amine protecting group, R 2, and H 3 are each low alkyl, And χ3 are each a tooth element. Q is an integer of 1 to 3, and r is 0 or 1. The above processes 1 to 9 are briefly explained as follows. [Reaction scheme 1] The known compound 1 or 2 is odorized and then reduced to obtain compound 3 (q = 1 or 2). Compound 3 (q = 3) can be obtained by subjecting Compound 1 to a borohydride reaction. The terminal alcohol portion of compound 3 is sulfonated to form compound 4, and then compound 5 is removed from the alcohol protecting group R1JL, and the ring is closed to obtain compound 7. In addition, the alcohol-protecting group Ru of compound 3 is removed to form compound 6, and this is reacted with a sulfonation reagent in the presence of a base to obtain compound 7. The hydroxyl group of compound 7 is inverted by compound 8 to obtain compound 9. [Reaction scheme 2] After the hydroxy group of the compound 9 obtained above is sulfonated, the compound 10 is substituted with an azide group, and then reduced to obtain the compound 11. The amine group of the compound 11 is protected to obtain the object 12 included in the compound (IV). This compound 12 is alkylated, or the amine protecting group Ri ′ is reduced to lower alkyl 1 {2 Introduction -22- (Please read the precautions on the back before filling this page) +1 -pack-
、1T 本紙張尺度適用中國國家標準(CNS ) Α4規格(210Χ297公釐) 491848 經濟部中央標準局員工消費合作社印製 A7 B7__五、發明説明(Η ) 胺基保護基Ri ’,得包括在化合物(IV)之目的物13。 〔反應流程3〕 完全仿反應流程2,從化合物7得包括在化合物(IV) 之目的物16及17。 〔反醮流程4〕 將化合物18之醇保護基RU脱離而生成化合物19,將 此以鹵化試劑處理,得化合物2(U化合物20之脱鹵化而 得化合物21。將化合物21之羥基經化合物22而反轉,得 化合物2 3。 〔反應流程5〕 完全仿反應流程2,從化合物2 3得包括在化合物(IV) 之目的物26。 〔反應流程6〕 完全仿反應流程2,從化合物21得包括在化合物(IV) 之目的物29。 〔反應—流程7〕 所反應流程1所得化合物7之羥基予以磺醛化後,以 β氮基取代成化合物30,還原而得化合物31。將此化合 物31之胺基保護,得包括在化合物(IV)之目的物32。 〔反應流程8〕 所反應流程1所得化合物7氣化成化合物3 3後,與低 烷基金屬試劑反應,得化合物34。將此還原,得化合物 3 5後,經立達反應,得包括在化合物(IV)之目的物36。 -23- (請先閱讀背面之注意事項再填寫本頁) 4! •裝· 、1Τ 本紙#〈吸4颸中《«家標準(CNS ) Α4規格(210Χ297公釐) 491848 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(》) 〔反應流程9〕 將反應流程1所得化合物3(q=2)脱水而得化合物37 ,將此經氣化反應及鹵化而得化合物38卜=〇)〇化合物 38(r=l)乃由化合物1之氣化反應及鹵化而得。得化合 物38之醇保護基Ru脱離成化合物39後,閉環而得化合物 40。將此予以鹵化而得化合物41。其後完全仿反應流程 2,從化合物41得包括在化合物(IV)之目的物44β 以上各反應在後述實施例Α〜Μ具體說明之❶ 次將本發明化合物(I)在試管内之抗菌活性及在活體 内之效果由下列數據說明。 表 1 乃示仿 Cheaotherapy 29(1),76(1981)拥| 定之最 低生長抑制濃度(MIC: #g/),表2乃示對小白鼠全身 越染症之效果(ED50, ing/kg)。對小白鼠全身感染症之 效果(EDso, ng/kg)乃對Stb-ddy条雄小白鼠(體重約20 克)每隻靜脈注射5X 108嫡金色葡萄球® (S.aureus) 50 7 7 4株(活菌)來威染,將供試化合物溶在當量NaOH溶 液後以生理食鹽水稀釋者口服(感染即後及6小時後之2 次),感染14日後,從小白鼠之存活率依Probit法算出。 對照化合物乃用以優異抗薗劑市售之enoxacin〔 1-乙 基-6-氟-1,4-二氫-1-氣- 7- (卜哌阱基)-1,8-暸啶-3-羧 酸,簡稱EHX〕。 表1及表1中供試化合物乃以後述實施例之编號來特 定。 -24- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) (請先閲讀背面之注意事項再填寫本頁) 裝· 訂 491848 B7 五、發明説明{ Η ) 經濟部中央標準局員工消費合作社印製 表1 試管肉杭舖活袢(Μ T f: : M g / μ 11 菌 株 實施例 金色葡 萄球菌 大腸菌 緣膜桿菌 50774 MS16405 N1HJ JC-2 No 12 1 S 0.003 0.39 0.013 0.39 2 0.006 0.39 0.013 0.39 3 0.013 1.56 0.006 0.2 4 0.006 0. 39 0.025 0.78 5 S 0.003 0.39 0.025 0.78 6 0.025 1.56 0. 025 1.56 7 0.006 0.39 0.025 0.39 8 0.013 3· 13 0.2 1.56 9 0. 025 1.56 0.05 1.56 10 0.013 0.39 0· 1 3· 13 11 0.013 — 0.025 0.39 12 0.013 0.39 0· 1 1.56 13 0.013 1.56 0.05 0.78 14 0.025 1.56 0.025 1.56 15 0.025 0.78 0.013 0.78 16 0.006 1.56 0· 1 1.56 17 0.05 一 0. 1 0.78 18 0.025 1.56 0.006 0.39 ENX 0.39 100 0.05 0.78 -25- (請先閱讀背面之注意事項再填寫本頁) 本紙張尺度適用中國W$:蠓瘳(、\S ) Α4况格(210X297公釐) 491848、 1T This paper size applies the Chinese National Standard (CNS) A4 specification (210 × 297 mm) 491848 A7 B7 printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs. 5. Description of the invention (Η) The amine-based protective group Ri 'must be included in Object 13 of Compound (IV). [Reaction scheme 3] The reaction scheme 2 is completely imitated, and the target compounds 16 and 17 included in the compound (IV) can be obtained from compound 7. [Reaction Scheme 4] The alcohol protecting group RU of compound 18 is removed to form compound 19, and this is treated with a halogenating agent to obtain compound 2 (U. Compound 20 is dehalogenated to obtain compound 21. The hydroxyl group of compound 21 is passed through the compound 22 and reverse to obtain compound 23. [Reaction scheme 5] Completely mimic reaction scheme 2, and obtain the target 26 included in compound (IV) from compound 23. [Reaction scheme 6] Completely mimic reaction scheme 2, from compound 21 can include the target compound 29 in compound (IV). [Reaction-Scheme 7] After the hydroxyl group of compound 7 obtained in the reaction scheme 1 is sulfonated, it is replaced with β nitrogen group to compound 30 and reduced to obtain compound 31. The amine group of the compound 31 is protected to obtain the target 32 of the compound (IV). [Reaction scheme 8] The compound 7 obtained in the reaction scheme 1 is gasified to a compound 33, and then reacted with a low alkyl metal reagent to obtain a compound 34 This reduction yields compound 35. After Rieter reaction, the target 36 of compound (IV) is included. -23- (Please read the precautions on the back before filling this page) 4! 1Τ 本 纸 # 〈Aspiring 4 飔 中 《« Standard (CNS) A4 specification (210 × 297 mm) 491848 A7 B7 printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 5. Description of the invention ("Reaction Scheme 9") Compound 3 (q = 2) obtained in Reaction Scheme 1 is dehydrated and Compound 37 is obtained, and compound 38 (r = 1) is obtained by gasification reaction and halogenation. Compound 38 (r = 1) is obtained by gasification reaction and halogenation of compound 1. After the alcohol-protecting group Ru of compound 38 is released to form compound 39, the ring is closed to obtain compound 40. This was halogenated to obtain compound 41. Thereafter, the reaction scheme 2 is completely imitated, and the objective 44β included in the compound (IV) is obtained from the compound 41. Each of the above reactions is specifically described in Examples A to M described later. The antibacterial activity of the compound (I) of the present invention in a test tube And the effect in vivo is explained by the following data. Table 1 shows the minimum growth inhibitory concentration (MIC: # g /) which is similar to Cheaotherapy 29 (1), 76 (1981). Table 2 shows the effect on mice's systemic overdose disease (ED50, ing / kg). . The effect on systemic infections in mice (EDso, ng / kg) is 5 x 108 嫡 Golden Grape® (S. aureus) 50 7 7 4 for each Stb-ddy male mouse (approximately 20 g). Strains (live bacteria) were used to stain, and the test compound was dissolved in an equivalent NaOH solution and diluted with physiological saline (orally 2 times after infection and 6 hours later). After 14 days of infection, the survival rate of mice was determined according to Probit Method to calculate. The control compound is commercially available enoxacin [1-ethyl-6-fluoro-1,4-dihydro-1-gas- 7- (bupiperinyl) -1,8-pyridine- 3-carboxylic acid, referred to as EHX]. The test compounds in Tables 1 and 1 are specified by the numbers of the examples described later. -24- This paper size applies to Chinese National Standard (CNS) A4 (210X297 mm) (Please read the notes on the back before filling out this page) Binding and binding 491848 B7 V. Description of the invention {Η) Central Bureau of Standards, Ministry of Economic Affairs Printed by Employee Consumption Cooperatives Table 1 Test tube meat hangpu (袢 T f:: M g / μ 11 Strain example S. aureus E. coli 50774 MS16405 N1HJ JC-2 No 12 1 S 0.003 0.39 0.013 0.39 2 0.006 0.39 0.013 0.39 3 0.013 1.56 0.006 0.2 4 0.006 0. 39 0.025 0.78 5 S 0.003 0.39 0.025 0.78 6 0.025 1.56 0. 025 1.56 7 0.006 0.39 0.025 0.39 8 0.013 3. 13 0.2 1.56 9 0. 025 1.56 0.05 1.56 10 0.013 0.39 0 · 1 3 · 13 11 0.013 — 0.025 0.39 12 0.013 0.39 0 · 1 1.56 13 0.013 1.56 0.05 0.78 14 0.025 1.56 0.025 1.56 15 0.025 0.78 0.013 0.78 16 0.006 1.56 0 · 1 1.56 17 0.05-0.1 0.78 18 0.025 1.56 0.006 0.39 ENX 0.39 100 0.05 0.78 -25- (Please read the notes on the back before filling this page) This paper size is applicable to China W $: 蠓 瘳 (, \ S) Α4 condition grid (210X297 mm) 491848
-Τ 7 A B 經濟部中央標準局員工消費合作社印製 五、發明説明(4) 表1 (續) 菌 株 賁施例 金色葡 萄球薗 大腸薗 綠膿桿_ 50774 MS16405 NIHJ JC-2 * No 12 19 0.013 0.78 0· 1 1.56 20 0. 1 3. 13 0.05 1·56 21 S 0.003 0.78 0.013 0.39 22 0.05 一 € 0.003 0.39 23 $0.003 0.78 0.025 0.78 24 0.013 1.56 0.025 0.78 25 0. 025 1.56 0.025 1.56 26 0.05 — 0.013 0.39 27 0.025 1.56 0.025 1.56 28 0.025 0.78 0.025 1.56 29 0.025 — 0.025 0.39 30 0.013 3. 13 0.05 0.78 31 0.013 0.78 0. 1 0.78 32 0.013 0.78 0· 1 1.56 33 0.025 1.56 0.05 3. 13 34 0.05 6.25 0.05 1.56 35 0.025 6.25 0· 1 3. 13 36 0.013 0.78 0.2 3. 13 ENX 0.39 100 «.05 0.78 —26 — 丨·--S---ί--mjp·裝-- (請先閱讀背面之注意事項再填寫本頁) 、1Τ J---Ί · 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 491848 fB7 經濟部中央標準局員工消費合作社印製 五、發明説明1义) 表1 (續) 菌 株 實施例 金色葡 萄球菌 大腸菌 綠膿桿菌 50774 MS16405 NIHJ JC-2 * No 12 37 0.05 6. 25 0. 1 3. 13 38 0· 1 一 0. 05 3. 13 39 0.025 3. 13 0.2 0.78 40 0.025 1.56 0.1 3. 13 47 0.013 0.39 0.05 0.78 48 0.013 1.56 0. 05 0.39 49 0.05 1.56 0. 1 3. 13 50 S 0.003 0.39 0.025 0.2 51 ^0.003 0.78 0.025 0· 1 52 0.013 1.56 0.025 1.56 53 0.013 1.56 S 0.003 1.56 54 0.013 0.78 0.025 1.56 55 0.013 1.56 0.05 0.39 57 0.006 0.39 ‘0.003 0.2 ΕΝΧ 0.39 100 0.05 0.78 -27- (請先閱讀背面之注意事項再填寫本頁) _Γ· 裝· 訂 本紙張尺度適用中國國家標準(CNS ) A4<1爲 ;:--) 491848 A7 B7 經濟部中央標準局員工消費合作社印製 五、發明説明(4 ) 表2對小白鼠伞身慼染痛之故果(EDm ng/kRi 實施例 菌 株 金色«萄球_ 50774 1 0.36 2 0.383 3 0.398 4 0.246 5 0.257 6 0.292 7 0. 331 8 0.345 9 0.415 10 0.465 11 0.579 12 0.715 實施例 金色16萄球闌 50774 η 0. 778 14 ^0.78 15 1. 12 16 0.78 17 0.78 18 0. 928 19 0. 928 47 0.478 52 0.503 53 0.576 57 1.43 ΕΝΧ 9.89 -28- —ϋ^ιϋ —ϋ Μϋ II 厘·* m 11 n (請先閲讀背面之注意事項再填寫本頁) 訂 --Γ- 本紙張尺度適用中國國家*♦ (Ά八4忧格(210X297公釐) 491848 經濟部中央標準局員工消費合作社印製 A7 __ B7 ______五、發明説明(W ) 如表1及表2所示,本發明化合物(I)之在試管内之 抗菌活性及在活體内之效果優異。尤其本發明化合物(1) 之對革蘭陽性菌之抗菌活性遠比ΕΝ X為強。 本發明化合物(I),其酯或生理容許鹽作為抗菌劑可 適用於人及動物之細菌疾病之處置。 本發明化合物(I)當作抗菌用於人時,其投予量雖視 年齡,體重,症狀,投予途徑等而異,但一般每日5ng 〜4克,作一次或分數次投予。投予途徑雖經口,非 經口或局部投予均可,惟宜經口投予。本發明化合物U) 雖可以原體投予人等,但通常與藥學容許添加物一起調 製成製劑(藥學組成物)投予。這種製劑可為錠劑,液劑 ,膠囊,顆粒,細粒,散劑,糖漿,注射劑,坐劑,軟 膏,噴霧劑,點眼劑等。這些製劑可用通常之添加劑, 依常法製造。例如經口添加劑可為澱粉,甘露糖,結晶 纖維素,羧甲基纖維素鈣,水,乙醇等製劑領域常用, 且不與本發明化合物(I)反應之固龌或液體之載體或稀釋 劑。注射用添加劑可為水,生理食鹽水,葡萄糖液,输 液等注射劑領域上常用者。 上逑噴霧劑或軟蕾劑亦可用於耳#咽喉科或眼科之治 療及處置。 實施例 次舉實施例說明本發明,實施例A〜Μ為有蘭中間臞二 環胺化合物(II)之製法,實施例1〜60為有關本發明化 合物(I)之製法,實施例H為有開製劑者。 -29- 本紙張尺度適用中國國家標準(CNS ) Α4規格(210Χ297公釐) C請先閲讀背面之注意事項存填寫本貫) 螬 •装· 、1Τ 491848 A7 B7 五、發明説明(W ) 之 」乃示 經濟部中央標準局員工消費合作社印製 以下含在化合物名之「R#J, 其化合物之立體構造為相對者而并绝對者,又以下構造 式之立體構造亦為相對者而并絶對 實施例中簡寫如下: Boc :第三丁氣羰基 Me :甲基 2 , 4-F 2 Ph : 2 , 4-二氟苯基 3-NH2 -4,6-F2 Ph: 3 -胺基-4,6_ 二氟苯基 實施例A (-)-(lR* ,5S* ,8R* )-8-(第三 丁氣羰胺基卜 2-鸣一 6-吖雙環〔3.3.0〕辛(化合物 II: βι ^Boc; R2,R3,U4 ,R 8 , R 9 = H ;酿=0; n= 1 ; P=fl) 〔製程1〕 以D-酒石酸為原料,仿J.Org· CheiuU,lfl3_l()8 (1995)製造之(3R* ,4S* ,51^ )·卜苄基- 3,4_雙(第三 丁基二甲基矽烷氣基)-5-(2-羥乙基)-卜毗咯啶酮125.5 克中加60%乙酸水1200B1,回流一夜。減壓濃縮後,加 濃氨水3 0 0 * 1及甲醇500b1,在室溫攪拌一夜後,減壓濃 縮在矽膠柱層析(氯仿:甲醇=10: 1),得(3R* ,4S* ,5R* )-1-苄基-3,4-二羥基-5-(2-羥乙基卜2-吡咯啶酮 35克。 I R (neat) c irr 丨:3370, 1682 MS (m/z) : 252 (MH+ ) ^-NMRCCDCla)^:?. 10-7.32 (m, 5 H) . 5. 52 ( b r s, 2 H) , 4.90 (d, 1 H, J = 15.0Hz) , 4.50 (d, 1H,J 二7. 請 先 聞 之 注 事 馬 旁 本紙張尺度適用中國國家標準(CNS ) A4規格(:Μ * ΝΊ ) 491848 經濟部中央標準局員工消費合作社印製 A7 / _B7^j_五、發明説明(巧) 5Hz), 4.21 (b r t, 1 H, J =7. 5Hz ),3· 94 ( d, 1 H, J = 15. Ο Hz), 3.55 (b r s, 3H), 2· 20 -2.00 (br s, 1 H) , 1.86 (b r s, 2 H) 〔製程2〕 將製程1所得化合物35克加至吡啶4fl0al,冰冷而加 對甲苯磺醯氣26. 6克,攪拌一夜,加水及氯仿。分取有 機層,以10%鹽酸水洗淨,以無水硫酸鎂乾燥,減壓蒸 除溶劑,得油狀之(1R* ,5S* ,8S* )- &苄基-8-羥基-7- 氣吖雙環〔3.3.0〕辛烷24克。 IR(淨)ciT1 : 3390, 1692 MS (m/z) : 234 (MH+ ) ^-NMR (CDC 1 a ) (5 : 7.40-7.18 (m, 5 H) . 4. 84 ( d, 1 H, J = 15. OHz) , 4.49 (b r, 1 H) , 4.42 (d d, 1 H, J -6. 5, 1·7Ηζ) , 4.32 (br, 1 H) , 4· 16 - 4· 06 (m, 2 H),3. 92-3. 66 (m, 2 H) , 1.92-1.82 (m, 2 H) 〔製程3〕 (1) 將製程2所得之化合物14克加至二氛甲烷250111,冰 冷而加吡啶14.6ial,徐徐加三氟甲磺酐13.111。2小時 後,加二甲基甲醯胺5 5 0 ml及乙酸鉀58.9克,攪拌一夜 後,濾除不溶物,減壓濃縮,加水及氛仿,分取有機層 而減壓蒸除溶劑,得粗製之(1IT ,5S* ,8S* )-8 -乙醯 氣基-6-苄基-7-氣m-6-吖雙環〔3·3·0〕辛烷。 (2) 於此化合物加乙醇5G0ral及濃氨水20Qb1,在室溫攪 -31- £___?丨_^_ (請先M讀背面之注意事項再填· 裝-- :寫本頁)-T 7 AB Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 5. Description of the invention (4) Table 1 (continued) Strains 贲 Examples Golden staphylococcus 薗 large intestine 薗 green pus stalk _ 50774 MS16405 NIHJ JC-2 * No 12 19 0.013 0.78 0 · 1 1.56 20 0. 1 3. 13 0.05 1.56 21 S 0.003 0.78 0.013 0.39 22 0.05 one € 0.003 0.39 23 $ 0.003 0.78 0.025 0.78 24 0.013 1.56 0.025 0.78 25 0. 025 1.56 0.025 1.56 26 0.05 — 0.013 0.39 27 0.025 1.56 0.025 1.56 28 0.025 0.78 0.025 1.56 29 0.025 — 0.025 0.39 30 0.013 3. 13 0.05 0.78 31 0.013 0.78 0. 1 0.78 32 0.013 0.78 0 · 1 1.56 33 0.025 1.56 0.05 3. 13 34 0.05 6.25 0.05 1.56 35 0.025 6.25 0 · 1 3. 13 36 0.013 0.78 0.2 3. 13 ENX 0.39 100 «.05 0.78 —26 — 丨 · --S --- ί--mjp · install-- (Please read the precautions on the back before (Fill in this page), 1T J --- Ί · This paper size is applicable to China National Standard (CNS) A4 (210X297 mm) 491848 fB7 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 5. Description of the invention 1 Table 1 (Continued) Strain Examples Staphylococcus coliform P. aeruginosa 50774 MS16405 NIHJ JC-2 * No 12 37 0.05 6. 25 0. 1 3. 13 38 0 · 1-0. 05 3. 13 39 0.025 3. 13 0.2 0.78 40 0.025 1.56 0.1 3 13 47 0.013 0.39 0.05 0.78 48 0.013 1.56 0. 05 0.39 49 0.05 1.56 0. 1 3. 13 50 S 0.003 0.39 0.025 0.2 51 ^ 0.003 0.78 0.025 0 · 1 52 0.013 1.56 0.025 1.56 53 0.013 1.56 S 0.003 1.56 54 0.013 0.78 0.025 1.56 55 0.013 1.56 0.05 0.39 57 0.006 0.39 '0.003 0.2 ΕΝχ 0.39 100 0.05 0.78 -27- (Please read the precautions on the back before filling out this page) _Γ · The size of the paper is applicable to the Chinese National Standard (CNS) A4 < 1 is ;:-) 491848 A7 B7 Printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 5. Description of the invention (4) Table 2 Causes of Pain Caused by the Umbrella of the Mouse (EDm ng / kRi Example Strain Golden «Grape Ball_ 50774 1 0.36 2 0.383 3 0.398 4 0.246 5 0.257 6 0.292 7 0. 331 8 0.345 9 0.415 10 0.465 11 0.579 12 0.715 Example Golden 16 Grape Ball Ball 50774 η 0. 778 14 ^ 0.78 15 1. 12 16 0.78 17 0.78 18 0. 928 19 0. 928 47 0.478 52 0.503 53 0.576 57 1.43 ΕΝχ 9.89 -28- —ϋ ^ ιϋ —ϋ Μϋ II ·· m 11 n (Please read the notes on the back before filling this page) Order --Γ- this The paper size is applicable to the Chinese country * ♦ (Ά84 4 格格 (210X297mm) 491848 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs A7 __ B7 ______ V. Description of the invention (W) As shown in Table 1 and Table 2, The compound (I) of the present invention is excellent in antibacterial activity in a test tube and in vivo. In particular, the compound (1) of the present invention has far stronger antibacterial activity against Gram-positive bacteria than EN X. The compound (I) of the present invention, its ester or physiologically acceptable salt can be used as an antibacterial agent for the treatment of bacterial diseases in humans and animals. When the compound (I) of the present invention is used as an antibacterial agent in humans, the amount of the compound (I) varies depending on age, weight, symptoms, administration route, etc., but it is generally administered once or in portions of 5 ng to 4 g per day. Although the administration route is oral, non-oral or partial administration is acceptable, but oral administration is preferred. Although the compound U) of the present invention can be administered to humans or the like as a precursor, it is usually prepared together with a pharmaceutically acceptable additive to prepare a preparation (pharmaceutical composition) for administration. Such preparations may be lozenges, liquids, capsules, granules, fine granules, powders, syrups, injections, troches, ointments, sprays, eye drops and the like. These preparations can be manufactured by usual methods using usual additives. For example, the oral additives may be starch, mannose, crystalline cellulose, carboxymethylcellulose calcium, water, ethanol and other formulations, and are solid or liquid carriers or diluents that do not react with the compound (I) of the present invention. . Additives for injection can be those commonly used in the field of injections such as water, physiological saline, glucose solution, infusion and the like. The palate spray or soft bud can also be used for the treatment and treatment of otology, throat, or ophthalmology. EXAMPLES The following examples illustrate the present invention. Examples A to M are methods for preparing the blue ring intermediate cyclic bicyclic amine compound (II). Examples 1 to 60 are methods for preparing the compound (I) of the present invention. Example H is There are prescribers. -29- This paper size applies to Chinese National Standard (CNS) A4 specification (210 × 297 mm) C Please read the notes on the back and fill in this document) 装 • Installation · 1T 491848 A7 B7 V. Description of the invention (W) "It means that the consumer cooperative of the Central Standards Bureau of the Ministry of Economic Affairs printed the following" R # J "which is included in the compound name. The three-dimensional structure of the compound is relative and absolute, and the three-dimensional structure of the following structural formula is also the opposite. The abbreviation in the absolute examples is as follows: Boc: the third butanecarbonyl group Me: methyl 2, 4-F 2 Ph: 2, 4-difluorophenyl 3-NH2-4, 6-F2 Ph: 3-amino group -4,6_ Difluorophenyl Example A (-)-(lR *, 5S *, 8R *)-8- (Third butanecarbonylamino group 2-Minga-6-acylbicyclo [3.3.0] Octane (Compound II: βι ^ Boc; R2, R3, U4, R8, R9 = H; brew = 0; n = 1; P = fl) [Process 1] D-tartaric acid is used as raw material, imitating J.Org · CheiuU, lfl3_l () 8 (1995) (3R *, 4S *, 51 ^) · Benzyl-3,4_bis (third butyldimethylsilylamino) -5- (2-hydroxyethyl Base)-125.5 g of pyrrolidone, 60% acetic acid water 1200B1 was added and refluxed overnight. After concentration under reduced pressure, add Concentrated ammonia water 3 0 * 1 and methanol 500b1, after stirring overnight at room temperature, concentrated under reduced pressure on a silica gel column chromatography (chloroform: methanol = 10: 1), to obtain (3R *, 4S *, 5R *)-1- 35 g of benzyl-3,4-dihydroxy-5- (2-hydroxyethylb-2-pyrrolidone. IR (neat) c irr 丨: 3370, 1682 MS (m / z): 252 (MH +) ^ -NMRCCDCla) ^:?. 10-7.32 (m, 5 H). 5. 52 (brs, 2 H), 4.90 (d, 1 H, J = 15.0Hz), 4.50 (d, 1H, J 2 7. Please note first. The paper size is applicable to the Chinese National Standard (CNS) A4 specification (: M * ΝΊ) 491848. Printed by the Consumers Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs A7 / _B7 ^ j_ V. Description of the Invention (Clever) 5Hz), 4.21 (brt, 1 H, J = 7. 5Hz), 3.94 (d, 1 H, J = 15. 〇 Hz), 3.55 (brs, 3H), 2.20 -2.00 (br s, 1 H), 1.86 (brs, 2 H) [Process 2] Add 35 g of the compound obtained in Process 1 to pyridine 4fl0al, add 26.6 g of p-toluenesulfonium gas under ice cooling, stir overnight, add water and chloroform. The organic layer was separated, washed with 10% hydrochloric acid, dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure to obtain (1R *, 5S *, 8S *)-& benzyl-8-hydroxy-7 -24 g of octane bicyclo [3.3.0] octane. IR (net) ciT1: 3390, 1692 MS (m / z): 234 (MH +) ^ -NMR (CDC 1 a) (5: 7.40-7.18 (m, 5 H). 4. 84 (d, 1 H, J = 15. OHz), 4.49 (br, 1 H), 4.42 (dd, 1 H, J -6. 5, 1. · 7Ηζ), 4.32 (br, 1 H), 4.16-4.06 (m , 2 H), 3. 92-3. 66 (m, 2 H), 1.92-1.82 (m, 2 H) [Process 3] (1) Add 14 g of the compound obtained in Process 2 to dihydromethane 250111, Add pyridine 14.6ial while cooling, and slowly add triflic acid 13.111. After 2 hours, add 550 ml of dimethylformamide and 58.9 g of potassium acetate. After stirring overnight, insoluble matter is filtered off and concentrated under reduced pressure. Water and atmosphere were added, and the organic layer was separated and the solvent was distilled off under reduced pressure to obtain the crude (1IT, 5S *, 8S *)-8-acetamido-6-benzyl-7-gas m-6-acylbicyclic ring. [3 · 3 · 0] Octane. (2) Add ethanol 5G0ral and concentrated ammonia water 20Qb1 to this compound, and stir at room temperature -31- £ ___? 丨 _ ^ _ (Please read the precautions on the back and fill in. (Install-: write this page)
、1T —ν^ϋ ami mntt · 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 491848 A7 B7 五、發明説明(V ) 拌一夜,減壓濃縮,加水及氡仿。分取有機層,減壓濃 縮而在砂_柱層析(氯仿:甲醇:=:3〇:1),得(1较*,58* ,8R*卜6_苄基羥基_7-氣_2-鸣_6-吖雙琛〔3.3.0〕 辛烷9 . 2克。 IR(淨)c通-1 : 3381, 1694 MS (m/z) : 234 (MH+ ) ^-NMR (CDC 1 ο ) ά : 7.40-7.20 (m, 5H),4.93(d, 1 H, J - 15·0Ηζ), 4. 50 ( d d , 1 H, J =6. 0, 5. 0Hz) , 4.28 (d, 1 H, J -6· 0Hz ) , 4· 09 ( d, 1 H, J = 15· 〇Hz) , 4. 08-3. 93 (m, 2 H) , 3.80-3. 66 (m, 1 H) , 3. 22 ( b r s , 1 H) , 2.24-2. 1 1 (m, 1 H) , 2. 01-1. 81 (m, 1 H) 〔製程4〕 將製程3(2)所得化合物9·2克加至二氯甲烷ioobI,冰 冷而加吡啶9.5nl,徐徐加三氟甲磺酐91ml。2小時後 ,加二甲基甲醛胺300β1及ft氮化鈉24·4克,攢拌一夜 ❶減壓濃縮,加水及氣仿,分取有機層而以稀鹽酸水洗 淨,以無水硫酸鎂乾燥,減Κ蒸除溶劑,得(1R* ,5S* ,8s* )-8-疊気基-6-苄基-7-氣-7-氣-2-If -6 -吖雙環 〔3 · 3 · 0〕辛烷 7 · 4克。 經濟部中央標準局員工消費合作社印製 (請先閲讀背面之注意事項再填寫本頁) IR(淨)ciT1 : 2109, 1 6 9 4 !H-NMR (CDCI3 ) δ : 7.40-7.20 (m, 5 Η) , 4.93 (d, 1 H, J = 15.0Hz), 4.23 (d d, 1 H, J=6.0,1·5Ηζ ) , 4. 16-4·0 2 (m, 3 Η) , 3·94-3·82 (m, 1 Η) , 3·8卜3.67 (m, 1 Η),2· 00-1.80 (m, 2 Η) -32- 本紙張尺度適用中國國家標準(CNS ) Α4規格(210Χ297公釐) 491848 A7 B7 五、發明説明(Μ ) 〔製程5〕 (1) 將製程4所得化合物7.4克加四氫呋喃3Gflel,冰冷 而加硼烷-四氫呋喃錯合物之1·0*四氫呋喃溶液116»1, 加熱30分後,回流1夜。冷卻至室溫,多餘之硼烷以乙 醇處理,減壓濃縮,加乙醇600nl,回流一夜。減壓濃 縮,加10%鹽酸水。分取水層,以氛彷洗淨,以20% NaOH水鹸化後,以氯仿萃取,以無水硫酸鎂乾燥,減壓 蒸除溶劑,得(1R* ,5R* ,8S*卜8-胺基-6-苄基-2-鸣 -6-吖雙環〔3·3·0〕-8-胺基-6-苄基-2-丨§-6-吖雙環 〔3 · 3 · 0〕辛烷 5 · 5 克。 (2) 次將此化合物加至甲醇lOflnl而冰冷後,加二硪酸二 第三丁酯7 .2克,攪拌一夜。減壓濃縮,在矽膠柱層析 (正己烷:乙酸乙酯=6: 1),得(1R* ,5R* ,8S* )-6- 苄基-8-(第三丁氧羰胺基吖雙環〔3·3·0〕辛 烷7 . 0克。 熔點:115-116 °C (乙酸乙酯再結晶) 〔cr〕 0^+2-3° (c=1.02,甲醇) 〔製程6〕 經濟部中央標準局員工消費合作社印製 (請先閲讀背面之注意事項再填寫本頁) 將製程5(2)所得化合物5. 4克溶在乙醇IOObI,加5% Pd-C 350ag,在40°C吸收理論量之氫,濾除觸媒,減壓 蒸除溶劑,所得粗結晶從乙醚異丙醚再結晶,得目的之 (-)-(lR* ,5S* ,8S* )-8-(第三丁氣羰胺基卜2-栲-6- 吖雙環〔3.3.0〕辛烷3.5克。, 1T —ν ^ ϋ ami mntt · This paper size is applicable to Chinese National Standard (CNS) A4 (210X 297 mm) 491848 A7 B7 V. Description of the invention (V) Mix overnight, concentrate under reduced pressure, add water and imitate. The organic layer was separated, concentrated under reduced pressure, and subjected to sand-column chromatography (chloroform: methanol: =: 30: 1) to obtain (1 *, 58 *, 8R *, 6_benzylhydroxy_7-gas, and 2-Ming_6-Acridine [3.3.0] 9.2 g of octane. IR (net) c-pass-1: 3381, 1694 MS (m / z): 234 (MH +) ^ -NMR (CDC 1 ο) ά: 7.40-7.20 (m, 5H), 4.93 (d, 1 H, J-15.0Ηζ), 4. 50 (dd, 1 H, J = 6. 0, 5. 0 Hz), 4.28 (d , 1 H, J-6.0 Hz), 4.0 09 (d, 1 H, J = 15.0 Hz), 4.08-3.93 (m, 2 H), 3.80-3.66 (m, 1 H), 3. 22 (brs, 1 H), 2.24-2. 1 1 (m, 1 H), 2. 01-1. 81 (m, 1 H) [Process 4] Process 3 (2) 9.2 g of the obtained compound was added to ioobI dichloromethane, 9.5 nl of pyridine was added with ice cooling, and 91 ml of trifluoromethanesulfonic anhydride was gradually added. After 2 hours, dimethylformamide 300β1 and ft sodium nitride 24.4 g were added. Stir overnight and concentrate under reduced pressure, add water and aerosol, separate the organic layer and wash it with dilute hydrochloric acid, dry over anhydrous magnesium sulfate, and remove the solvent by reducing K to obtain (1R *, 5S *, 8s *)-8 -Azido-6-benzyl-7-qi-7-qi-2-If -6-acridine [3 · 3 · 0] octane 7.4 g. Consumer Co-operation of the Central Standards Bureau of the Ministry of Economic Affairs Printed by the company (please read the precautions on the back before filling in this page) IR (net) ciT1: 2109, 1 6 9 4! H-NMR (CDCI3) δ: 7.40-7.20 (m, 5 Η), 4.93 (d , 1 H, J = 15.0Hz), 4.23 (dd, 1 H, J = 6.0, 1.5 · ζ), 4. 16-4 · 0 2 (m, 3 Η), 3.94-3 · 82 (m , 1 Η), 3 · 8, 3.67 (m, 1 Η), 2.0 · 0-1.80 (m, 2 Η) -32- This paper size applies to the Chinese National Standard (CNS) A4 specification (210 × 297 mm) 491848 A7 B7 V. Description of the invention (M) [Process 5] (1) Add 7.4 g of tetrahydrofuran compound 3Gflel obtained in process 4, add ice cold 1 + 0 tetrahydrofuran solution 116 »1 of borane-tetrahydrofuran complex, and heat for 30 minutes After that, reflux for 1 night. Cool to room temperature, treat excess borane with ethanol, concentrate under reduced pressure, add 600nl of ethanol, and reflux overnight. It was concentrated under reduced pressure, and 10% hydrochloric acid water was added. The aqueous layer was separated, washed with chloroform, washed with 20% NaOH, extracted with chloroform, dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure to obtain (1R *, 5R *, 8S *, 8-amino- 6-benzyl-2-Ming-6-azinebicyclo [3 · 3 · 0] -8-amino-6-benzyl-2- 丨 -6-azinebicyclo [3 · 3 · 0] octane 5 · 5 g. (2) After adding this compound to methanol lOflnl and ice-cooling, add 7.2 g of di-tert-butyl diacetate and stir overnight. Concentrate under reduced pressure, and chromatograph on a silica gel column (n-hexane: acetic acid). Ethyl ester = 6: 1), (1R *, 5R *, 8S *)-6-benzyl-8- (third butoxycarbonylamino acyclobicyclo [3 · 3 · 0] octane 7.0 g Melting point: 115-116 ° C (ethyl acetate recrystallization) [cr] 0 ^ + 2-3 ° (c = 1.02, methanol) [Process 6] Printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs (please read first) Note on the back side, please fill in this page again.) 5.4 g of the compound obtained in process 5 (2) was dissolved in ethanol 100bI, 5% Pd-C 350ag was added, and the theoretical amount of hydrogen was absorbed at 40 ° C. The solvent was distilled off under reduced pressure, and the obtained crude crystals were recrystallized from diethyl ether isopropyl ether to obtain the target (-)-(lR *, 5S *, 8S *)-8- (third butanecarbonylamino-2-2--6 - 3.5 g of aziridine [3.3.0] octane.
融點:1 1 0 - 1 1 1 eC -33- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 491848 A7 B7 五、發明説明(P ) IRUBr)c 祖-1 : 3 3 7 7 , 3228, 1 68 0 ία) 〇 29 一 4 4. 4° (c= 1. 0 3,甲酵) ^H-NMR (CDC 1 3 ) 5 : 4.22 (d, 1 H, J=5.5Hz ) , 4.02-3. 69 (m, 4 Η) , 3· 15 (d d, 1 H, J = 11· 5,5· 0Hz ) , 2· 84 ( d d , 1 H, J-11.5, 3.0Hz ) , 2. 19-1.99 (m, 1 H) , 1.83-1.68 (m, 2H) , 1.45 (s, 9 H)Melting point: 1 1 0-1 1 1 eC -33- This paper size applies to Chinese National Standard (CNS) A4 (210X297 mm) 491848 A7 B7 V. Description of the invention (P) IRUBr) c Zu-1: 3 3 7 7, 3228, 1 68 0 ία) 〇29-4 4. 4 ° (c = 1. 0 3, formazan) ^ H-NMR (CDC 1 3) 5: 4.22 (d, 1 H, J = 5.5 Hz), 4.02-3. 69 (m, 4 Η), 3.15 (dd, 1 H, J = 11.5, 5.0 Hz), 2.84 (dd, 1 H, J-11.5, 3.0Hz ), 2. 19-1.99 (m, 1 H), 1.83-1.68 (m, 2H), 1.45 (s, 9 H)
實施例B (-)-(lir ,5S* ,8S* )-8-(第三丁氧羰胺基 吖雙環〔3.3.0〕辛烷(化合物II: Ri = Boc; R2 ,R3, R 4 9 R ^ y R 8 9 R 9 == H 5 ffl = 0 > π = 1 j P = 〇 ) 〇 將實施例A之製程2所得之(1IT ,5S* ,8S* )-6-苄 基-8-羥基-7-氣-2-ΪΙ-6-吖雙環〔3·3·0〕辛烷仿實施例 Α之製程4〜6處理,得標題物。 〔ct〕D w - 7 9 · 3 ° ( c = 1 · 0 2 ,甲醇) MS (m/z) : 229 (MH+ ) !H~NMR (CDC13 ) δ :5.17(br s, 1H), 4.29 ( t, 經濟部中央標準局員工消費合作社印製 (請先閱讀背面之注意事項再填寫本頁) 1 H,J=5.5Hz ) , 4.04-3.74 (m, 4 H) , 3.23 (d d, 1 H, J = 11.5. 7.0Hz ), 2. 50 ( t , 1 H, J = 11.5Hz) , 2.26-2.08 (m, 1 H) » 1-86 (s, 1 H) , 1.88-1.73 (m, 1 H) , 1.45 (s, 9 H)Example B (-)-(lir, 5S *, 8S *)-8- (third butoxycarbonylamino acyclobicyclo [3.3.0] octane (Compound II: Ri = Boc; R2, R3, R 4 9 R ^ y R 8 9 R 9 == H 5 ffl = 0 > π = 1 j P = 〇) 〇 (1IT, 5S *, 8S *)-6-benzyl obtained in the process 2 of Example A -8-Hydroxy-7-gas-2-ΪΙ-6-acylbicyclo [3 · 3 · 0] octane was treated in the same manner as in process 4 to 6 of Example A to obtain the title compound. [Ct] D w-7 9 · 3 ° (c = 1 · 0 2, methanol) MS (m / z): 229 (MH +)! H ~ NMR (CDC13) δ: 5.17 (br s, 1H), 4.29 (t, employee of Central Bureau of Standards, Ministry of Economic Affairs Printed by a consumer cooperative (please read the precautions on the back before filling this page) 1 H, J = 5.5Hz), 4.04-3.74 (m, 4 H), 3.23 (dd, 1 H, J = 11.5. 7.0Hz) , 2. 50 (t, 1 H, J = 11.5 Hz), 2.26-2.08 (m, 1 H) »1-86 (s, 1 H), 1.88-1.73 (m, 1 H), 1.45 (s, 9 H)
實施例C 仿實施例A得( + )-(lR* ,5S* ,8R* )-8-(第三丁氣羰 胺基吖雙環〔3.3.0〕辛烷(化合物II: R 1 = B 〇 c 9 R 2 > K 3 , R 4 » R 5 9 R θ— H ^ ffl -- 0 } π = 1 -34- 本紙張尺度適用中國國家標準(CNS ) Α4規格(210Χ297公釐) 491848 A7 B7 五、發明説明(W ) ;P= 〇)〇Example C: (+)-(lR *, 5S *, 8R *)-8- (Third butanecarbonylaminoacylbicyclo [3.3.0] octane (Compound II: R 1 = B 〇c 9 R 2 > K 3, R 4 »R 5 9 R θ— H ^ ffl-0} π = 1 -34- This paper size applies the Chinese National Standard (CNS) Α4 specification (210 × 297 mm) 491848 A7 B7 V. Description of the invention (W); P = 〇) 〇
融黏:1 Ο 8 - 1 Ο 9 °C IRUBr)c 麗-1 : 3 3 7 7 , 3228, 1680 〔a〕 0^+44.5° (c=1.01,甲酵) 1H-NMR (CDC 1 3 ) (5 : 4·22 (d, 1 Η, J =5· 5Hz ) , 4· 02 - 3· 69 (m, 4 Η) , 3· 15 (d d, 1 Η, J = 11· 5· 5· ΟΗζ ) , 2· 84 ( d d , 1 Η, J=11.5, 3.0Hz ) , 2.19-1.99 (m, 1 Η) , 1.83-1.68 (m, 2Η) , 1·45 (s, 9 Η)Melting: 1 〇 8-1 Ο 9 ° C IRUBr) c Li-1: 3 3 7 7, 3228, 1680 〔a〕 0 ^ + 44.5 ° (c = 1.01, formazan) 1H-NMR (CDC 1 3 ) (5: 4.22 (d, 1 Η, J = 5.5 Hz), 4.02-3.69 (m, 4 Η), 3.15 (dd, 1 Η, J = 11.5 · 5 ΟΗζ), 2.84 (dd, 1 Η, J = 11.5, 3.0Hz), 2.19-1.99 (m, 1 Η), 1.83-1.68 (m, 2Η), 1.45 (s, 9 Η)
實施例D 仿實施例Β得( + )-(lR* ,5S* ,8S* )-8-(第三丁氣羰 胺基卜2-丨§-6-吖雙璟〔3·3·0〕辛烷(化合物II: R 1 =Boc; R 2 » R 3 9 K 4 9 R 8 » R 9 = Η 5 ιβ=0; π= 1 ;ρ= 〇)〇 〔cr〕 (c=1.00,甲醇) MS (m/z) : 229 (MH+ ) *H-NMR (CDC 1 3 ) 5 : 5. 17 (b r s, 1 Η) , 4· 29 ( t, 經濟部中央標準局員工消費合作社印製 (請先閱讀背面之注意事項再填寫本頁)Example D: (+)-(lR *, 5S *, 8S *)-8- (Third butanecarbonylamino group 2- 丨 §-6-azepine bis (3 · 3 · 0) ] Octane (Compound II: R 1 = Boc; R 2 »R 3 9 K 4 9 R 8» R 9 = Η 5 ιβ = 0; π = 1; ρ = 〇) 〇 [cr] (c = 1.00, Methanol) MS (m / z): 229 (MH +) * H-NMR (CDC 1 3) 5: 5. 17 (brs, 1 Η), 4 · 29 (t, printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs (Please read the notes on the back before filling this page)
1 H, J =5. 5Hz ) , 4· 04-3· 74 (m, 4 Η) , 3· 23 ( d d , 1 H, J = 11. 5. 7. OHz ) , 2. 50 ( t, 1 H, J = 11. 5Hz) , 2. 26-2. 08 (m, 1 H),1.86 (s, 1 H) , 1.88-1.73 (m, 1 H),1· 45 ( s,9 H) 實施例E (1R* ,6S* ,9R* )_9-(第三丁氣羰胺基)-2-丨§-7-吖 雙環〔4 · 3 · 0〕壬烷 (化合物 II: Ri =Boc; R2,尺3,尺4,Rs,Re,R7 ,R 8 9 R 9 = H; ffl= 0 5 n=l; p= l)〇 -35- 本紙張尺t钃*Η’Λ钃家螵率(CNS ) A4規格(210X297公釐) 491848 A 7 B7 五、發明説明(Μ ) 〔製程1〕: 以 D-酒石酸為原料依 J.Org· Chea.M,103-108(1995) 製造之(3R* ,4S* ,5R* )-5-烯丙基-1-苄基-3,4-雙(第 三丁基二甲矽烷氣基)-2-吡咯啶_1〇〇克加至四氫呋喃 6 7 0 ·1而冰冷後,加硼烷-四氫呋喃錯合物之1·〇Μ-四氫 呋喃溶液87.1*1,在室溫攪拌1小時後•滴加水7β1· 作一次加入5N-Na0H水33.4搬1。次將30%雙氣水33·4·1 以反應溫度達30〜50 eC之速度加入,攪拌一夜後,加水 及乙酸乙酯。分取有機層而以無水硫酸鎂乾燥,減壓蒸 除溶劑,在矽膠柱層析(氯仿),得(3R* ,4S* ,5R· )-1- 苄基-3,4-雙(第三丁基二甲基矽烷氧基)-5-(3-羥丙基> -2-吡咯啶_ 33 · 4克。 IR(淨)cm 一1 : 3444,1697 MS (m/z) : 494 (MH+ )1 H, J = 5.5 Hz), 4.04-3.74 (m, 4 Η), 3.23 (dd, 1 H, J = 11. 5. 7. OHz), 2.50 (t, 1 H, J = 11.5Hz), 2. 26-2. 08 (m, 1 H), 1.86 (s, 1 H), 1.88-1.73 (m, 1 H), 1.45 (s, 9 H ) Example E (1R *, 6S *, 9R *) _ 9- (Third Butane Carboxamido) -2- 丨 §-7-Acridine [4 · 3 · 0] Nonane (Compound II: Ri = Boc; R2, Ruler 3, Ruler 4, Rs, Re, R7, R 8 9 R 9 = H; ffl = 0 5 n = l; p = l) 〇-35- Paper rule t 钃 * Η'Λ 钃Furniture ratio (CNS) A4 specification (210X297 mm) 491848 A 7 B7 V. Description of invention (M) [Process 1]: Using D-tartaric acid as raw material according to J. Org · Chea.M, 103-108 (1995) (3R *, 4S *, 5R *)-5-allyl-1-benzyl-3,4-bis (third butyldisilylamino) -2-pyrrolidine 100 g After adding to tetrahydrofuran 6 7 0 · 1 and ice-cooling, add a 1.0M-tetrahydrofuran solution 87.1 * 1 of borane-tetrahydrofuran complex, and stir at room temperature for 1 hour • Add 7β1 water dropwise. Add 5N-Na0H once Water 33.4 moved 1. 30% double gas water 33 · 4 · 1 was added at a reaction temperature of 30 to 50 eC, and after stirring overnight, water and ethyl acetate were added. The organic layer was separated and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the product was subjected to silica gel column chromatography (chloroform) to obtain (3R *, 4S *, 5R ·) -1-benzyl-3,4-bis (No. Tributyldimethylsilyloxy) -5- (3-hydroxypropyl > -2-pyrrolidine_ 33 · 4 g. IR (net) cm-1: 3444,1697 MS (m / z): 494 (MH +)
^-NMRCCDCla)^: 7.40-7.20 (m, 5 H) , 4.86 (d, 1 H, J= 15·0Ηζ),4.20 (d, 1 H, J =6· 0Hz ) , 4· 12 ( d, 1 H,J = 15.0Hz),4.12-4.06(m,lH),3.65_3.40(m,3H),1.75_l· 25 (m, 4 H) , 0.95 (S, 9 H) , 0.90 ( s , 9 H) , 0.23 ( s , 3 Η) , 0·17 (s, 3H) , 0. 10 (s, 3 H) , 0. 02 ( s , 3 H) 經濟部中央標準局員工消費合作社印製 (請先間讀背面之注意事項再填寫本頁) 〔製程2〕: 將前製程1所得化合物33· 4克及三乙胺1〇· 3克加至二 氛甲烷40 Onl,冰冷後,加對甲苯磺醯氯15· 5克,攪拌 1·5日後,加水及氯仿,分取有機層而水洗,以無水硫 酸鎂乾燥,減壓濃縮,在矽膠柱層析(正己烷:乙酸乙 -36- 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X297公釐) 經濟部中央標準局員工消費合作社印製 491848 A7 B7 五、發明説明(W ) 酯=5:1),得(31{*,481|,511*)_1-苄基-3,4-雙(第三 丁基二甲基矽烷氣基)_5_(3_甲苯磺酵氧丙基卜卜吡咯 啶酮32.8克。 IR(淨)c B-1 : 1 7 1 5 , 1 3 6 0 , 1 2 5 4 , 1 1 7 6 MS (m/z) : 648 (MH+ ) !H-NMR (CDC 1 a ) ά : 7.80-7.73 (m, 2 H) , 7. 39-7. 19 (m, 7 H) , 4.82 (d, 1 H, J = 15· 0Hz) , 4.15 - 4· 07 (m, 2 H), 4.00(d, 1H, J = 15.0Hz), 3·91-3·83 (m, 2H), 3.45-3.35 (m, 1H), 2.47( s, 3 H), 1.70-1.25 (m, 4 Η), 0.95( s, 9 H) , 0· 84 ( s , 9 H),0· 22 ( s , 3 H) , 0· 15 ( s,3 H) · 0· 08 (s, 3H) , -0.03 (s, 3H) 〔製程3〕: 將前製程2所得化合物32. 8克加至四氫呋喃5 0 0 * 1 , 次加氟化四-正丁銨之1.0M四氫呋喃溶液60·7·1,加熱 回流30分後,加水及乙酸乙酯。分取有機層而以無水硫 酸鎂乾燥,減壓濃縮,在矽驂柱層析(氣仿•·甲醇=30 :1),得(1R* ,6S* ,9S* 卜7-苄基-9-羥基-8-氣-2-鸣 -7-吖雙環〔4.3.0〕壬烷10·6克。 融點:1 3 6 - 1 3 8 °C I R ( K B r ) c nr1 : 3 2 9 5 , 1 6 6 4 MS (m/z) :248 (MH+ ) U〕D 3 0 — 9 0· 6。 (c = 1 · 〇 〇,甲醇) -37- 本紙張尺度適用中國國家標卑UNS ; A4说格(210X 297公釐) ^^^1· m i —^ϋ -ϋ·—. ϋ (請先閲讀背面之注意事項再填寫本頁) 訂 J, 491848 A7 B7 五、發明説明(4 ) ]Η-ΝΜΚ (CDC13 ) δ : 7.40-7.20 (m, 5H),4.88(d, 1 H, J = 15.0Hz) , 4.40 (d d, 1 H, J =2.8, 5.0Hz) , 4. 18 (d, 1 H, J = 15.0Hz) , 4.05 ( t, 1 H, J =5· 0Hz ),3. 82-3. 68 (m, 1 H),3.65-3.46 (m, 2 H) , 3.40 (d, 1 H, J=2.8Hz ) , 1.97-1. 78 (m, 1 H) , 1.73-1.30 (m, 3 H) 〔製程4〕: 將前製程3所得化合物12. 5克仿實施例A製程3(1)處 理,得(1 R 11 , 6 S * , 9 R # ) - 9 -乙醯氣基-7 -苄基-8 -氧-2- 栲-7-吖雙環〔4.3.0〕壬烷11.9克。 IR(淨)CUT1 : 3564,1715,1230 MS (m/z) : 290 (MH+ ) ^-NMRCCDCla)^: 7.40-7.20 (m, 5 Η) , 5.29 (d, 1 Η, J=4.2 Hz) , 4·95 (d, 1 Η, J 二 15·0Ηζ) , 4·28 (d d, 1 Η, J=2.5, 4·5Ηζ) , 4· 13 (d, 1 Η, J = 15. ΟΗζ),3· 98-3· 86 (m, 1 Η) , 3.44-3.37 (m, 1 Η) , 3.33 (d t,1 Η, J =2. 5· 11· 1Hz ), 2.38 (s, 3 Η), 2.38-2.20 (m, 1 Η) , 1.74-1.25 (m, 3 Η) 〔製程5〕: 將前製程4所得化合物11. 9克仿實施例Α製程3(2)處 理,得(1R* ,6S* ,9IT )-7-苄基-9-羥基-8-氣-2-鸣-7- 經濟部中央標準局員工消費合作社印製 (請先閱讀背面之注意事項再填寫本頁) 吖雙環〔4 · 3 · 0〕壬烷10 · 8克。 融點:163-165 °C (從二氯甲烷-正己烷再結晶) I R (K B r ) cm : 3340, 1692 MS (m/z) : 248 (MH+ ) ία) d 20 -55. 7° (c=l. 〇〇» 甲酵) -38- 本纸張尺度適用中國國家標準(CNS ) A4g ( 210X297公釐) 491848 A7 B7 五、發明説明(W ) ’H-NMRCCDCldoJMOUOCmJHhS.OiKd,1 H, J = 15.0 Hz ) , 4.26 (b r , 1 H) , 4. 11 (d d, 1 H, J=2.8, 4.2Hz), 4.05( d, 1H, J= 15· OHz), 4.00-3.90 (m,1H), 3· 48-3·32 (m, 2 H) , 2.89 (b r , 1 H) , 2.25-2.20 (m, 1 H), I. 70-1.30 (m, 3 H) 〔製程6〕: 將前製程5所得化合物10.6克仿實施例A製程4處理 ,得(1R* ,6S* ,9S* )-9-疊氮基-7-苄基-8-氣-2-鸣-7- 吖雙環〔4 · 3 · 0〕壬烷9 · 3克。 IR(淨)cm: 2107,1698 MS (m/z) : 273 (MH+ ) 'H-NMR (CDC 1 a ) (5 : 7.40-7.20 (m, 5 H) , 4.95 (d, 1 H, J = 15.0Hz) , 4. 15 (d, 1 H, J =3. 9Hz ),4· 06 ( d , 1 H, J 二 15.0Hz) , 3. 9卜3.72 (m, 2 H) , 3.56-3.41 (m, 2 Η) , 1. 94-1· 25 (m, 4H) 〔製程7〕: 將前製程6所得化合物9. 2克仿實施例A製程5(1)處 理,得(1R* ,6R* ,9S* )-9-胺基-7-苄基-2-鸣-7-吖雙 環〔4 · 3 · 0〕壬烷7 · 3克。 經濟部中央標準局員工消費合作社印製 (請先閲讀背面之注意事項再填寫本頁) IR(淨)cm·1 : 3372 MS (m/z) : 233 (MH+ ) ^-NMR (CDC 1 3 ) 5 : 7.38-7.18 (m, 5 Η) , 4· 01 ( d , 1 H, J -15.0Hz) , 3.90-3.87 (m, 1 H) 3.58 (d, 1 H, J=3.6Hz -39- 本紙張尺度適用中國國家標準(CNS ) A4規格(2丨心> 1、· } 491848 A7 B7 五、發明説明(w) ),3.50-3.25 (m, 3H), 3.28( d, 1 H, J = 15.〇Hz), 2.62 (d d, 1 H, J=6.8, 3.8 Hz ) , 2.15-1.92 (m, 2 H) , 1.86 (d d, 1 H, J=10. 〇r 5.0Hz) 1.80-1.60 (m, 1 Η) , 1. 42-1· 12 (m, 3 H) 〔製程8〕: 將前製程7所得化合物7.2克仿實施例A製程5(2)處 理,得(1R* ,6R* ,9S*卜7-苄基-9-(第三丁氣羰胺基) -2-丨1-7-吖雙環〔4·3·0〕壬烷10.1克。^ -NMRCCDCla) ^: 7.40-7.20 (m, 5 H), 4.86 (d, 1 H, J = 15.0Ηζ), 4.20 (d, 1 H, J = 6.0 Hz), 4.12 (d, 1 H, J = 15.0 Hz), 4.12-4.06 (m, lH), 3.65_3.40 (m, 3H), 1.75_l · 25 (m, 4 H), 0.95 (S, 9 H), 0.90 (s , 9 H), 0.23 (s, 3 Η), 0 · 17 (s, 3H), 0. 10 (s, 3 H), 0. 02 (s, 3 H) (Please read the precautions on the back before filling this page) [Process 2]: Add 33.4 g of the compound obtained in the previous process 1 and 10.3 g of triethylamine to 40 Onl dichloromethane. After cooling, 15.5 g of p-toluenesulfonyl chloride was added, and after stirring for 1.5 days, water and chloroform were added, the organic layer was separated and washed with water, dried over anhydrous magnesium sulfate, concentrated under reduced pressure, and subjected to silica gel column chromatography (hexane: ethyl acetate- 36- This paper size is in accordance with Chinese National Standard (CNS) A4 (210X297 mm) printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs 491848 A7 B7 V. Description of the Invention (W) Ester = 5: 1), get (31 { *, 481 |, 511 *) _ 1-benzyl-3,4-bis (third butyldimethylsilylamino) _5_ (3_toluenesulfonyloxypropylbopyrrolidone 32.8 g. IR (net) c B-1: 1 7 1 5, 1 3 6 0, 1 2 5 4, 1 1 7 6 MS (m / z): 648 (MH +)! H-NMR (CDC 1 a ) ά: 7.80-7.73 (m, 2 H), 7. 39-7. 19 (m, 7 H), 4.82 (d, 1 H, J = 15.0Hz), 4.15-4.07 (m, 2 H), 4.00 (d, 1H, J = 15.0Hz), 3 · 91-3 · 83 (m, 2H), 3.45-3.35 (m, 1H), 2.47 (s, 3 H), 1.70-1.25 (m , 4 Η), 0.95 (s, 9 H), 0 · 84 (s, 9 H), 0 · 22 (s, 3 H), 0 · 15 (s, 3 H) · 0 · 08 (s, 3H ), -0.03 (s, 3H) [Process 3]: 32.8 g of the compound obtained in the previous process 2 was added to tetrahydrofuran 50 0 * 1, and tetra-n-butylammonium fluoride in 1.0M tetrahydrofuran solution 60 · 7 was added once. -1. After heating under reflux for 30 minutes, add water and ethyl acetate. The organic layer was separated, dried over anhydrous magnesium sulfate, concentrated under reduced pressure, and then subjected to silica gel column chromatography (aerosol · · methanol = 30: 1) to obtain (1R *, 6S *, 9S *, and 7-benzyl-9. -Hydroxy-8-Ga-2-Ming-7-Acridine [4.3.0] nonane 10.6 g. Melting point: 1 3 6-1 3 8 ° CIR (KB r) c nr1: 3 2 9 5 , 1 6 6 4 MS (m / z): 248 (MH +) U] D 3 0 — 9 0 · 6. (C = 1 · 〇〇, methanol) -37- This paper size applies to the national standard UNS; A4 grid (210X 297 mm) ^^^ 1 · mi — ^ ϋ -ϋ · —. Ϋ (Please read the notes on the back before filling out this page) Order J, 491848 A7 B7 V. Description of the invention (4) ] Η-NMK (CDC13) δ: 7.40-7.20 (m, 5H), 4.88 (d, 1 H, J = 15.0Hz), 4.40 (dd, 1 H, J = 2.8, 5.0Hz), 4. 18 ( d, 1 H, J = 15.0 Hz), 4.05 (t, 1 H, J = 5.0 Hz), 3. 82-3. 68 (m, 1 H), 3.65-3.46 (m, 2 H), 3.40 (d, 1 H, J = 2.8Hz), 1.97-1. 78 (m, 1 H), 1.73-1.30 (m, 3 H) [Process 4]: 12.5 g of the compound obtained in the previous process 3 was simulated. Example A is processed in process 3 (1) to obtain (1 R 11, 6 S *, 9 R #)-9 -acetamidinyl-7 -benzyl-8 -oxo-2-fluorene-7-azabicyclo [4 . 3.0] 11.9 g of nonane. IR (net) CUT1: 3564, 1715, 1230 MS (m / z): 290 (MH +) ^ -NMRCCDCla) ^: 7.40-7.20 (m, 5 Η), 5.29 (d, 1 Η, J = 4.2 Hz), 4.95 (d, 1 Η, J 2 15.0Ηζ), 4.28 (dd, 1 Η, J = 2.5, 4 · 5Ηζ), 4.13 (d, 1 Η , J = 15. ΟΗζ), 3.98-3 · 86 (m, 1 Η), 3.44-3.37 (m, 1 Η), 3.33 (dt, 1 Η, J = 2. 5.1.1 · 1Hz), 2.38 (s, 3 Η), 2.38-2.20 (m, 1 Η), 1.74-1.25 (m, 3 Η) [Process 5]: 11.9 g of the compound obtained in the previous process 4 was prepared according to Example A, process 3 (2 ) Processing, get (1R *, 6S *, 9IT) -7-benzyl-9-hydroxy-8-qi-2-ming-7- printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs (please read the note on the back first) Please fill in this page for more details) Acridine [4 · 3 · 0] nonane 10 · 8 g. Melting point: 163-165 ° C (recrystallized from dichloromethane-n-hexane) IR (KB r) cm: 3340, 1692 MS (m / z): 248 (MH +) ία) d 20 -55. 7 ° ( c = l. 〇〇 »Formazan) -38- This paper size applies to Chinese National Standard (CNS) A4g (210X297 mm) 491848 A7 B7 V. Description of the invention (W) 'H-NMRCCDCldoJMOUOCmJHhS.OiKd, 1 H, J = 15.0 Hz), 4.26 (br, 1 H), 4. 11 (dd, 1 H, J = 2.8, 4.2Hz), 4.05 (d, 1H, J = 15.0 Hz), 4.00-3.90 (m, 1H), 3.48-3 · 32 (m, 2 H), 2.89 (br, 1 H), 2.25-2.20 (m, 1 H), I. 70-1.30 (m, 3 H) [Process 6] : Processing 10.6 g of the compound obtained in the previous process 5 in the same manner as in the process 4 of Example A to obtain (1R *, 6S *, 9S *)-9-azido-7-benzyl-8-gas-2-ming-7- Acridine [4 · 3 · 0] nonane 9.3g. IR (net) cm: 2107,1698 MS (m / z): 273 (MH +) 'H-NMR (CDC 1 a) (5: 7.40-7.20 (m, 5 H), 4.95 (d, 1 H, J = 15.0Hz), 4. 15 (d, 1 H, J = 3. 9Hz), 4.06 (d, 1 H, J 25.0Hz), 3. 9 and 3.72 (m, 2 H), 3.56- 3.41 (m, 2 Η), 1. 94-1 · 25 (m, 4H) [Process 7]: 9.2 g of the compound obtained in the previous process 6 was processed in the same manner as in process 5 (1) of Example A to obtain (1R * , 6R *, 9S *)-9-Amino-7-benzyl-2-Ming-7-acylbicyclo [4 · 3 · 0] nonane 7.3g. Printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs (Please read the notes on the back before filling this page) IR (net) cm · 1: 3372 MS (m / z): 233 (MH +) ^ -NMR (CDC 1 3) 5: 7.38-7.18 (m, 5 Η), 4.01 (d, 1 H, J -15.0Hz), 3.90-3.87 (m, 1 H) 3.58 (d, 1 H, J = 3.6Hz -39- This paper size applies to Chinese National Standard (CNS ) A4 specification (2 丨 heart > 1, ·) 491848 A7 B7 5. Invention description (w)), 3.50-3.25 (m, 3H), 3.28 (d, 1 H, J = 15.〇Hz), 2.62 (dd, 1 H, J = 6.8, 3.8 Hz), 2.15-1.92 (m, 2 H), 1.86 (dd, 1 H, J = 10. 〇r 5.0Hz) 1.80-1.60 (m, 1 Η), 1. 42-1 · 12 (m, 3 H) Process 8]: 7.2 g of the compound obtained in the previous Process 7 was treated in the same manner as in Process 5 (2) of Example A to obtain (1R *, 6R *, 9S *, 7-benzyl-9- (third butanecarbonylamino) -2- 丨 1-7-acylbicyclo [4 · 3 · 0] nonane 10.1 g.
融黏:1 2 0 - 1 2 3 °C I R (KB r) cm 一3367, 1683 MS (m/z) : 333 (MH+ ) - U〕D 30 + 5 7. 8。(c = 1 · 0 1 ,甲醇) ^-NMR (CDC 1 a ) d : 7.38-7.20 (m, 5 H) , 4.38 (b r , 1 H) , 4.05-3.72 (m, 4 H) , 3.56-3.22 (m, 3 H) , 2.60-2.47 (m, 1 H) , 2.08-1.84 (m, 3 H),1.80-1.64 (m, 1 H) , 1.42 (s, 9 H) , 1.39-1.23 (m, 1 H)' 〔製程9〕: 經濟部中央標準局員工消費合作社印製 (請先聞讀背面之注意事項再填寫本頁) 將前製程8所得化合物7·4克仿實施例A製程6處理 ,得目的之(1R* ,6S* ,9R* )-9-(第三丁氣羰胺基)-2-«琴-7-吖雙璟〔4.3.0〕壬烷4·2克。 融點:110-111 °C (從二氯甲烷-正己烷再結晶) I R (KB r) cm -1: 3311,1711, 1687 MS (m/z) : 243 (MH+ ) 〔a〕D 30 +2. 4。 (c 二 1. 0 0,甲酵) -40- 本紙張尺度適用中國國家標準(CNS ) A4規格(210 X 297公釐) 經濟部中央標準局員工消費合作社印製 491848 A 7 _B7_ 五、發明説明(β ) ]H~NMR (CDC 1 a ) 5 : 4.53 (b r , 1 H) , 3.98-3.80 (m, 2H),3.74-3.55 (m, 2H) , 3,36 (d t, 1 H, J = 11.5, 2.5Hz ),3.01-2.92 (m, 1 H) , 2.55 (d d, 1 H, J = 12· 5· 3. 8Hz ), 2.20-1.58 (m, 5H) , 1.44 (s, 9H)Melting: 1 2 0-1 2 3 ° C I R (KB r) cm-3367, 1683 MS (m / z): 333 (MH +)-U] D 30 + 5 7.8. (C = 1 · 0 1, methanol) ^ -NMR (CDC 1 a) d: 7.38-7.20 (m, 5 H), 4.38 (br, 1 H), 4.05-3.72 (m, 4 H), 3.56- 3.22 (m, 3 H), 2.60-2.47 (m, 1 H), 2.08-1.84 (m, 3 H), 1.80-1.64 (m, 1 H), 1.42 (s, 9 H), 1.39-1.23 ( m, 1 H) '[Process 9]: Printed by the Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs (please read the precautions on the back before filling out this page). 7.4 g of the compound obtained in the previous process 8 is simulated in the process of Example A. 6 treatment, to get the purpose of (1R *, 6S *, 9R *)-9- (third butane carbonylamino) -2- «qin-7-azepine [4.3.0] nonane 4.2g . Melting point: 110-111 ° C (recrystallized from dichloromethane-n-hexane) IR (KB r) cm -1: 3311, 1711, 1687 MS (m / z): 243 (MH +) 〔a〕 D 30 + twenty four. (C 2 1. 0 0, formentase) -40- This paper size applies to China National Standard (CNS) A4 (210 X 297 mm) Printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 491848 A 7 _B7_ V. Invention Explanation (β)] H ~ NMR (CDC 1 a) 5: 4.53 (br, 1 H), 3.98-3.80 (m, 2H), 3.74-3.55 (m, 2H), 3,36 (dt, 1 H, J = 11.5, 2.5Hz), 3.01-2.92 (m, 1 H), 2.55 (dd, 1 H, J = 12.5 · 3. 8Hz), 2.20-1.58 (m, 5H), 1.44 (s, 9H )
實施例F (1R* ,6S* ,9S* )-9-(第三丁氣羰胺基)-2-枵-7-吖 雙環〔4 · 3 · 0〕壬烷 (化合物 I I ·· R1 = Β Ο C ; R 2 ,R 3 , B 4 ,Rs * R 6 ) R 7 9 R 8 9 R 9 = H j n=0; π=1; ρ = 1) 〔製程1〕: 將實施例E之製程3所得之(1R* ,6S* ,9S* )-7-苄 基-9-羥基-8-氣吖雙環〔4.3.0〕壬烷10·6克 仿實施例Α之製程4處理,得(1R* ,6S· ,9R* )-9 -疊 氤基-7-苄基-8-氧-2-鸣-7-吖雙環〔4·3·0〕壬烷9·3克。 IR(淨)CIT1 : 2108,1694 MS (m/z) : 273 (MH+ )Example F (1R *, 6S *, 9S *)-9- (Third-butanecarbonylamino) -2-fluorene-7-acylbicyclo [4 · 3 · 0] nonane (Compound II ·· R1 = Β Ο C; R 2, R 3, B 4, Rs * R 6) R 7 9 R 8 9 R 9 = H jn = 0; π = 1; ρ = 1) [Process 1]: In Example E, (1R *, 6S *, 9S *) of 7-benzyl-9-hydroxy-8-pyrazine [4.3.0] nonane 10.6 g obtained in the process of Example 3 was processed in the same manner as in the process of Example A to obtain (1R *, 6S ·, 9R *) 9.3 g of 9-azido-7-benzyl-8-oxo-2-ming-7-acylbicyclo [4 · 3 · 0] nonane. IR (net) CIT1: 2108,1694 MS (m / z): 273 (MH +)
^-NMR (CDC 1 a ) 5 : 7.40-7.20 (m, 5H),5.02(d, 1 H, J = 15.0Hz), 4· 15( dd, 1H, J =2.7,4.2Hz), 4.07( d, 1 H, J = 15.0Hz) , 4.04-3.92 (m, 1H), 3.87( d, 1H, J 二4.2H z ) , 3.46-3.31 (m, 2 H) , 2.26-2· 12 (m, 1 H) , 1.73-1.28 (m, 3 H) 〔製程2〕: 將前製程1所得化合物9. 3克仿實施例A製程5(1)處 理,得(1R* ,6R* ,9R* )-9-胺基-7-苄基 _2_ 哼-7- -4 1 - 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) (請先閲讀背面之注意事項再填寫本頁) -ΙΓ · -裝· 491848 A7 B7 經濟部中央標準局員工消費合作社印製 五、發明説明(和) 吖雙璟〔4·3·0〕壬烷7.2克0 IR(淨)c 通-1 : 3 36 5 MS (m/z) :233 (MH+ ) - NMR(CDC13)(5: 7.40-7. 18 (m, 5 Η) , 4· 10 - 3·97 (m, 1 Η) , 3.93 (d, 1 H, J = 15· 0Hz) , 3· 66 ( d d , 1 H, J = 4.2, 2.5Hz) , 3.52-3.33 (m, 3 H) , 2.21-1.52 (m, 5 H) , 1.40 -1.24 (m, 1 H) 〔製程3〕: 將前製程2所得化合物7· 2克仿實施例A製程5(2)處 理,得(1R* ,6S* ,9R* )-7 -苄基- 9- (第三丁氣羰胺基) -2 -丨f-7 -吖雙環〔4·3·0〕壬烷9.5克。 融點:82-84 °C I R (KB r) cm 叫:3446· 1711 MS (m/z) : 333 (MH+ ) ία) D 30 +41. 3° (c = K 00,甲醇) ^-NMR (CDC 1 3 ) o : 7.38-7.15 (m, 5H)5,21(br d, 1 H, J=8.3Hz ) , 4.27-4.09 (m, 1 H) , 4.07-3.96 (m, 1 H), 3.94(d, 1H, J= 15.0Hz), 3.83( dd, 1H, J =4.8, 2· 5Hz), 3.51-3.34 (m, 1H), 3,33( d, 1 H, J =15.0Hz) , 2.92-2.64 (m, 3 H) , 2.21-1.88 (m, 2 H) , 1.74-1.24 (m, 2 H) , 1.40 (s, 9H) 〔製程4〕: 將前製程3所得化合物9·1克仿實施例A製程6處理 ,得目的之(1R* ,6S* ,9S* )-9-(第三丁氣羰胺基)-2- -42- t___ (請先閱讀背面之注意事項再填· 裝-- :寫本頁)^ -NMR (CDC 1 a) 5: 7.40-7.20 (m, 5H), 5.02 (d, 1 H, J = 15.0Hz), 4.15 (dd, 1H, J = 2.7, 4.2Hz), 4.07 ( d, 1 H, J = 15.0 Hz), 4.04-3.92 (m, 1H), 3.87 (d, 1H, J 4.2H z), 3.46-3.31 (m, 2 H), 2.26-2 · 12 (m , 1 H), 1.73-1.28 (m, 3 H) [Process 2]: 9.3 g of the compound obtained in the previous process 1 was processed as in process 5 (1) of Example A to obtain (1R *, 6R *, 9R * ) -9-Amino-7-benzyl_2_ Hum-7- -4 1-This paper size applies to China National Standard (CNS) A4 (210X297 mm) (Please read the precautions on the back before filling this page ) -ΙΓ · -Installation · 491848 A7 B7 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 5. Description of the invention (and) Acridine [4 · 3 · 0] Nonane 7.2g 0 IR (Net) c 通 -1 : 3 36 5 MS (m / z): 233 (MH +)-NMR (CDC13) (5: 7.40-7. 18 (m, 5 Η), 4 · 10-3 · 97 (m, 1 Η), 3.93 (d, 1 H, J = 15.0 Hz), 3.66 (dd, 1 H, J = 4.2, 2.5 Hz), 3.52-3.33 (m, 3 H), 2.21-1.52 (m, 5 H), 1.40 -1.24 (m, 1 H) [Process 3]: 7.2 g of the compound obtained in the previous process 2 is treated as in the process 5 (2) of Example A to obtain (1R *, 6S *, 9R *)-7-benzyl-9- (third butane carbonylamino) -2-丨 f-7-azinebicyclo [4 · 3 · 0] nonane 9.5 g. Melting point: 82-84 ° CIR (KB r) cm is called: 3446 · 1711 MS (m / z): 333 (MH +) D 30 +41. 3 ° (c = K 00, methanol) ^ -NMR (CDC 1 3) o: 7.38-7.15 (m, 5H) 5,21 (br d, 1 H, J = 8.3Hz), 4.27-4.09 (m, 1 H), 4.07-3.96 (m, 1 H), 3.94 (d, 1H, J = 15.0Hz), 3.83 (dd, 1H, J = 4.8, 2.5Hz), 3.51-3.34 (m, 1H), 3,33 (d, 1 H, J = 15.0Hz), 2.92-2.64 (m , 3 H), 2.21-1.88 (m, 2 H), 1.74-1.24 (m, 2 H), 1.40 (s, 9H) [Process 4]: 9.1 g of the compound obtained in the previous process 3 was simulated as in Example A Process 6 processing, the purpose is (1R *, 6S *, 9S *)-9- (Third Butane Carboxamido) -2- -42- t___ (Please read the precautions on the back before filling and filling- : Write this page)
、1T .—Aw* 象紙ft尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 491848 A7 B7 五、發明説明(4ί ) 哮-卜吖雙環〔4·3·0〕壬烷5.9克。 IR(淨)CBT1 : 3 4 51, 1710, 1 1 7 0 MS (m/z) : 243 (MH+ ) U〕D 30 - 4 1 · 1 〇 (c = 1 · 0 3,甲酵) !H-NMR (CDC 1 3 ) (5 : 5. 17 (b r , 1 Η),4· 30_4· H) (m, 1 H) , 4.01-3.87 (m, lH),3.69(dd, 1 H, J =4.2, 2· 2Hz), 3.44-3.22 (m,2 H),3,08 (br,1H), 2· 84( dd, 1H,J = 11. 0, 7·2Ηζ ), 2. 00- 1.70 (m, 5 H), 1.45 (s , 9 Η) 實 施例G (1R* ,5S* ,8R* ^ )-8 -(N- 第 三丁 氣羰 基甲 胺基卜2-啤 -6 -吖雙璟〔 3 . 3 . D 丨〕辛 烷 (化合物II :R i *= Β ο c ; R 2 =M e ;R Ξ 3,R / % , R 5 f R 8 f S C )=Η ; m = 0 ; η = =1 ; p= 0 ) 〔製程1〕: 將氫化雙(2-甲氣乙氣基)虧納之70%甲苯溶液36·7克 溶在甲苯120111而冰冷後,加實施例Α製程5(2)所得之 (1R* ,5R* ,8S* )-6-苄基-8-(第三丁氣羰胺基)-2-1等 經濟部中央標準局員工消費合作社印製 (請先閱讀背面之注意事項再填寫本頁) -6-吖雙環〔3·3·0〕辛烷8.1克,徐徐加熱至10fl°C,攪 拌2小時。冰冷後,加冰而分解多餘之試劑後,加10% NaOH水,以乙酸乙酯萃取,以無水硫酸鎂乾燥,減壓蒸 除溶劑,加甲醇150al及二碩酸二第三丁酯7·2克,在室 溫攪拌一夜。減壓濃縮後,在矽膠柱層析(正己烷:乙 酸乙酯=5: 1),得(1R* ,5S* ,8R* )-6 -苄基- 8- (Ν -第 三丁氣羰基甲胺基吖雙環〔3·3·0〕辛烷8β1 -43- 本紙張尺度適用中國國家標準(CNS ) Α4規格(21〇X:297公釐) 經濟部中央標準局員工消費合作社印製 491848 A7 B7 五、發明説明(Ο ) 克。 IR(淨)Cl·1 : 2972,1698 MS (m/z) : 333 (MH+ ) ^-NMR (CDC 1 3 ) (5 : 7.38-7.20 (m, 5H),4.63(dd, 1 H,J=6.5, 4·5Ηζ) , 4· 18-4.02 (m, 1 Η) , 3.98-3.80 (m, 3 Η) , 3.41 (d, 1 Η, J=13.0Hz), 3.35-3.25 (m, 1 Η) , 2.95 (d d, 1 Η, J=9.0, 7·5Ηζ) , 2·85 (s,3Η) , 2.42 (d d, 1 Η, J=10.0, 9.0Hz), 1.86-1.59 (m, 2 Η) , 1.43 (s, 9 Η) 〔製程2〕: 將前製程1所得化合物8.1克溶在乙醇15Gil,加5% P d - C 8 0 0 b g ,在4 0 °C吸收理論量氫,濂除觭媒,減壓蒸 除溶劑,得目的之(1R* ,5S* ,8ΙΤ )-8-(N-第三丁氣羰 基甲胺基)-21琴-6-吖雙環〔3·3·0〕辛烷5·9克。 IR (淨)CH-1 : 3 3 4 8 , 2 9 7 3 , 1 6 8 2 MS (m/z) : 243 (MH+ ) (a) D 30 - 5 6. 3 ° (c = 1 . 0 5,甲醇) 1H — NMR (CDC 1 3 ) ά : 4.52 (d d, 1 H, J =6· 0,3. 0Hz) , 4· 11 (d t, 1 Η, 7.5, 3. ΟΗζ), 3. 97-3. 74 (m, 3 Η), 3.21 (d d, 1 Η, J = 11.0, 7.5Ηζ ) , 2.97 (d d, 1 Η, 11.0, 7.5Hz ) 2. 87 ( s , 3 Η) ,2· 11-1.91 (m, 1 Η), 1.83- 1.67 (m, 1 Η), 1.73 (b r s , 1 Η) , 1.46 ( s, 9 Η) 實施例Η (lR* , 5 s* ,8S * ) -8-(Ν-第 三丁氣 羰 基 甲胺 基)- 2 - ϊ§ -6-吖雙環〔3.3.0〕辛烷 -44- 本紙涞尺廣4《中躪《家螵率(CNS ) A4規格(210X 297公釐) 零裝! (請先閲讀背面之注意事項再填寫本頁) 訂 491848 經濟部中央標準局員工消費合作社印製 A7 B7五、發明説明(43 ) (化合物 II: Ri = Boc; R2 = Me; R3 ,R4 ,R8 , R9=H;粗=0:11=1:0=0) 〔製程1〕: 仿實施例G之製程1 ,得(1R* ,5S· ,8S* )-6-苄基 -8-(N-第三丁氣羰基甲胺基)-2-枵-6-吖雙環〔3·3·0〕 辛烷。 IR(淨)car1 : 1682 MS (m/z) : 333 (MH+ ) !Η —NMR(CDC13)(5: 7·20-7.38 (m, 5 Η) , 4.47-4.56 (m, 1 Η) , 4.00-3.84 (m, 2 Η),3.95 (d, 1 H, J = 15.0Hz), 3. 30 ( d, 1H, J= 15.0Hz), 3.25-3.17 (m, 1H), 2· 94-2· 85 (m, 1 H) , 2.85 (m, 3 H) , 2.52-2.35 (m, 1 H) , 2.05-1.72 (m, 3H) , 1.45 (s, 9H) 〔製程2〕: 將前製程1所得化合物9. 5克仿實施例G之製程2處 理,得目的之(lR* ,5S* ,8S* )-8-(N-第三丁氣羰基甲 胺基)-2-»§-6-吖雙環〔3·3·0〕辛烷5.0克〇 I R (淨)c IT1 : 16 9 2 MS (m/z) : 243 (MH+ ) ^-NMR (CDC 1 3 ) ά : 4.39 ( t , 1 Η, J=5.0Hz ) , 4.29-4. 10 (br,1 Η) , 3.98-3.70 (m,3 Η),2·99 (d,2 Η, J 二9.0 Hz ) , 2.93 (s, 3Η) , 2.25-2.07 (m, 1 Η) , 1.88-1.74 (m, 1 Η) , 1.73-1.64 (b r,1 Η) , 1.48 (s, 9 Η) -45- (請先閱讀背面之注意事項再填寫本頁) .U___9— •裝_ 、1Τ J---5-. 本紙張又度適用中國國家標準(CNS ) Α4規格(21 〇 X 297公釐) 經濟部中央標準局員工消費合作社印製 491848 A7 B7 五、發明説明(斜)、 1T .—Aw * The size of the paper ft is applicable to the Chinese National Standard (CNS) A4 specification (210X297 mm) 491848 A7 B7 V. Description of the invention (4ί) Hou-buacic bicyclo [4 · 3 · 0] nonane 5.9 g . IR (net) CBT1: 3 4 51, 1710, 1 1 7 0 MS (m / z): 243 (MH +) U] D 30-4 1 · 1 〇 (c = 1 · 0 3, formazan)! H -NMR (CDC 1 3) (5: 5. 17 (br, 1 Η), 4.30_4 · H) (m, 1 H), 4.01-3.87 (m, lH), 3.69 (dd, 1 H, J = 4.2, 2.2 Hz), 3.44-3.22 (m, 2 H), 3,08 (br, 1H), 2.84 (dd, 1H, J = 11. 0, 7 · 2Ηζ), 2. 00- 1.70 (m, 5 H), 1.45 (s, 9 Η) Example G (1R *, 5S *, 8R * ^) -8-(N- tertiary butane carbonylmethylaminobull 2-beer-6- Acridine [3.3. D 丨] octane (Compound II: Ri * = Βοc; R 2 = Me; R Ξ 3, R /%, R 5 f R 8 f SC) = Η; m = 0; η = = 1; p = 0) [Process 1]: Dissolve 36.7 g of 70% toluene solution of hydrogenated bis (2-methylethane) based on toluene in 120111 and ice-cool, add Example A (1R *, 5R *, 8S *)-6-benzyl-8- (third butanecarbonylamino) -2-1 and other consumer cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs Printed (please read the precautions on the back before filling in this page) -8.1 g of 6-acylbicyclo [3 · 3 · 0] octane, slowly heat to 10fl ° C, and stir for 2 hours. After ice-cooling, add ice to decompose excess reagents, add 10% NaOH water, extract with ethyl acetate, dry over anhydrous magnesium sulfate, evaporate the solvent under reduced pressure, add 150al of methanol and di-tert-butyl di-ortho-acid 7 · 2 grams, stirred overnight at room temperature. After concentration under reduced pressure, chromatography on a silica gel column (n-hexane: ethyl acetate = 5: 1) gave (1R *, 5S *, 8R *)-6-benzyl-8- (N-third butanecarbonyl) Methylamino acryl bicyclo [3 · 3 · 0] octane 8β1 -43- This paper size applies to China National Standard (CNS) A4 specification (21 × X: 297 mm) Printed by the Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs 491848 A7 B7 V. Description of the invention (0) g. IR (net) Cl · 1: 2972,1698 MS (m / z): 333 (MH +) ^ -NMR (CDC 1 3) (5: 7.38-7.20 (m, 5H), 4.63 (dd, 1 H, J = 6.5, 4.5 Ηζ), 4.18-4.02 (m, 1 Η), 3.98-3.80 (m, 3 Η), 3.41 (d, 1 Η, J = 13.0Hz), 3.35-3.25 (m, 1 Η), 2.95 (dd, 1 Η, J = 9.0, 7.5Ηζ), 2.85 (s, 3Η), 2.42 (dd, 1 Η, J = 10.0, 9.0Hz), 1.86-1.59 (m, 2 Η), 1.43 (s, 9 Η) [Process 2]: Dissolve 8.1 g of the compound obtained in the previous process 1 in 15Gil of ethanol, and add 5% P d-C 8 0 0 bg Absorb the theoretical amount of hydrogen at 40 ° C, remove the solvent, evaporate the solvent under reduced pressure to obtain the target (1R *, 5S *, 8ΙΤ) -8- (N-third butanecarbonylmethylamino)- 21 Qin-6-acylbicyclo [3 · 3 · 0] octane 5.9 g IR (net) CH-1: 3 3 4 8, 2 9 7 3, 1 6 8 2 MS (m / z): 243 (MH +) (a) D 30-5 6. 3 ° (c = 1.0 0.05, methanol) 1H — NMR (CDC 1 3) ά: 4.52 (dd, 1 H, J = 6.0, 3.0 Hz), 4.11 (dt, 1 Η, 7.5, 3. ΟΗζ), 3. 97-3. 74 (m, 3 Η ), 3.21 (dd, 1 Η, J = 11.0, 7.5Ηζ), 2.97 (dd, 1 Η, 11.0, 7.5Hz) 2. 87 (s, 3 Η), 2.11-1.91 (m, 1 Η) , 1.83- 1.67 (m, 1 Η), 1.73 (brs, 1 Η), 1.46 (s, 9 Η) Example Η (lR *, 5 s *, 8S *) -8- (Ν- 三 丁 气Carboxymethylamino)-2-ϊ§ -6-Acridine bicyclic [3.3.0] octane-44- This paper has a wide range of 4 "Chinese paper" "Household Ratio (CNS) A4" (210X 297 mm) !! (Please read the notes on the back before filling this page) Order 491848 Printed by the Consumer Standards Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs A7 B7 V. Invention Description (43) (Compound II: Ri = Boc; R2 = Me; R3, R4, R8, R9 = H; Coarse = 0: 11 = 1: 0 = 0) [Process 1]: Process 1 of Example G is imitated to obtain (1R *, 5S ·, 8S *)-6-benzyl-8- (N-Third butanecarbonylmethylamino) -2-fluorene-6-acylbicyclo [3.3.0] octane. IR (net) car1: 1682 MS (m / z): 333 (MH +)! Η—NMR (CDC13) (5: 7.20-7.38 (m, 5 Η), 4.47-4.56 (m, 1 Η), 4.00-3.84 (m, 2 Η), 3.95 (d, 1 H, J = 15.0Hz), 3. 30 (d, 1H, J = 15.0Hz), 3.25-3.17 (m, 1H), 2.94- 2.85 (m, 1 H), 2.85 (m, 3 H), 2.52-2.35 (m, 1 H), 2.05-1.72 (m, 3H), 1.45 (s, 9H) [Process 2]: 9.5 g of the compound obtained in Process 1 was treated in Process 2 of Example G to obtain the target (lR *, 5S *, 8S *)-8- (N-third butanecarbonylmethylamino) -2- »§ -6-Acridine bicyclo [3 · 3 · 0] octane 5.0 g 〇IR (net) c IT1: 16 9 2 MS (m / z): 243 (MH +) ^ -NMR (CDC 1 3) ά: 4.39 ( t, 1 Η, J = 5.0Hz), 4.29-4. 10 (br, 1 Η), 3.98-3.70 (m, 3 Η), 2.99 (d, 2 Η, J 2 9.0 Hz), 2.93 ( s, 3Η), 2.25-2.07 (m, 1 Η), 1.88-1.74 (m, 1 Η), 1.73-1.64 (br, 1 Η), 1.48 (s, 9 Η) -45- (Please read the back first Please pay attention to this page and fill in this page again). U ___ 9— • Packing _, 1T J --- 5-. This paper is again applicable to China National Standard (CNS) Α4 Specification (2 0 × 297 mm) Employees of the Central Standards Bureau of the Ministry of Economic Affairs Consumer cooperatives 491848 A7 B7 braking five invention is described (uphill)
實施例J (1R* ,5S* ,8R*卜8-三覦乙醯胺基-2-鸣-6-吖雙環 〔3 · 3 · 0〕辛烷 (化合物 II: Ri = C0CF3 ; R2 ,Ra ,R4 ,Rs ,Rs , R 9 = H ; m = 0 ; n = 1 ; p = 0 ) 〇 〔製程1〕: 實施例A製程5(1)所得(1R* ,5^ ,8S* )-8-胺基-6- 苄基-2-枵-6-吖雙璟〔3·3·0〕辛烷4·8克投入二氯甲烷 150nl,而冰冷後,徐徐加無水三氟乙酸6.9克之二氯甲 烷50β1溶液。攪拌一夜後,加氛仿,分取有機層,以無 水硫酸鎂乾燥,減壓蒸除溶劑,在矽膠柱層析(正己烷 :乙酸乙酯=1: 1)。所得祖結晶從二氛甲烷-正己烷之 混液再結晶,得(1R* ,5R* ,8S* )-6-苄基-8-三氟乙醯 胺基HI-6-吖雙琛〔3.3.0〕辛烷4.7克。Example J (1R *, 5S *, 8R *, 8-trimethylacetamido-2-ming-6-azabicyclo [3 · 3 · 0] octane (Compound II: Ri = COCF3; R2, Ra , R4, Rs, Rs, R 9 = H; m = 0; n = 1; p = 0) 〇 [Process 1]: (1R *, 5 ^, 8S *) obtained in the process 5 (1) of Example A 8-amino-6-benzyl-2-fluorene-6-azepine [3 · 3 · 0] octane 4.8g was put into 150nl of dichloromethane, and after ice cooling, 6.9g of anhydrous trifluoroacetic acid was slowly added A 50β1 solution of dichloromethane. After stirring overnight, dichloromethane was added, the organic layer was separated, dried over anhydrous magnesium sulfate, the solvent was distilled off under reduced pressure, and the product was subjected to silica gel column chromatography (n-hexane: ethyl acetate = 1: 1). The ancestral crystal was recrystallized from a mixture of dichloromethane and n-hexane to obtain (1R *, 5R *, 8S *)-6-benzyl-8-trifluoroacetamido HI-6-azepine [3.3.0 ] 4.7 grams of octane.
融點:1 5 β - 1 5 4 °C I R (KB r ) cm -*1: 3305, 1702, 1180 MS (m/z) : 315 (MH+ )Melting point: 1 5 β-1 5 4 ° C I R (KB r) cm-* 1: 3305, 1702, 1180 MS (m / z): 315 (MH +)
Ca) 〇 30 一 4. 6° (c = 1 . 0 0, 甲醇) !H~NMR (CDC 1 a ) (5 : 7.40-7.20 (m, 5 H) , 6. 50 ( b r , i H) , 4.34 (d d, 1 H, J =7.0· 4.0Hz) , 4.25—4. 11 (m, 1 H), 3.98 -3.76 (m, 3 H), 3.58 - 3.46 (m, 2 H), 3.15 (dd, 1H, J=9.5, 6·0Ηζ), 2.33(dd, 1H, J 二 9.5,7.0Hz), 1.94-1.64 (m, 2 H) -46- 本纸張尺度適用中國國家標準(CNS 蟢i 2iOx 297公釐) (請先閲讀背面之注意事項再填寫本頁)Ca) 〇30-4.6 ° (c = 1.0, methanol)! H ~ NMR (CDC 1 a) (5: 7.40-7.20 (m, 5 H), 6. 50 (br, i H) , 4.34 (dd, 1 H, J = 7.0 · 4.0Hz), 4.25-4.11 (m, 1 H), 3.98 -3.76 (m, 3 H), 3.58-3.46 (m, 2 H), 3.15 ( dd, 1H, J = 9.5, 6 · 0Ηζ), 2.33 (dd, 1H, J 2 9.5, 7.0Hz), 1.94-1.64 (m, 2 H) -46- This paper size applies to the Chinese national standard (CNS 蟢i 2iOx 297 mm) (Please read the notes on the back before filling this page)
、1T #1 491848 經濟部中央標準局員工消費合作社印製 A7 ____ B7五、發明説明(4J:) , 〔製程2〕 將前製程1所得化合物6.0克溶在乙醇IOObI,加10% Pd-C 6 0 0ttg,在50〜60°C吸收理論量氫後,濾除觸媒, 減壓蒸除溶劑,從氛仿-正己烷再結晶,得目的之(1R* ,5S* ,8R* )-8-三氟乙醛胺基m-6-吖雙環〔3.3.0〕 辛烷4 . 0克。融點:1 0 6 - 1 1 0 °C IR (KBr) cm*1: 3319, 1706, 1559, 1180 MS (m/z) : 225 (MH+ ) Ca) D 30 一 40. 5。 (c=l· 00,甲醇) 1H — NMR (CDC 1 3 ) δ : 6.69 (b r, 1 H) , 4· 34 - 4. 21 (m, 2 H) , 4. 08-3. 72 (m, 3 H) , 3. 28 ( d d , 1 H, J = 1L0. 5.0Hz ),2.90 (d d d, 1 H, J = 11.0. 3.5, 1.0Hz), 2.24-2.05 (m, 1 H) , 1.85-1.68 (m, 2 H) 實施例K (1R11 ,5S* ,8S* )-8-(第三丁氣羰胺基)-3-甲基-2 -鸣-6-吖雙環〔3 · 3 · 0〕辛烷 (化合物 II: Ri = Boc; R2 ,ΙΪ3 ,Rs ,R8 ,^9 = H; R 4 = M e ; 1=0; n = 1 ; p = 0 ) 〔製程1〕: 以 D-酒石酸為原料依 J.Org· Chea.U,103-108(1995) 製造之(31^,48*,51^)-5-烯丙基-1-苄基-3,4-雙(第 三丁基二甲基矽烷氣基)-2 -吡咯啶酮150克乙醇500ml及 濃鹽酸2 Q m 1之混合物攪拌加熱5 0 °C 2日後,減壓濃縮而 -47- 裝-- (請先閲讀背面之注意事項再填寫本頁) V__ 、1Τ #, 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 491848 A7 ______B7_ 五、發明説明(6) 加水,以正己烷洗淨,以氛仿萃取而以無水硫酸鎂乾燥 ,減壓蒸除溶劑,加乙醚及正己烷,濾集結晶,得 (311*,48||,511||)-5-烯丙基-1-苄基-3,4-二羥基-2-吡 咯啶酮24 . 8克。 融點:9 0 - 9 3 T: 1 R (KB r ) cm -1: 3345, 1682 MS (m/z) : 248 (MH+ ) ^-NMR (C DC 1 3 ) δ : 7.38-7.14 (m, 5 H) , 5.92-5.64 (m, 1 H) , 5.27-4.95 (m, 4 H) , 4.53-4.14 (m, 3 H) , 3.99 (d, 1 H, J = 15· OHz) , 3.62-3.47 (m, 1 H) , 2.60-2.26 (m, 2 H) 〔製程2〕: 於二氯甲烷50 G ml溶解前製程1所得化合物15克,碘 化鈉45克及18-冠-6 5克,冰冷下激烈攪拌,徐徐滴加 間氛過苯甲酸19.5克之二氯甲烷溶液500ul,在室溫攪拌 一夜後,加氯仿及NaOH水,分取有機層,以硫代硫酸鈉 水洗淨,以無水硫酸鎂乾燥,減壓蒸除溶劑,在矽膠柱 層析(氯仿:甲醇= 30: 1),得(1R* ,5S· ,8S* )-6-苄 經濟部中央標準局員工消費合作社印製 基-8-羥基-3-碘甲基-7-氣-2-Ϊ琴-6-吖雙璟〔3.3.0〕辛 烷13.8克。 IR(淨)cm: 3364,1682 MS (m/z) : 374 (MH+ ) ^-NMRCCDCla)^: 7.41-7. 19 (m, 5 Η) , 4.93 (d, J = 14·5Ηζ)及4·88 (d, J = 14.5Hz)共為 1 Η, 4· 64-4.32 (m, 2 Η) , 4. 26-3. 84 (m, 3 Η) , 3. 52 ( b r s , 1 Η) , 3. 30-3. 12 (m, 2 Η) , 2.30-2. 13 (m, 1 Η) , 1.74-1.54 (m, 1 Η) 一 48- (請先Μ讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準(CNS ) Α4規格(21〇 X 馨 491848 經濟部中央標準局員工消費合作社印製 A7 B7五、發明説明(47 ) 〔製程3〕 將前製程2所得化合物14克溶在甲醇200®1,加三乙 胺6·9ιι1及5%Pd-C 1·4克,在室溫吸收理論量氫後,濾 除觸媒,減壓蒸除溶劑,加水及氯仿,分取有機層,以 稀鹽酸水及水洗淨,以無水硫酸鎂乾燥,減壓蒸除溶劑 ,得(1R* ,5S* ,8S* )-6 -节基-8-經基-3-甲基-7-氣- 2- 枵-6-吖雙環〔3·3·0〕辛烷10.9克。 IR(淨)c通-1 : 3351,1682 MS (ια/ζ) : 2 4 8 (MH+ ) ^-NMR (CDC 1 3 ) (5 : 7.41-7. 18 (m,· 5 Η) , 4· 90 ( d,1 Η, J = 15· 0Hz) , 4· 45-4· 31 (m, 3 Η) , 4.18-3.87 (m, 3 Η), 2.20-1.95 (m, 1 Η) , 1.48-1.20 (m, 4 Η) 〔製程4〕: 將前製程3所得化合物8.4克仿實施例Α製程4處理 ,得(IR* ,5S* ,8ΙΤ )-8-昼氤基-6-芣基-3-甲基-7-氣 -2-鸣-6-吖雙環〔3.3.0〕辛烷6.2克。 IR (淨)cm: 2108,1694 MS (m/z) : 2 7 3 (MH+ ) 1 H-NHR(CDC1 3 ) δ : 7 · 4 1 - 7 · 1 8 (姐,5Η), 5 . 0 5 ( d , J = 15·0Ηζ)及 4.98(d,J= 15·0Ηζ)共為 lH,4.67(dd,J = 5.0 6·0Ηζ)及 4.44(t,J=6.0Hz)共為 1H, 4.24-3.87(m,4H), 2,32-2. 11(βι,1Η),1.74-1.39(m,lH),1.29(d,J = 6.0Hz) 及 1.27(d,J=6.0Hz)共為 3H) 〔製程5〕: -49- (請先閱讀背面之注意事項再填寫本頁) -裝· 訂 丨%丨 4、紙供>1瓊遏用中國國家標準(CNS ) A4規格(210X297公釐) 491848 A7 B7_ 五、發明説明(4 ) 將前製程4所得化合物8 .2克仿實施例A之製程5處理 ,得(1R* ,5R* ,8R* )-6 -苄基-8-(第三丁氣羰胺基)-3- 甲基- 2-1琴-6-叮雙環〔3·3·0〕辛院10.1克。 IR(淨)cm·1 : 3447,1714 MS (m/z) : 333 (MH+ ) !H-NMR (CDC 1 a ) ά : 7.34-7.21 (m, 5 Η) , 5. 20 ( b r m, 1 Η) , 4·57 ( t, J=6.0Hz )及 4.35 ( t, J=6.0Hz )共為 1 H, 4.26-3.28 (m, 5 H) , 2.99-2.45 (m, 2 H) , 2.09-1.60 (m, 2 H) , 1· 44 ( s , 9 Η) , 1. 32-1· 21 (m, 3 H) 〔製程6〕: 將前製程5所得化合物9· 7克仿實施例A之製程6處 理,得目的之(1R* ,5S* ,8S* )-8-(第三丁氧羰胺基) -3-甲基-2-B琴-6-吖雙環〔3.3.0〕辛烷6.7克。 IR (淨)cm-1 : 3317,1714 MS(i/z) : 2 4 3 (ΜΗ + ) 1 Η - N H R ( C D C 1 3 ) : 5 · 1 6 ( d , J = 9 · 0 Η ζ )及 5 · 1 8 ( d , J = 9·0Ηζ)共為 1H, 4.19(dd,J = 6.6, 5·4Ηζ)及 4M4(t,J = 5·3Ηζ)共為 lH,3.99(ddd,J = 9.0,6_6, 6·4Ηζ)及 3.98 (dd,J = 6.6,5·3Ηζ)共為 1Η, 3.84(ddq,J=10.7, 5.2, 6 · 0 H z )及 4 · 1 0 ( d d q , J = 9 · 4,4 · 8 , 6 · 0 H z )共為 1 H , 3 · 8 0 (d d d d , J = 1 0 · 6,9 · 0,6 · 6,5 · 4 H z )及 3 · 8 9 ( d d d d , J = 1 0 . 0 ,9·0, 7·1, 5·3Ηζ)共為 1H, 3.16(dd, J=11.3, 6.6 Hz)及 3.28(dd,J= 11·3, 7.1Hz)共為 1H, 2.54(dd,、 1T # 1 491848 Printed by A7 ____ B7 in the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 5. Description of the invention (4J :), [Process 2] Dissolve 6.0 g of the compound obtained in the previous process 1 in ethanol 100bI, add 10% Pd-C 60 0ttg, after absorbing the theoretical amount of hydrogen at 50 ~ 60 ° C, filter the catalyst, evaporate the solvent under reduced pressure, and recrystallize from chloroform-n-hexane to obtain the target (1R *, 5S *, 8R *)- 8-trifluoroacetaldehyde amino m-6-acylbicyclo [3.3.0] octane 4.0 g. Melting point: 1 0 6-1 10 ° C IR (KBr) cm * 1: 3319, 1706, 1559, 1180 MS (m / z): 225 (MH +) Ca) D 30-40.5. (C = 1, 00, methanol) 1H — NMR (CDC 1 3) δ: 6.69 (br, 1 H), 4.34-4. 21 (m, 2 H), 4. 08-3. 72 (m , 3 H), 3. 28 (dd, 1 H, J = 1L0.5.0Hz), 2.90 (ddd, 1 H, J = 11.0. 3.5, 1.0Hz), 2.24-2.05 (m, 1 H), 1.85 -1.68 (m, 2 H) Example K (1R11,5S *, 8S *)-8- (Third butanecarbonylamino) -3-methyl-2 · 0] Octane (Compound II: Ri = Boc; R2, IΪ3, Rs, R8, ^ 9 = H; R4 = Me; 1 = 0; n = 1; p = 0) [Process 1]: To D-tartaric acid (31 ^, 48 *, 51 ^)-5-allyl-1-benzyl-3,4-bis (31 ^, 48 *, 51 ^) manufactured by J. Org · Chea.U, 103-108 (1995) Tertiary butyl dimethylsilyl gas group)-2-Pyrrolidone 150 g of ethanol 500 ml and concentrated hydrochloric acid 2 Q m 1 of the mixture was stirred and heated at 50 ° C for 2 days, then concentrated under reduced pressure and -47- pack-( Please read the notes on the back before filling in this page) V__ 、 1Τ #, This paper size is applicable to China National Standard (CNS) A4 specification (210X297 mm) 491848 A7 ______B7_ 5. Description of the invention (6) Add water and wash with n-hexane Net, extracted with atmospheric imitation and dried over anhydrous magnesium sulfate, evaporated under reduced pressure After adding ether and n-hexane, the crystals were collected by filtration to obtain (311 *, 48 ||, 511 ||) -5-allyl-1-benzyl-3,4-dihydroxy-2-pyrrolidone 24. 8 grams. Melting point: 9 0-9 3 T: 1 R (KB r) cm -1: 3345, 1682 MS (m / z): 248 (MH +) ^ -NMR (C DC 1 3) δ: 7.38-7.14 (m , 5 H), 5.92-5.64 (m, 1 H), 5.27-4.95 (m, 4 H), 4.53-4.14 (m, 3 H), 3.99 (d, 1 H, J = 15.0 Hz), 3.62 -3.47 (m, 1 H), 2.60-2.26 (m, 2 H) [Process 2]: 15 g of compound obtained in process 1 before dissolving in 50 G ml of dichloromethane, 45 g of sodium iodide and 18-crown-6 5 grams, stir vigorously under ice cold, slowly add 500ul of dichloromethane solution of 19.5 grams of isobenzoic acid, and stir overnight at room temperature, add chloroform and NaOH water, separate the organic layer, and wash with sodium thiosulfate , Dried over anhydrous magnesium sulfate, distilled off the solvent under reduced pressure, and subjected to silica gel column chromatography (chloroform: methanol = 30: 1) to obtain (1R *, 5S ·, 8S *)-6-benzyl employees of the Central Standards Bureau of the Ministry of Economic Affairs Cooperative printed 13.8 g of base-8-hydroxy-3-iodomethyl-7-gas-2-pyrene-6-azepine [3.3.0] octane. IR (net) cm: 3364,1682 MS (m / z): 374 (MH +) ^ -NMRCCDCla) ^: 7.41-7. 19 (m, 5 Η), 4.93 (d, J = 14.5Ηζ) and 4 88 (d, J = 14.5Hz) total 1 Η, 4.64-4.32 (m, 2 Η), 4. 26-3. 84 (m, 3 Η), 3. 52 (brs, 1 Η) , 3. 30-3. 12 (m, 2 Η), 2.30-2. 13 (m, 1 Η), 1.74-1.54 (m, 1 Η)-48- (Please read the precautions on the back before filling (This page) This paper is in accordance with China National Standards (CNS) A4 specifications (21〇X 491848 Printed by A7 B7, Consumer Cooperatives of the Central Standards Bureau, Ministry of Economic Affairs. 5. Description of the invention (47) [Process 3] The compound obtained in the previous process 2 14 grams dissolved in methanol 200®1, plus 4.9 grams of triethylamine and 1.4 grams of 5% Pd-C. After the theoretical amount of hydrogen was absorbed at room temperature, the catalyst was filtered off, the solvent was distilled off under reduced pressure, and water and chloroform were added. , The organic layer was separated, washed with dilute hydrochloric acid water and water, dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure to obtain (1R *, 5S *, 8S *)-6-septyl-8-jingji-3 -Methyl-7-gas- 10.9 g of 2- fluorene-6-acylbicyclo [3 · 3 · 0] octane. IR (net) c-pass-1: 3351,1682 MS (ια / ζ): 2 4 8 (MH +) ^-NMR (CDC 1 3) (5: 7.41-7. 18 (m, 5 Η), 4.90 (d, 1 Η, J = 15.0 Hz), 4.45-4 · 31 (m, 3 Η), 4.18-3.87 (m, 3 Η), 2.20-1.95 (m, 1 Η), 1.48-1.20 (m, 4 Η) [Process 4]: 8.4 g of the compound obtained in the previous Process 3 was treated as in Example A, Process 4 to obtain (IR *, 5S *, 8ΙΤ) -8-dayyl 6.2 g of 6-fluorenyl-3-methyl-7-gas-2-ming-6-acylbicyclo [3.3.0] octane. IR (net) cm: 2108,1694 MS (m / z): 2 7 3 (MH +) 1 H-NHR (CDC1 3) δ: 7 · 4 1-7 · 1 8 (sister, 5Η), 5. 0 5 (d, J = 15 · 0Ηζ) and 4.98 (d, J = 15 · 0Ηζ) are 1H, 4.67 (dd, J = 5.0 6.00Ηζ) and 4.44 (t, J = 6.0Hz) are 1H, 4.24-3.87 (m, 4H), 2,32-2. 11 ( βι, 1Η), 1.74-1.39 (m, lH), 1.29 (d, J = 6.0 Hz) and 1.27 (d, J = 6.0 Hz) are 3H in total) [Process 5]: -49- (Please read the back first Please pay attention to this page and fill in this page again)-Binding and ordering 丨% 丨 4. Paper supply> 1 Qionghua uses the Chinese National Standard (CNS) A4 specification (210X297 mm) 491848 A7 B7_ V. Description of the invention (4) 8.2 g of the compound obtained in Process 4 was treated as in Process 5 of Example A to obtain (1R *, 5R *, 8R *)-6-benzyl-8- (third butanecarbonylamino) -3-methyl -2-1 Qin-6-Ding Shuanghuan [3 · 3 · 0] Xinyuan 10.1g. IR (net) cm · 1: 3447,1714 MS (m / z): 333 (MH +)! H-NMR (CDC 1 a) : 7.34-7.21 (m, 5 Η), 5. 20 (brm, 1 Η), 4.57 (t, J = 6.0Hz) and 4.35 (t, J = 6.0Hz) are 1 H, 4.26-3.28 (m, 5 H), 2.99-2.45 (m, 2 H), 2.09 -1.60 (m, 2 H), 1.44 (s, 9 Η), 1. 32-1 · 21 (m, 3 H) [Process 6]: 9.7 g of the compound obtained in the previous process 5 is a simulated example The process 6 of A is processed to obtain the target (1R *, 5S *, 8S *)-8- (third butoxycarbonylamino) -3-methyl-2-Bqin-6-acylbicyclo [3.3.0 ] 6.7 grams of octane. IR (net) cm-1: 3317,1714 MS (i / z): 2 4 3 (ΜΗ +) 1 Η-NHR (CDC 1 3): 5 · 1 6 (d, J = 9 · 0 Η ζ) And 5 · 1 8 (d, J = 9 · 0Ηζ) are 1H, 4.19 (dd, J = 6.6, 5. · 4Ηζ) and 4M4 (t, J = 5. · 3Ηζ) are 1H, 3.99 (ddd, J = 9.0, 6_6, 6. · 4Ηζ) and 3.98 (dd, J = 6.6, 5. · 3Ηζ) are 1Η, 3.84 (ddq, J = 10.7, 5.2, 6 · 0 H z) and 4 · 1 0 (ddq, J = 9 · 4, 4 · 8, 6 · 0 H z) are 1 H, 3 · 8 0 (dddd, J = 1 0 · 6, 9 · 0, 6 · 6, 5 · 4 H z) and 3 · 8 9 (dddd, J = 1 0. 0, 9 · 0, 7 · 1, 5 · 3Ηζ) are 1H, 3.16 (dd, J = 11.3, 6.6 Hz) and 3.28 (dd, J = 11 · 3, 7.1Hz) total 1H, 2.54 (dd,
J = 11.3,10·6Ηζ0及 2.50(dd, J = 11.3, 10·0Ηζ)共為 1H -5 0 - 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) (請先閱讀背面之注意事 、丨""0 意事項再填· 裝— 寫本頁) 經濟部中央標準局員工消費合作社印製 491848 A7 B7 五、發明説明(49 )J = 11.3, 10 · 6Ηζ0 and 2.50 (dd, J = 11.3, 10 · 0Ηζ) are 1H-5 0-This paper size applies to China National Standard (CNS) A4 (210X297 mm) (Please read the back Attention, 丨 " " 0 Refill and install the intentions — write this page) Printed by the Employees' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 491848 A7 B7 V. Description of the invention (49)
,2-38(ddd,ί = 12·9ι 9·〇, 5·2Ηζ)及 uKddd, j = 12·9,9·4,6·6Ηζ)共為 1H, 1.83(s,lH), 1.45(s)及 I44(s)共為 9H,i 26(d J = 6 〇Hz)及 i.23(d J = 6 〇Hz) 共為 3H , 1 · 2 3 Udd , J= 12 · 9 , 10 · 7 , 6 · 4Hz ) 1 · 97 (dd,J = 12·9,4·8ΗΖ)共為 1H 實施例L UR* ,5S* ,8S* )-8-(第三丁氣羰胺基)一 3-甲基-2- H辱-6-吖雙環〔3 · 3 · 〇〕辛烷 (化合物 II: Ri :Boc; R2 ,R3 ,Re ,1Ϊ9 = H; R 4 = Me; ii = 〇 ; n = 1 ; p = 0 ) 〔製程1〕: 將實施例K之製程3所得(1R* ,5S* ,8S* )-6 -苄基 -8-羥基-3-甲基-7-氣U琴-6-吖雙璟〔3.3.0〕辛烷 8·7克仿實施例A之製程3處理,得(1R* ,5S* ,8R·) -6-苄基-8-羥基-3-甲基-7-氣-2-鸣-6-吖雙環〔3·3·0〕 辛烷6 · 4克。 融點:98-101°C I R (KB r ) cm 3388. 1692 MS (m/z) : 248 (MH+ ) ^-NMR (CDCla ) δ : 7.40-7. 15 (m, 5 H) , 5.03 (d, J = 15·0Ηζ)及 4.95(d,J=l5.0Hz)共為 1H, 4.60(dd,J = 6.0 ,6·0Ηζ)及 4.46(臟)共為 5H, 3.17(br d,J = 6.0Hz)及 3 · 1 2 ( b r d,J = 6 · 0 H z ) *&1Η,2·32-2·10(ιϊ,1Η),1·73-1.39(m,lH), 1.26(d, 3H, J=6.0Hz) -5 1 - 本紙張尺度適用中國國窜钂攀ί 規格(2丨〇><297公釐) (請先閲讀背面之注意事項再填寫本頁) i裝· 訂 經濟部中央標準局員工消費合作社印製 經濟部中央標準局員工消費合作社印製 491848 A7 B7 五、發明説明(扣) 〔製程2〕 ·· 將前製程1所得化合物6· 5克仿實施例A製程4處理 ,得(1R* ,5S* ,8S* )-8-疊氮基-6-苄基-3-甲基-7-氣 -2-枵-7-吖雙環〔3·3·0〕壬烷5·6克。 融點:7 0 - 7 3 X! I R (KB r ) cm -1: 2122,1690 MS (m/z) : 273 (MH+ ) lH-NMR (C DC 1 3 ) 5 : 7.41-7.19 (m, 5 H) , 4.97 (d, 1 H, J=15.flHz),4.34(dd, J=6.0, 1·5Ηζ)及 4·22-3·89 (B)共為 5H,2·23-2·02(·,1Η), 1.48-1.28(a,1H), I. 26(d, J = 6.0Hz)及 1.24(d, J = 6.0Hz)共為 3Η 〔製程3〕: 將前製程2所得化合物5·6克仿實施例A製程5處理 ,得(1R* ,5R* ,8S* )-6-苄基-8-(第三丁氣羰胺基-3-甲基-2-鸣-6-吖雙環〔3·3·0〕辛烷6.8克。 融點:56-60 X: I R (K B r ) cm -1: 3369,1700 MS (m/z) : 333 (MH+ ) 〔製程4〕: 將前製程3所得化合物6· 8克仿實施例A製程6處理, 得目的之(1R* ,5S* ,8R* )-8-(第三丁氧羰胺基)-3 -甲 基- 2-BI-6 -吖雙環〔3·3·0〕辛烷4·8克。, 2-38 (ddd, ί = 12.9m 9 · 〇, 5 · 2Ηζ) and uKddd, j = 12 · 9, 9 · 4, 6 · 6Ηζ) are 1H, 1.83 (s, lH), 1.45 ( s) and I44 (s) are 9H in total, i 26 (d J = 6 〇Hz) and i.23 (d J = 6 〇Hz) are 3H in total, 1 · 2 3 Udd, J = 12 · 9, 10 · 7, 6 · 4Hz) 1 · 97 (dd, J = 12 · 9, 4 · 8ΗZ) are 1H in total Example L UR *, 5S *, 8S *) -8- (Third butanecarbonylamino group) Monomethyl 3-Hydroxy-6-azabicyclo [3 · 3 · 〇] octane (Compound II: Ri: Boc; R2, R3, Re, 1Ϊ9 = H; R4 = Me; ii = 〇 ; N = 1; p = 0) [Process 1]: (1R *, 5S *, 8S *) obtained from Process 3 of Example K-6-benzyl-8-hydroxy-3-methyl-7-gas Uqin-6-azepine [3.3.0] octane 8.7 g was treated in the same manner as in Process A of Example A to obtain (1R *, 5S *, 8R ·) -6-benzyl-8-hydroxy-3 -Methyl-7-qi-2-Ming-6-azepine bicyclo [3 · 3 · 0] octane 6.4 g. Melting point: 98-101 ° CIR (KB r) cm 3388. 1692 MS (m / z): 248 (MH +) ^ -NMR (CDCla) δ: 7.40-7. 15 (m, 5 H), 5.03 (d , J = 15 · 0Ηζ) and 4.95 (d, J = l5.0Hz) are 1H, 4.60 (dd, J = 6.0, 6. · 0 · ζ) and 4.46 (dirty) are 5H, 3.17 (br d, J = 6.0Hz) and 3 · 1 2 (brd, J = 6 · 0 H z) * & 1Η, 2.32-2 · 10 (ιϊ, 1Η), 1.73-1.39 (m, lH), 1.26 ( d, 3H, J = 6.0Hz) -5 1-The size of this paper is applicable to Chinese specifications (2 丨 〇 > < 297 mm) (Please read the precautions on the back before filling this page) i Binding · Printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs and printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs and printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 491848 A7 B7 V. Description of the invention (deduction) [Process 2] Example A is processed in process 4 to obtain (1R *, 5S *, 8S *)-8-azido-6-benzyl-3-methyl-7-gas-2-fluorene-7-acylbicyclo [3 · 3.0] 5.6 grams of nonane. Melting point: 7 0-7 3 X! IR (KB r) cm -1: 2122, 1690 MS (m / z): 273 (MH +) lH-NMR (C DC 1 3) 5: 7.41-7.19 (m, 5 H), 4.97 (d, 1 H, J = 15.flHz), 4.34 (dd, J = 6.0, 1.5 · ζ) and 4.22-3 · 89 (B) are 5H, 2.23-2 · 02 (·, 1Η), 1.48-1.28 (a, 1H), I. 26 (d, J = 6.0Hz) and 1.24 (d, J = 6.0Hz) are 3Η [Process 3]: the previous process 2 5.6 g of the obtained compound was treated in the same manner as in Example 5 to obtain (1R *, 5R *, 8S *)-6-benzyl-8- (third butanylcarbonylamino-3-methyl-2-mingle) -6-Acridine bicyclo [3 · 3 · 0] octane 6.8 g. Melting point: 56-60 X: IR (KB r) cm -1: 3369, 1700 MS (m / z): 333 (MH +) [Process 4]: 6.8 g of the compound obtained in the previous process 3 is processed as in the process 6 of the example A to obtain the target (1R *, 5S *, 8R *)-8- (third butoxycarbonylamino) -3 -methyl 2.8 g of 2-BI-6-acylbicyclo [3 · 3 · 0] octane.
融點:69-72 °C -52- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) — (請先閲讀背面之注意事項再填寫本頁) |裝· 訂 491848 經濟部中央標準局員工消費合作社印笨 A7 B7五、發明説明(W )I R (KB r) cm 一1: 3356, 1678 MS (m/z) : 243 (MH+ ) — NMR (CDC 1 3 ) ά : 4.78 (b r s)七5.23 (b r s ) 共為 1Η,4·10(β)及 4.37(dd,J = 5.5,2·0Ηζ)共為 1H,4.00 (tt)及 3.95U)共為 1H, 3.90(B)及 3.95(a)共為 1H, 3.79 (hep , J = 6 · 0Hz )及 4 · 1 7 (»)共為 1H,3 . 14 (dd , 1H, J = 11.5, 4.5Hz), 2 . 86 (br d , J = 1 1 · 5Hz )及 2 · 80 ( dd , J= 1 1 . 5 , 4·0Ηζ)共為 1H, 2.33(ddd, J=13.0, 8·5, 6·0Ηζ)及 1·90 (br dd, J = 13.0,5·0Ηζ)共為 1Η, 1.93(s,1Η), 1·44 (s, 9H), 1·26((1, J = 6.0Hz)及 1.22(d, J = 6.0Hz)共為 3H, 1.20(ddd, J=13.0, 10·5, 6·0Ηζ)及 1.60(ddd, J = 13.0,9·5, 6· 5 Ηz )共為 1 Η 實施例Μ (1R* ,5R* )-8-(第三丁氧毅胺甲基)-2-栲-6-吖雙環 〔3 · 3 · 0〕辛烷 (化合物 II: Ri = Boc; R2 ,R3 ,R4 = H;»= 1 ; n = 1 ; p = 0 ) 〔製程1〕: 將實施例A之製程2所得(1R* ,5S* ,8S* )-6-节基 -8 -羥基-7-氣-2-丨I - 6-吖雙環〔3·3·0〕辛烷I5克加至 二氯甲烷300nl,冰冷下加三乙胺16.3ιι1,次滴加甲横 酸氣7.5丨1而摄拌一夜後,加水及二氯甲烷,分取有機 層,以無水硫酸鎂乾燥,減壓蒸除溶劑,得UR" ,5S# ,8S* )-6-节基-8-甲磺醯氣基-7-氣-2-挎-6-吖雙環 -5 3 - (請先閲讀背面之注意事項再填寫本頁) i裝. 訂 --5· 本紙張尺度適用中國國家標準(CNS ) A4規格(2…* ) 491848 A 7 B7 五、發明説明(A ) 〔3 · 3 · 0〕辛烷 20 · 6克。 IR(淨)CIT1 : 1714 MS (m/z) : 312 (MH+ ) 1H-NMR(CDC13 )5:7.42- 7.20 (m, 5H), 5.08 (d, 1 H, J = 1.5Hz ), 4.91 (d, 1 H, J = 15.0Hz) , 4.61 (d d, 1 H, J =6.0, 1.5Hz) , 4.21-4. 10 (m, 1 H) , 4. 12 (d, 1 H, 15.0Hz), 3.98-3.68 (m, 2H), 3.28( s, 3 H) , 1.99-1.81 (m, 2 H) 〔製程2〕 ·· 將前製程1所得化合物23. 6克,氰化鈉26克及18-冠 -6 40.2克投入乙腈800al中,加熱45 °C而攪拌5日。減 壓濃縮後,加乙酸乙酯及水。分取有機層而以無水硫酸 鎂乾燥,減壓蒸除溶劑,在矽膠柱層析(正己烷:乙酸 乙酯=1: 1),得(1R* ,5R* )-6-苄基-8-氰基-7-氣-2-鸣-6-吖雙環〔3.3.0〕壬烷6.3克。 IR(淨)chT1 : 2210,1714 MS (ι/ζ) : 2 4 2 (MH+ ) — NMR (CDC 1 3 ) ά : 7,45-7.22 (m, 5 H) , 4.95 (d, 1 Η, 15·0Ηζ) , 4·77 (d d, 1 Η, J =7· 0,1· 6Hz) , 4· 31 ( d, 1 Η, 經濟部中央標準局員工消費合作社印製 (請先閲讀背面之注意事項再填寫本頁) J = 15.0Hz), 3.94-3.67 (m, 2Η), 2.94(dd, J=7.0, 0.7Ηζ) 及 2 · 8 5 ( d d,J = 7 · 0 , 0 · 7 Η z )共為 1 Η , 2 · 6 9 ( d,J = 1 · 6 Η z ) 及 2.6fl(d,J=1.6Hz)共為 1H,2.27-1.9 6(m,2H) 〔製程3〕 將前製程2所得之化合物6. 3克加至四氫呋喃200bi1, 冰冷下加硼烷-四氫呋喃錯合物之1.0M -四氫呋喃溶液 -54- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 經濟部中央標準局員工消費合作社印製 491848 A7 B7 五、發明説明(G ) 104ml,加熱30分後,回流一夜。冷卻至室溫,多餘之 試劑以乙醇處理,減壓濃縮,加乙醇5 0 0 * 1,回流一夜 ,減壓濃缩後,加1〇%蘧酸水。分取水靥,以乙酸乙酯 洗淨,以20% NaOH水鹸化後,以氛仿萃取而以無水硫 酸鎂乾燥,減壓蒸除溶劑,加甲醇2G0II1而冰冷後,加 二碩酸二第三丁酯6.8克,在室溫攪拌一夜後,減壓濃 縮而在矽膠柱層析(正己烷:乙酸乙酯=2: 1),得(1IT ,5R* )-6-苄基-8-(第三丁氣羰胺基卜2-鸣-6-吖雙環 〔3 · 3 · 0〕辛烷 2 · 7克。 IR(淨)car1 : 3359,1714 MS (m/z) : 333 (MH+ ) ^-NMR (CDC 1 3 ) 5 : 7.30 (m, 5 Η) , 5. 12 (b r d, 1 H, J 二 9·0Ηζ ) , 4· 18 (b r d , 1 H, J =5· 5Hz ) , 3· 98 ( d d d, 1H, J =9.0,7.7,3· 0Hz ), 3.77( d, 1H,J = 13.0Hz), 3.67 (d d d, 1 H, J =9·7, 9·0· 5·5Ηζ ) , 3.50 (b r d d, 1 H, J = 13.5, 9.0Hz ), 3.35 (d, 1 H, J = 13. 0Hz),3· 14 ( d d,1 H, J = 13· 5, 1· 8Hz ) , 2· 80 (m, 1 H) , 2. 50 ( d d , J = 10. 8. 6. Ollz )及 2.46 (d d, J =10.0, 7. 1Hz )共為 1H, 2.14(ddd, 1 H, J = 12. 5, 9. 7, 7. 5Hz) , 1· 70 (m, 2 H) , 1· 50 (m, 1 H) , 1. 46 (s, 9 H) 〔製程4〕: 將前製程3所得化合物2J克溶在乙醇lGOml,加5%Melting point: 69-72 ° C -52- This paper size applies to Chinese National Standard (CNS) A4 (210X297 mm) — (Please read the precautions on the back before filling this page) | Binding · Order 491848 Ministry of Economic Affairs Central Standard Bureau Staff Consumer Cooperatives Benben A7 B7 V. Description of Invention (W) IR (KB r) cm 1 1: 3356, 1678 MS (m / z): 243 (MH +) — NMR (CDC 1 3) ά: 4.78 ( brs) Seven 5.23 (brs) are 1Η, 4.10 (β) and 4.37 (dd, J = 5.5, 2.00 · ζ) are 1H, 4.00 (tt) and 3.95U) are 1H, 3.90 (B) And 3.95 (a) are 1H, 3.79 (hep, J = 6.0 Hz) and 4.17 (») are 1H, 3.14 (dd, 1H, J = 11.5, 4.5Hz), 2.86 (br d, J = 1 1 · 5Hz) and 2 · 80 (dd, J = 1 1.5, 4 · 0Ηζ) are 1H, 2.33 (ddd, J = 13.0, 8. · 5, 6 · 0Ηζ) and 1.90 (br dd, J = 13.0, 5.00 · ζ) are 1 共, 1.93 (s, 1Η), 1.44 (s, 9H), 1.26 ((1, J = 6.0Hz), and 1.22 ( d, J = 6.0 Hz) for a total of 3H, 1.20 (ddd, J = 13.0, 10.5, 6 · 0Ηζ) and 1.60 (ddd, J = 13.0, 9.5, 6 · 5 Ηz) for a total of 1 Η Implementation Example M (1R *, 5R *)-8- (Third-butoxyamine methyl) -2-fluorene-6-azinebicyclic [3 · 3 · 0 ] Octane (compound II: Ri = Boc; R2, R3, R4 = H; »= 1; n = 1; p = 0) [Process 1]: obtained from Process 2 of Example A (1R *, 5S * , 8S *) -6-benzyl-8-hydroxy-7-gas-2- 丨 I-6-acylbicyclo [3 · 3 · 0] octane I5g was added to 300ml of dichloromethane, and triethyl under ice cooling Amine 16.3mι1, after adding dropwise methanoic acid 7.5 丨 1 and stirring overnight, water and dichloromethane were added, the organic layer was separated, dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure to obtain UR ", 5S #, 8S *) -6-Septyl-8-Methanesulfonylamino-7-Ga-2-Side-6-Acetyl-5-3-(Please read the precautions on the back before filling this page) --5 · This paper size applies to Chinese National Standard (CNS) A4 specifications (2 ... *) 491848 A 7 B7 5. Description of the invention (A) [3 · 3 · 0] octane 20 · 6 g. IR (Net) CIT1: 1714 MS (m / z): 312 (MH +) 1H-NMR (CDC13) 5: 7.42- 7.20 (m, 5H), 5.08 (d, 1 H, J = 1.5Hz), 4.91 ( d, 1 H, J = 15.0Hz), 4.61 (dd, 1 H, J = 6.0, 1.5Hz), 4.21-4. 10 (m, 1 H), 4. 12 (d, 1 H, 15.0Hz) , 3.98-3.68 (m, 2H), 3.28 (s, 3 H), 1.99-1.81 (m, 2 H) [Process 2] ·· 23.6 g of the compound obtained in the previous process 1 and 26 g of sodium cyanide and 18-crown-6 40.2 g was put into 800al of acetonitrile, and heated at 45 ° C for 5 days. After concentration under reduced pressure, ethyl acetate and water were added. The organic layer was separated and dried over anhydrous magnesium sulfate, and the solvent was evaporated under reduced pressure. The residue was subjected to silica gel column chromatography (n-hexane: ethyl acetate = 1: 1) to obtain (1R *, 5R *)-6-benzyl-8. -Cyano-7-gas-2-naphth-6-azabicyclo [3.3.0] nonane 6.3 g. IR (net) chT1: 2210,1714 MS (ι / ζ): 2 4 2 (MH +) — NMR (CDC 1 3): 7,45-7.22 (m, 5 H), 4.95 (d, 1 Η, 15 · 0Ηζ), 4.77 (dd, 1 Η, J = 7.0.0, 1.6 Hz), 4.31 (d, 1 Η, printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs (please read the Note: Please fill in this page again) J = 15.0Hz), 3.94-3.67 (m, 2Η), 2.94 (dd, J = 7.0, 0.7Ηζ) and 2 · 8 5 (dd, J = 7 · 0, 0 · 7 Η z) is 1 Η, 2 · 6 9 (d, J = 1 · 6 Η z) and 2.6fl (d, J = 1.6 Hz) are 1H, 2.27-1.9 6 (m, 2H) [Process 3 〕 6.3 g of the compound obtained in the previous process 2 was added to tetrahydrofuran 200bi1, and borane-tetrahydrofuran complex 1.0M-tetrahydrofuran solution-54- was added under ice-cooling. This paper size applies Chinese National Standard (CNS) A4 specification (210X297). (Mm) Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs 491848 A7 B7 V. Description of the Invention (G) 104ml, heated for 30 minutes, and then refluxed overnight. After cooling to room temperature, the excess reagent was treated with ethanol and concentrated under reduced pressure. Ethanol 500 * 1 was added under reflux overnight. After concentrated under reduced pressure, 10% aqueous acid was added. Water leeches were collected separately, washed with ethyl acetate, hydrolyzed with 20% NaOH, extracted with chloroform, and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, methanol 2G0II1 was added, and the mixture was ice-cooled, and then added with di-orthoic acid. 6.8 g of butyl ester was stirred at room temperature overnight, then concentrated under reduced pressure and then subjected to silica gel column chromatography (n-hexane: ethyl acetate = 2: 1) to obtain (1IT, 5R *)-6-benzyl-8- ( The third butane carboamino group 2-Ming-6-acylbicyclo [3 · 3 · 0] octane 2. 7 g. IR (net) car1: 3359,1714 MS (m / z): 333 (MH +) ^ -NMR (CDC 1 3) 5: 7.30 (m, 5 Η), 5. 12 (brd, 1 H, J 2 9.0Ηζ), 4 · 18 (brd, 1 H, J = 5.5 Hz), 3 · 98 (ddd, 1H, J = 9.0, 7.7, 3.0Hz), 3.77 (d, 1H, J = 13.0Hz), 3.67 (ddd, 1H, J = 9 · 7, 9 · 0 · 5 · 5Ηζ), 3.50 (brdd, 1 H, J = 13.5, 9.0Hz), 3.35 (d, 1 H, J = 13. 0Hz), 3.14 (dd, 1 H, J = 13.5, 1 · 8Hz ), 2.80 (m, 1 H), 2. 50 (dd, J = 10. 8. 6. Ollz) and 2.46 (dd, J = 10.0, 7. 1Hz) are 1H, 2.14 (ddd, 1 H, J = 12. 5, 9. 7, 7. 5 Hz), 1.70 (m, 2 H), 1.50 (m, 1 H), 1. 46 (s, 9 H) (Process 4 : The resulting compound prior to the process 3 2J g was dissolved in ethanol lGOml, plus 5%
Pd-C 0.25克,加熱50°C,吸收理論量氫,濾除觸媒, 減壓蒸除溶劑,得目的之(1R" ,5R* )-8-(第三丁氣羰 -55- 本紙張尺度適用中國國家標準(CNS ) A4規格!门a· 297vt > (請先閲讀背面之注意事項再填寫本頁) >裝· #1 491848 A7 B7 五、發明説明(坤)0.25 g of Pd-C, heated at 50 ° C, absorbed theoretical amount of hydrogen, filtered off catalyst, and distilled off the solvent under reduced pressure to obtain the purpose (1R ", 5R *) -8- (third butane carbonyl-55- this Paper size applies Chinese National Standard (CNS) A4 specifications! Door a · 297vt > (Please read the precautions on the back before filling this page) > Equipment · # 1 491848 A7 B7 V. Description of the invention (Kun)
胺甲基)-2-11-6-吖雙環〔3.3.0〕辛烷1·8克 融點:5 9 - 6 7 °C I R (KB r ) cm -1: 3447, 1697 MS (m/z) : 243 (MH+ ) !H-NMR (CDC 1 3 ) ά : 5.00 (b r s, 1 H) , 4. 11 (m, 1 H) , 3· 94 (m, 1 H) , 3. 73 (m,1 H) , 3· 25 (m, 2 H),3· 07 (m, 1 H) , 2. 98 (m, 1 Η) , 2·03 (m, 1 H),1· 90 (m)及 1· 88 (m)共為 1 H, 1.80 (m,1 H) , 1.77 (m, 1 Η) , 1·63 (b r s, 1 Η) , 1·44 (s,9 H) 實施例1 7-〔(lR* ,5R* ,8S* )-8-胺基-2-枵-6-吖雙環 〔3·3·0〕辛-6-基〕-1-環丙基-6-氟-1,4-二氫-8-甲氧 基-4-氯睹啉-3-羧酸 (1) 將實施例Α所得(1R* ,5S* ,8R* )-8-(第三丁氣 羰胺基)-2-鸣-6-吖雙環〔3.3.0〕辛烷0.96克及1-環丙 基-6, 7 -二氟-1,4-二氫-8-甲氧基-4-氣β咐-3-錢酸-BF 2 螯合物1.2克及三乙胺0.69ial,加至二甲亞硪13al,在 經濟部中央標準局員工消費合作社印製 (請先閲讀背面之注意事項再填寫本頁) 室溫攪拌5日後,加水而濾集結晶,加乙醇60al,水1祖1 及三乙胺2al,加熱80°C,攪拌一夜後,減壓濃縮,加 水及氯仿〇分取有機層,以無水硫酸鎂乾燥,減壓蒸除 溶劑,得7_〔(1R* ,5R* ,8S" )-8-(第三丁氣羰胺基) -2-^-6-吖雙環〔3.3.0〕辛-6-基〕-1-環丙基-6-氟-1 ,4-二氫-8-甲氣基-4-氣ί奎啉-3-羧酸1.65克。 (2) 將前(1)所得之化合物1.65克溶在乙醇4il,加10% -56- 表紙張尺度適用中國國家標準(CNS ) Α4規格(210Χ297公釐) 491848 經濟部中央標準局員工消費合作社印製 A7 B7__五、發明説明(β ) 鹽酸水15il,攪拌加熱80°C3.5小時後,減壓蒸除溶劑 ,加10%鹽酸水使完全溶解,以氯仿洗淨•減壓盡量蒸 除鹽酸,加濃氨水至驗性,使完全溶解後,再以氣仿洗 淨,減壓盡量蒸除氨後,以稀鹽酸中和為PH7。次以氮 仿萃取而以無水硫酸鎂乾燥,減壓蒸除溶劑,所得粗結 晶從二氯甲烷及乙酸乙酯之混液再結晶,得目的之7-〔 (1R* ,5R* ,8S* )-8-胺基-2-時-6-ΓΓ 雙環〔3·3·0〕辛 -6 -基〕-1-環丙基-6-氣-1,4 -二氮-8-甲氣基-4-氣睹 -3-羧酸。 融點:1 8 7 - 1 8 9。0 實施例2 仿實施例1得下列化合物。 7-〔(lR* ,5R* ,8s* )-8-胺基-2-榨-6-吖雙璟 〔3.3.0〕辛-6-基〕-6-氟-l-〔(lR,2S)-2-氟環丙基〕 -1,4-二氫-8-甲氣基-4-氣睦啉-3-羧酸 融點:184-187 °C 實施例3 5-胺基-7-〔(lR* ,5R* ,8S· )-8-胺基-2-氧-6-吖雙 環〔3.3.0〕辛-6-基〕-1-環丙基- 6,8-二氟-1,4-二氫 -4-氣1«啉-3-羧酸 (1)將實施例A之所得(1R* ,5S* ,8R* )-8-(第三丁 氧羰胺基卜2-B§-6-吖雙環〔3·3·0〕辛烷1·5克5-胺基 -1-環丙基-6, 7,8 -三氟-1,4 -二氫-4-氣1¾咐-3-錢酸1.75 克,1,8 -二吖雙環〔5·4·0〕-7-H--碩烯(DBU)920ffig 及 -57- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公嫠〉 (請先閱讀背面之注意事- -·0 意事項再填· 裝— 寫本頁)Amine methyl) -2-11-6-azepine bicyclic [3.3.0] 1.8 g of octane Melting point: 5 9-6 7 ° CIR (KB r) cm -1: 3447, 1697 MS (m / z ): 243 (MH +)! H-NMR (CDC 1 3) ά: 5.00 (brs, 1 H), 4. 11 (m, 1 H), 3.94 (m, 1 H), 3. 73 (m , 1 H), 3.25 (m, 2 H), 3.07 (m, 1 H), 2. 98 (m, 1 Η), 2.03 (m, 1 H), 1.90 (m ) And 1.88 (m) are 1 H, 1.80 (m, 1 H), 1.77 (m, 1 Η), 1.63 (brs, 1 Η), 1.44 (s, 9 H). 1 7-[(lR *, 5R *, 8S *)-8-amino-2-fluoren-6-acylbicyclo [3 · 3 · 0] oct-6-yl] -1-cyclopropyl-6- Fluoro-1,4-dihydro-8-methoxy-4-chloroquinoline-3-carboxylic acid (1) The (1R *, 5S *, 8R *)-8- (Third-butyl) obtained in Example A Carboxylamido) -2-Ming-6-azinebicyclo [3.3.0] octane 0.96g and 1-cyclopropyl-6, 7-difluoro-1,4-dihydro-8-methoxy- 4-Gas β commanded 3-glycinic acid-BF 2 chelate 1.2g and triethylamine 0.69ial, added to dimethylarsine 13al, printed on the staff consumer cooperative of the Central Standards Bureau of the Ministry of Economic Affairs (please read the back Note: Please fill in this page again) After stirring at room temperature for 5 days, add water to filter the crystals, add ethanol 60al, water 1 zu 1 and triethylamine 2 al, heated at 80 ° C, stirred overnight, concentrated under reduced pressure, added water and chloroform to separate the organic layer, dried over anhydrous magnesium sulfate, and evaporated the solvent under reduced pressure to obtain 7 _ [(1R *, 5R *, 8S ")- 8- (Third butanecarbonylamino) -2-^-6-azepinebicyclo [3.3.0] oct-6-yl] -1-cyclopropyl-6-fluoro-1,4-dihydro-8 -Methylamino-4-aminoquinoline-3-carboxylic acid 1.65 g. (2) Dissolve 1.65 g of the compound obtained in (1) in 4 il of ethanol, add 10% -56- The paper size applies the Chinese National Standard (CNS) A4 specification (210 × 297 mm) 491848 Employees' Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs Print A7 B7__V. Description of the invention (β) 15 liters of hydrochloric acid water, stir and heat at 80 ° C for 3.5 hours, evaporate the solvent under reduced pressure, add 10% hydrochloric acid water to completely dissolve, and wash with chloroform. In addition to hydrochloric acid, add concentrated ammonia water until it is completely dissolved, and then wash it with gas imitation. After removing ammonia as much as possible under reduced pressure, neutralize with dilute hydrochloric acid to PH7. It was extracted with chloroform, dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained crude crystals were recrystallized from a mixture of dichloromethane and ethyl acetate to obtain the target 7- [(1R *, 5R *, 8S *). -8-amino-2-hr-6-ΓΓ bicyclo [3 · 3 · 0] oct-6-yl] -1-cyclopropyl-6-gas-1,4-diaza-8-methylamino -4-Gamm-3-carboxylic acid. Melting point: 1 8 7-1 8 9.0 Example 2 The following compound was obtained by simulating Example 1. 7-[(lR *, 5R *, 8s *)-8-amino-2-carbox-6-azepine [3.3.0] oct-6-yl] -6-fluoro-l-[(lR, 2S) -2-fluorocyclopropyl] -1,4-dihydro-8-methylamino-4-carbazolin-3-carboxylic acid Melting point: 184-187 ° C Example 3 5-amino- 7-[(lR *, 5R *, 8S ·) -8-amino-2-oxo-6-azinebicyclo [3.3.0] oct-6-yl] -1-cyclopropyl-6,8-di Fluoro-1,4-dihydro-4-gas 1 «morpholine-3-carboxylic acid (1) The (1R *, 5S *, 8R *)-8- (third butoxycarbonylamino group) obtained in Example A Bu 2-B§-6-Azabicyclo [3 · 3 · 0] octane 1.5 g 5-amino-1-cyclopropyl-6, 7,8-trifluoro-1,4-dihydro- 4-Gas 1¾ Commands 1.75 g of 3-thanoic acid, 1,8-diazine bicyclic [5 · 4 · 0] -7-H-Sulene (DBU) 920ffig and -57- This paper size applies to Chinese national standards (CNS) A4 specification (210X297 public address) (Please read the precautions on the back--· 0 the remarks and fill in-install — write this page)
、tT -Lr I if 0 491848 A7 B7 五、發明説明(a ) 吡啶Ual之混合物在6(TC 16小時,8(TC小時之加溫後 ,減壓蒸除溶劑,溶在氯仿,先後以冷稀酸及飽和食鹽 水洗淨,以無水硫酸鎂乾燥,減壓蒸除溶劑,得油狀物。 (2)混合(1)之油狀物,1〇%鹽酸水3·5ιι1及四氫呋喃 9ffil,加溫8G*C 2小時後,減壓蒸除溶劑,加水及 10%鹽酸水8nl而過濾。濾液以氯仿10·1洗3次,以10% NaOH水鹸化,以氯仿洗3次,以10%鹽酸水諝為ΡΗ8-9 ,以氯仿萃取,以無水硫酸鎂乾燥,減壓蒸除溶劑,從 二氯甲烷-乙酸乙酯再結晶,得標題物UlBg。 融點:258-263 °C (分解) 實施例4-38 仿實施例1或3 ,得下列化合物。 (請先閲讀背面之注意事項再填寫本頁) 裝· 訂 經濟部中央標準局員工消費合作社印製 -58- 本紙張尺度遙緬鬮謇_窣(CNS ) A4規格(210X297公釐) 491848 A7 B7 五、發明囈噚(β 經濟部中央標準局員工消費合作社印製 実 施 例 ^#7 (CH2)V A R X W t n B 融点rc) 4 C-OMe nh2 H2N I in 1 — 253-257 (分解) 5 C-OMe ~< Me H2N ||h 1 0.5HC1 244-247 (分解) 6 C - OMe ~<j H MeHN 1111 1 一 201-203 7 C - OMe —F H H2N I in 1 一 121-125 8 C-OMe -< Me MeHN 1111 1 — 194-196 9 COMe -< nh2 MeHN 1111 1 一 227-230 10 C-OMe H H2N丨|丨丨 2 — 205-208 11 N 2,4-F2Ph H H2N ||m 1 一 144-146 (請先閱讀背面之注意事項再填寫本頁) -59- -裝· 訂 本紙張尺度適用中國國家標準(CNS ) Α4規格(210Χ297公釐) 491848, TT -Lr I if 0 491848 A7 B7 V. Description of the invention (a) After heating the mixture of pyridine Ual at 6 (TC 16 hours, 8 (TC hours), the solvent was distilled off under reduced pressure, dissolved in chloroform, followed by cold The diluted acid and saturated brine were washed, dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure to obtain an oily substance. (2) The oily substance of (1) was mixed with 10% hydrochloric acid water 3.5ml and tetrahydrofuran 9ffil, After heating at 8G * C for 2 hours, the solvent was distilled off under reduced pressure, and water and 10% hydrochloric acid water 8nl were added for filtration. The filtrate was washed 3 times with chloroform 10.1, decanted with 10% NaOH water, washed 3 times with chloroform, and 10 % Hydrochloric acid hydrochloride is pH 8-9, extracted with chloroform, dried over anhydrous magnesium sulfate, distilled off the solvent under reduced pressure, and recrystallized from dichloromethane-ethyl acetate to obtain the title substance UlBg. Melting point: 258-263 ° C ( Decomposition) Example 4-38 The following compounds were obtained by simulating Example 1 or 3. (Please read the precautions on the back before filling this page) Binding and printing Remote Myanmar 阄 謇 窣 (CNS) A4 size (210X297 mm) 491848 A7 B7 V. Invention 呓 噚 (β Staff Consumption of Central Standards Bureau, Ministry of Economy Cooperative cooperative printing example ^ # 7 (CH2) VARXW tn B Melting point rc) 4 C-OMe nh2 H2N I in 1 — 253-257 (decomposed) 5 C-OMe ~ < Me H2N || h 1 0.5HC1 244- 247 (decomposition) 6 C-OMe ~ < j H MeHN 1111 1 1 201-203 7 C-OMe —FH H2N I in 1 1 121-125 8 C-OMe-< Me MeHN 1111 1 — 194-196 9 COMe-< nh2 MeHN 1111 1-227-230 10 C-OMe H H2N 丨 | 丨 丨 2 — 205-208 11 N 2,4-F2Ph H H2N || m 1 144-146 (Please read the Please fill in this page again for the matters needing attention) -59--The size of the binding and binding paper is applicable to China National Standard (CNS) Α4 specification (210 × 297 mm) 491848
7 B 五、發明説明(w) 表4 經濟部中央標準局員工消費合作社印製 実 施 例 νγ.Β (CH2)n, A R X W 9 n B 融点(°c) 12 C-OMe -< nh2 H2N丨|丨丨 2 — 253-255 (分解) 13 C - OMe nh2 h2n ► 1 — 260-263 (分解) 14 C-OCHF2 -< H H2N III丨 1 一 182-185 15 C - Cl -< H H2N ||n 1 一 130-135 16 C-OMe -< Me h2n ► 1 — 230-233 (分解) 17 N 2,4-F2Ph H MeHN 1 111 1 0. 1HC1 153-155 18 CF 4 H H2N j|M 1 0. 1HC1 218-223 19 C-OMe <1 H h2n ► 2 — 196-198 —60— 本紙張尺度適用中國國家標準(CNS ) AOIL格(2丨0 < 297公釐) 丨 ---U---§--裝-- (請先閲讀背面之注意事項再填寫本頁) 訂 #- •J-. 491848 A7 B7 五、發明説明(”) 表5 經 濟 部 t 矣 標 準 局 員 工 消 合 作 社 印 製 実 施 例 vAV— 〇^n a V ·Β (CH2)n, A R X W 9 n B 融点(°c) 20 C - Cl < H MeHN 1111 1 一 105-110 (分解) 21 C-F < NH2 H2N ► 2 — 245-248 22 N < H H2N ||n 1 — 230-233 (分解) 23 C-OMe A H h2n ► 1 — 199-201 24 C-Me A Me H2N I III 1 一 205-213 (分解) 25 C - Cl -F H H2N ||n 1 一 144-148 26 CH H H2N丨|丨丨 1 — 233-238 (分解) 27 C-C = CH H H2N ||h 1 — 232-234 (分解) 請 先 閱 讀 背 之 注 意 -61- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐)7 B V. Description of the invention (w) Table 4 Example printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs νγ.Β (CH2) n, ARXW 9 n B Melting point (° c) 12 C-OMe-< nh2 H2N 丨| 丨 丨 2 — 253-255 (decomposition) 13 C-OMe nh2 h2n ► 1 — 260-263 (decomposition) 14 C-OCHF2-< H H2N III 丨 1 182-185 15 C-Cl-< H H2N || n 1 -130-135 16 C-OMe-< Me h2n ► 1 — 230-233 (decomposed) 17 N 2,4-F2Ph H MeHN 1 111 1 0. 1HC1 153-155 18 CF 4 H H2N j | M 1 0. 1HC1 218-223 19 C-OMe < 1 H h2n ► 2 — 196-198 —60— This paper size applies the Chinese National Standard (CNS) AOIL grid (2 丨 0 < 297 mm)丨 --- U --- §--Installation-- (Please read the precautions on the back before filling this page) Order #-• J-. 491848 A7 B7 V. Description of the invention (") Table 5 Ministry of Economy t 矣Printed by the Bureau of Standards and Consumers Cooperatives vAV— 〇 ^ na V · Β (CH2) n, ARXW 9 n B Melting point (° c) 20 C-Cl < H MeHN 1111 1-105-110 (decomposed) 21 CF < NH2 H2N ► 2 — 245-248 22 N < H H2N || n 1 — 230 -233 (decomposition) 23 C-OMe AH h2n ► 1 — 199-201 24 C-Me A Me H2N I III 1 one 205-213 (decomposition) 25 C-Cl -FH H2N || n 1 one 144-148 26 CH H H2N 丨 | 丨 丨 1 — 233-238 (decomposed) 27 CC = CH H H2N || h 1 — 232-234 (decomposed) Please read the note at the back first-61- This paper size applies to Chinese National Standard (CNS ) A4 size (210X297 mm)
I 4·I 4 ·
裝 訂Binding
1 4I 卜I 4918481 4I Bu I 491848
A B 五、發明説明U。) 經濟部中央標準局員工消費合作社印製 表6 実 施 例 X 0 。尺A卜 (CH2)nf A R X W n’ B 融点(°C) 28 C-〇Me (1 R. 2 S) H MeHN | | M 1 — 143-146 29 N 2,4-F2Ph H h2n ► 1 HC1 258-261 (分解) 30 C-CN Me h2n ► 2 — 260-265 31 C,e 一p H h2n ► 1 — * 202-205 (分解) 32 C-OMe -< NH2 h2n ► 2 — 272-276 (分解) 33 C-CH=CH2 -< H H2N ||i丨 1 — 218-221 34 C-CN < H h2n ► 2 — 223-226 35 C-OMe < H MeHN^ 1 — 174-177 -62- (請先閱讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公* 491848 A7 B7 五、發明説明(W ) 表7 実 施 例 X 0 wr-FAVc〇〇H 〇^N A V - (CH2)nf A R X W η’ B 融点(°C) 36 C-OMe < Me h2n ► 2 — 205-208 37 C-ochf2 H h2n ► 1 — 193-196 38 C - CN H H2N丨丨丨丨 1 — 144-148 (請先閱讀背面之注意事 4 •項再填. 裝— :寫本頁) 訂 實施例39 仿實施例3 ,得下列化合物。 7-〔(1R* , 5R* ,8S11 卜 8-胺基-2-11 -6-吖雙環〔3 · 3 · 0〕 辛-6-基〕-1-(2 ,4-二氟苯基)=6-氟-1,4-二氫-5-甲基 -4 -氣-1,8 -瞭淀-3-錢酸 融點:224-227 T (分解) 實施例40 仿實施例1 ,得下列化合物。 7-〔(lR* ,5R* ,8R* )-8 -胺基-3-甲基- 2-Β 琴-6-吖雙 環〔3.3.0〕辛-6-基〕-1-環丙基-6-氟-1,4-二氫-8-甲 氣基- -4 -氣暗啉-3-羧酸 -63- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) :— 經濟部中央標準局員工消費合作社印製 經濟部中央標隼局員工消費合作社印製 491848 A7 B7 五、發明説明(h ) 融點:1 6 6 - 1 6 8 °C 實施例41 仿實施例1,得下列化合物。 lO-CUR11 ,5ίΤ ,8s* )-8-胺基-2-鸣-6-吖雙環 〔3.3.0〕辛-6-基〕-9-氟- 2,3-二氫- (3S)-3-甲基- 7-氧-7H-吡啶駢〔1 , 2 , 3-de〕 〔 1,4〕苯駢枵阱-6 -羧酸 融點:2 3 1 - 2 3 3 °C 實施例42 仿實施例3 ,得下列化合物。 7-〔(1R* , 5R* , 8R* )-8-胺基-2H -6-吖雙環〔3 · 3 · 0〕 辛-6-基〕-1-環丙基-6-氟-1,4 -二氫-4-氣If淋-3-錢酸 融點:2 3 8 - 2 4 1 °C (分解) 實施例4 3 仿實施例1 ,得下列化合物。 7-〔(1R* , 5R* , 8S* )-8-胺基-2-1琴-6-吖雙環〔3 · 3 · 0〕 辛-6-基〕-1-環丙基-6-氟-1,4 -二氩-8-甲硫基-4-氣B奎 啉-3-羧酸 融點:226-228 °C (分解) 實施例44 仿實施例3 ,得下列化合物。A B V. Description of Invention U. ) Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs Table 6 実 Example X 0. Ruler Ab (CH2) nf ARXW n 'B Melting point (° C) 28 C-〇Me (1 R. 2 S) H MeHN | | M 1 — 143-146 29 N 2,4-F2Ph H h2n ► 1 HC1 258-261 (decomposition) 30 C-CN Me h2n ► 2 — 260-265 31 C, e-p H h2n ► 1 — * 202-205 (decomposition) 32 C-OMe-< NH2 h2n ► 2 — 272- 276 (decomposed) 33 C-CH = CH2-< H H2N || i 丨 1 — 218-221 34 C-CN < H h2n ► 2 — 223-226 35 C-OMe < H MeHN ^ 1 — 174 -177 -62- (Please read the precautions on the back before filling out this page) This paper size applies Chinese National Standard (CNS) A4 specification (210X297 male * 491848 A7 B7 V. Description of invention (W) Table 7 実 例 例 X 0 wr-FAVc〇〇H 〇 ^ NAV-(CH2) nf ARXW η 'B Melting point (° C) 36 C-OMe < Me h2n ► 2 — 205-208 37 C-ochf2 H h2n ► 1 — 193-196 38 C-CN H H2N 丨 丨 丨 丨 1 — 144-148 (Please read the notes on the back 4 • Items and then fill in. Pack —: Write this page) Order Example 39 The same compound as Example 3 was obtained. 7- [(1R *, 5R *, 8S11, 8-amino-2-11-6-azabicyclo [3 · 3 · 0] oct-6-yl] -1- (2 , 4-difluorophenyl) = 6-fluoro-1,4-dihydro-5-methyl-4 -gas-1,8-leidan-3-caproic acid Melting point: 224-227 T (decomposition) Example 40 The following compound was obtained by imitating Example 1. 7-[(lR *, 5R *, 8R *)-8-amino-3-methyl-2-β-phenyl-6-azinebicyclo [3.3.0] Octyl-6-yl] -1-cyclopropyl-6-fluoro-1,4-dihydro-8-methylamino- -4 -gasoline-3-carboxylic acid-63- This paper is applicable to China Standard (CNS) A4 specification (210X 297 mm):-Printed by the Employees 'Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs Printed by the Employees' Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 491848 A7 B7 5. Description of the invention (h) Melting point: 1 6 6-1 6 8 ° C Example 41 Following Example 1, the following compounds were obtained. lO-CUR11, 5ίΤ, 8s *)-8-amino-2-ming-6-acylbicyclo [3.3.0] oct-6-yl] -9-fluoro-2,3-dihydro- (3S)- 3-methyl-7-oxo-7H-pyridine hydrazone [1,2,3-de] [1,4] benzene hydrazone-6-carboxylic acid Melting point: 2 3 1-2 3 3 ° C Example 42 Following Example 3, the following compounds were obtained. 7-[(1R *, 5R *, 8R *)-8-amino-2H-6-azabicyclo [3 · 3 · 0] oct-6-yl] -1-cyclopropyl-6-fluoro-1 , 4-Dihydro-4-gas If leaching-3-carboxylic acid Melting point: 2 3 8-2 4 1 ° C (decomposition) Example 4 3 Following Example 1, the following compounds were obtained. 7-[(1R *, 5R *, 8S *)-8-Amino-2-1qin-6-azinebicyclo [3 · 3 · 0] oct-6-yl] -1-cyclopropyl-6- Fluoro-1,4-diargon-8-methylthio-4-gas B quinoline-3-carboxylic acid Melting point: 226-228 ° C (decomposition) Example 44 The following compound was obtained by simulating Example 3.
1-(3-胺基-4,6-二氟苯基)-7-〔(11**,51{*,83*)-8-胺基-2-唁- 6-B 丫雙環〔3.3.0〕辛-6-基〕-6 -氣-1,4 -二 氫-4-氧-1 , 8-暸啶-3-羧酸 融點:1 6 0 - 1 6 3 °C -6 4 - 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) (請先閱讀背面之注意事項再填寫本頁) #1 J. 491848 經濟部中央標準局員工消費合作社印製 A7 « B7五、發明説明(W ) 實施例45 仿實施例1,得下列化合物。 7-〔(ΠΤ ,5R* ,8S* 卜8 -胺基-3-甲基- 2-1 等-6-吖雙 環〔3.3.0〕辛-6-基〕-1-環丙基-6 _氟-1,4 -二數-8 _甲卓基 -4-氣丨奎啉-3-羧酸 融點:1 0 9 - 1 1 2 °C 實施例4 6 仿實施例3 ,得下列化合物。 7-〔(lR* ,5R* )-8 -胺甲基-2-鸣-6-吖雙環〔3.3.0〕 辛-6-基〕-1-(2,4-二氟苯基卜6-氟-1,4-二氫-4-氧-1, 8-暸啶-3-羧酸 融點:2 3 0 - 2 3 3 °C 實施例47 仿實施例1 ,得下列化合物。 5-胺基7-〔(lR* ,5R* ,8S*卜8-胺基-2-鸣-6-吖雙璟 〔3·3·0〕辛-6-基〕-6-氟-l-〔(lR,2S)-2-氟環丙基〕 -1 ,4 -二氫-8-甲氣基-4-氣ί奎咐-3-錢酸 融點:2 5 3 - 2 6 0 °C (分解) 實施例48-56 仿實施例1或3 ,得以下化合物。 (請先閲讀背面之注意事項再填寫本頁) f裝· -65- 象紙度遍用中國國家標準(CNS ) A4g ( 210X297公釐) 491848 A7 B7 五、發明説明(W ) 經濟部中央標準局員工消費合作社印製 表8 実 施 例 X 〇 w^fotcooh 〇^N A V - (CH2)n, A R X W * n B 融点(°c) 48 N 3-NH2~4.6-F2Ph Me IUN 1 2IIC1 266-268 49 C-C = CH H H2N 2 一 133-138 (分角?) 50 CH 3-NH2-4,6-F2Ph Me h2n 1 一 205-207 —66— (請先閲讀背面之注意事項再填寫本頁) •裝·1- (3-amino-4,6-difluorophenyl) -7-[(11 **, 51 {*, 83 *)-8-amino-2-fluorene-6-B yambicyclo [3.3 .0] oct-6-yl] -6-gas-1,4-dihydro-4-oxo-1, 8-pyridin-3-carboxylic acid Melting point: 1 6 0-1 6 3 ° C -6 4-This paper size is in accordance with Chinese National Standard (CNS) A4 (210X297 mm) (Please read the notes on the back before filling out this page) # 1 J. 491848 Printed by the Consumer Standards Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs A7 «B7 V. Description of the invention (W) Example 45 The following compounds were obtained by simulating Example 1. 7-[(ΠΤ, 5R *, 8S *, 8-amino-3-methyl-2-1, etc.-6-azabicyclo [3.3.0] oct-6-yl] -1-cyclopropyl-6 _Fluoro-1,4 -bis-8 _Metrazyl-4-gas 丨 Quinolin-3-carboxylic acid Melting point: 1 0 9-1 1 2 ° C Example 4 6 Imitating Example 3, the following Compound 7-[(lR *, 5R *)-8-Aminemethyl-2-Ming-6-azinebicyclo [3.3.0] oct-6-yl] -1- (2,4-difluorophenyl 6-Fluoro-1,4-dihydro-4-oxo-1,8-pyridine-3-carboxylic acid Melting point: 2 3 0-2 3 3 ° C Example 47 The following compounds were obtained by simulating Example 1. 5-Amino 7-[(lR *, 5R *, 8S *, 8-Amino-2-Ming-6-Azabispyrene [3 · 3 · 0] oct-6-yl] -6-fluoro- l-[(lR, 2S) -2-fluorocyclopropyl] -1, 4 -dihydro-8-methylamino-4-gas Fluoro-3-carboxylic acid Melting point: 2 5 3-2 6 0 ° C (decomposition) Example 48-56 The following compounds were obtained by imitating Example 1 or 3. (Please read the precautions on the reverse side before filling out this page) CNS) A4g (210X297 mm) 491848 A7 B7 V. Description of invention (W) Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs. 8 実 例 X 〇w ^ fotcooh 〇 ^ NAV-(CH2) n, ARXW * n B Melting point (° c) 48 N 3-NH2 ~ 4.6-F2Ph Me IUN 1 2IIC1 266-268 49 CC = CH H H2N 2 one 133-138 (divide angle?) 50 CH 3-NH2-4,6 -F2Ph Me h2n 1 205-207 —66— (Please read the precautions on the back before filling this page) • Installation ·
、1T #·· 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 491848 A7 B7 五、發明説明千 經濟部中央標準局員工消費合作社印製 表9 実 施 例 X 〇 -•nFOTCOOH 0^N A V - (CH2)n· A R X W % n B 融点(°c) 51 CH 3-NH2-4, 6-F2Ph nh2 II2N 1 — 200-203 52 C-OC2H5 H H2N 1 一 97-100 53 C-OCH2 1 CH2F <1 H h2n 1 HC1 216-219 (分解) 54 C - OMe OH h2n 1 HC1 233-236 (分解) 55 CH 3-NH2-4. 6-F2Ph NH2 MeHN 1 一 233-236 (分酹) 56 C-OCH2 1 CH2F 人 NH2 H2N 1 一 234-237 (分解) _6 7— 裝-- (請先閲讀背面之注意事項再填寫本頁) 、11 本紙張尺度適用办阈钃家蟫寧CNS > A4規格(210X297公釐) 491848 A7 B7 五、發明説明(W ) 實施例57 Θ 7-〔(lR* ,5R* JS* )-8-胺基-2-鸣-6-吖雙琛〔3·3·0〕 辛-6-基〕-1-環丙基-6-氟-1,4 -二氫-8-甲基-4-氣Β奎咐 -3-羧酸 (1) 在氬氣流中,混合二異丙胺23·8μ1及四氫呋喃3 0 0道1、 1T # ·· This paper size applies to Chinese National Standard (CNS) A4 specification (210X297mm) 491848 A7 B7 V. Description of the invention Table 9 printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Thousands of Economics ^ NAV-(CH2) n · ARXW% n B Melting point (° c) 51 CH 3-NH2-4, 6-F2Ph nh2 II2N 1 — 200-203 52 C-OC2H5 H H2N 1-97-100 53 C-OCH2 1 CH2F < 1 H h2n 1 HC1 216-219 (decomposition) 54 C-OMe OH h2n 1 HC1 233-236 (decomposition) 55 CH 3-NH2-4. 6-F2Ph NH2 MeHN 1-233-236 (minutes) ) 56 C-OCH2 1 CH2F human NH2 H2N 1 234-237 (decomposed) _6 7 — equipment-(Please read the precautions on the back before filling out this page), 11 This paper is applicable to the standard > A4 specification (210X297 mm) 491848 A7 B7 V. Description of the invention (W) Example 57 Θ 7-[(lR *, 5R * JS *)-8-amino-2-ming-6-azine [3 · 3 · 0] oct-6-yl] -1-cyclopropyl-6-fluoro-1,4-dihydro-8-methyl-4-air βquinol-3-carboxylic acid (1) In an argon stream, mix diisopropylamine 23.8μ1 and tetrahydrofuran 3 0 0 channel 1
,在-78*^滴加正丁鋰之己烷溶液(1·63Μ)100β1。在同溫 攪拌15分後,滴加2-(2,4,5-三氟苯基)-4,4-二甲基锷 唑啉33.4克與四氫呋喃150»1之混合物。在同溫攪拌30分 後,滴加甲酸乙酯29nl, 1小時後徐徐舁溫,在約-l〇eC 加氣化銨。次以乙酸乙酯萃取而以飽和食鹽水洗淨,以 無水硫酸鈉乾燥,減壓蒸除溶劑,加異丙醚,濾集結晶 ,得2-(2,4,5-三氟-3-甲醯苯基)-4,4-二甲基-2-鸣唑 啉2 1 · 6克。 融點:115-117 °C (從乙酸乙酯-正己烷再結晶> I R (KB r ) cm -1 : 1697, 1624 —NMR (CDC 1 3 ) 5 ·· 10.36 (ηκ 1 Η) , 7·98 (m, 1 Η), 4· 13 ( s , 2 Η) , 1· 40 ( s , 6 Η) 經濟部中央標準局員工消費合作社印製 (請先閲讀背面之注意事項再填寫本頁) (2) 將(1)所得之化合物15·8克與10%鹽酸水220H1混 合物加熱回流4小時。冷卻後,以乙酸乙酯萃取而水洗 ,以無水硫酸鈉乾燥,減壓蒸除溶劑,加正己烷。濾集 結晶,得2,4,5 -三氟-3-甲醯基苯甲酸12.0克。At -78 * ^, a solution of n-butyllithium in hexane (1.63M) 100β1 was added dropwise. After stirring for 15 minutes at the same temperature, a mixture of 33.4 g of 2- (2,4,5-trifluorophenyl) -4,4-dimethyloxazoline and tetrahydrofuran 150 »1 was added dropwise. After stirring at the same temperature for 30 minutes, 29nl of ethyl formate was added dropwise. After 1 hour, the temperature was gradually increased, and ammonium vaporization was added at about -10eC. It was extracted with ethyl acetate and washed with saturated brine, dried over anhydrous sodium sulfate, the solvent was distilled off under reduced pressure, isopropyl ether was added, and crystals were collected by filtration to obtain 2- (2,4,5-trifluoro-3- Formamylphenyl) -4,4-dimethyl-2-oxazoline 21 1.6 g. Melting point: 115-117 ° C (recrystallized from ethyl acetate-n-hexane> IR (KB r) cm -1: 1697, 1624 —NMR (CDC 1 3) 5 ·· 10.36 (ηκ 1 Η), 7 · 98 (m, 1 Η), 4.13 (s, 2 Η), 1.40 (s, 6 Η) Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs (Please read the notes on the back before filling out this page (2) A mixture of 15.8 g of the compound obtained in (1) and 220H1 10% hydrochloric acid water was heated under reflux for 4 hours. After cooling, it was extracted with ethyl acetate and washed with water, dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. N-hexane was added and the crystals were collected by filtration to obtain 12.0 g of 2,4,5-trifluoro-3-methylfluorenylbenzoic acid.
融點:147-148 °C I R (KB r) cm -1 : 3062, 1687,1618 ^-NMR (DMSO-de ) 5 : 13.84-13.64 (b r, 1 Η) , 1〇·2〇 (m, 1 Η) , 8· 19 (m, 1 H) -68- 本紙張尺度適用中國國家標準(CNS ) Α4ϋ格(210 X 297公釐) 491848 A7 B7 經濟部中央標準局員工消費合作社印製 五、發明説明(π ) (3) 混合(2)所得之化合物12·0克,碩酸鉀8·9克及=甲 基甲醯胺120»1,加苄基溴7·7·1,在室溫攪拌I6小時後, 加10%鹽酸水,以乙酸乙酯萃取,先後以飽和®酸 水及飽和食鹽水洗淨,以無水硫酸納乾燥,減®蒸除溶 劑,在矽膠柱層析(氯仿),從乙酸乙酯-正己烷再結晶, 得2,4, 6-三氟-3-甲醛基苯甲酸苄酯13·4克。 融點:7 0 - 7 1 eCI R (K B r ) cm -1 : 1731, 1710, 1622^-NMR (CDC 1 a ) 5 : 10.35 (m, 1 Η) , 8.05 (m, 1 Η), 7.44 (m, 5H) , 5. 46 (s, 2 H)(4) 於乙腈100ml中加(3)所得之化合物6.15克,實施例A所得之卜)(11{* ,5S* ,8R* )-8-(第三丁氣羰胺基) -2-鸣-6-吖雙璟〔3.3.0〕辛烷5·25克及三乙胺2·8克, 在室溫攪拌7日後,減壓濃縮,加水及乙酸乙酯。分取 有機層,以無水硫酸鎂乾燥,減壓蒸除溶劑•在矽膠柱 層析(氣仿:甲醇= 50: 1),得 4-〔(1ϋ* ,5R* ,8S* )-8-(第三丁氣羰胺基吖雙璨〔3.3.0〕辛-6-基〕-3 -甲醯基-2, 5 -二氟-苯甲酸节酿9.81克。 融點:6 1 - 6 3 °C IR(KBr)ciB"1 : 3368,1712,1681,1619MS (m/z) : 503 (MH+ )!H-NMR (CDC 1 a ) ά : 10.30 (d, 1 H, J =3· 0Hz ),7· 78 (dd, 1 H, J = 14. 0, 7. 0Hz ) , 7. 49-7. 33 (m, 5 H) , 5. 38 ( s , -69- (請先閱讀背面之注意事項再填寫本頁) 裝·Melting point: 147-148 ° CIR (KB r) cm -1: 3062, 1687, 1618 ^ -NMR (DMSO-de) 5: 13.84-13.64 (br, 1 Η), 10.2 · (0, m, 1 Η), 8.19 (m, 1 H) -68- This paper size applies to the Chinese National Standard (CNS) Α4ϋ 格 (210 X 297 mm) 491848 A7 B7 Printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs Explanation (π) (3) 12.0 g of compound obtained in (2), 8.9 g of potassium sulphate, and methylformamide 120 »1, plus benzyl bromide 7.7.1, at room temperature After stirring for 6 hours, add 10% hydrochloric acid water, extract with ethyl acetate, wash with saturated® acid water and saturated brine, dry with anhydrous sodium sulfate, distill the solvent off, and then use silica gel column chromatography (chloroform). And recrystallized from ethyl acetate-n-hexane to obtain 13.4 g of benzyl 2,4,6-trifluoro-3-formylbenzoate. Melting point: 7 0-7 1 eCI R (KB r) cm -1: 1731, 1710, 1622 ^ -NMR (CDC 1 a) 5: 10.35 (m, 1 Η), 8.05 (m, 1 Η), 7.44 (m, 5H), 5. 46 (s, 2 H) (4) To 100 ml of acetonitrile, add 6.15 g of the compound obtained in (3), obtained from Example A) (11 {*, 5S *, 8R *) -8- (Third butanecarbonylamino) -2-Ming-6-azepine [3.3.0] 5.25 g of octane and 2.8 g of triethylamine. After stirring at room temperature for 7 days, reduce Concentrate under pressure, add water and ethyl acetate. The organic layer was separated, dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. • Chromatographed on a silica gel column (gas-form: methanol = 50: 1) to obtain 4-[(1ϋ *, 5R *, 8S *)-8- (Third butanecarbonylamino acridine [3.3.0] octane-6-yl] -3 -methylamido-2,5-difluoro-benzoic acid. 9.81 g. Melting point: 6 1-6 3 ° C IR (KBr) ciB " 1: 3368,1712,1681,1619MS (m / z): 503 (MH +)! H-NMR (CDC 1 a) ά: 10.30 (d, 1 H, J = 3 · 0Hz), 7.78 (dd, 1 H, J = 14. 0, 7. 0Hz), 7. 49-7. 33 (m, 5 H), 5. 38 (s, -69- (Please read first (Notes on the back then fill out this page)
、1T .4 •l·. 本紙張尺度適用中國國家標準(CNS ) Λ4ΙΜΙ 2丨公# ) 經濟部中央標準局員工消費合作社印製 491848 A7 B7 五、發明説明(^ ) 2 Η) , 5. 01 ( b r s , 1 H) , 4. 87 ( b r s , 1 H) , 4. 43 ( d, 1 H, J =4· 0Hz ) , 4· 30 ( b r s,1 H) , 4. 03-3. 80 (ni, 3 II), 2. 94 ( b r d, 1 H, J = 12· 0Hz) , 2. 09-1· 86 (m, 1 H) , 1· 79-1· 61 (m, 1 H) , 1.43 (s, 9H) (5) 於甲醇lOOil加(4)所得之化合物8.78克,冰冷而 徐徐加硼氫化鈉330b g,攪拌2小時後,加丙酮而減壓 濃縮,加水及乙酸乙酯。分取有機層,以無水硫酸鎂乾 燥,減壓蒸除溶劑,加乙酸乙酯及正己烷,得4-〔(lR# ,5R* ,8S* )-8-(第三丁氣羰胺基)-2-枵-6-吖雙璟 〔3.3.0〕辛-6-基〕-2,5-二氟-3-羥甲基苯甲酸甲酯 4.2 3克。將濾液在矽膠柱層析(氯仿:甲醇=100: 1), 再得上述化合物1.3克。 融點:1 3 9 - 1 4 2 °C I R (KB r ) cm -1 : 3331, 1681 MS (m/z) : 429 (MH+ ) 1H —NMR (CDC 1 3 ) ά : 7.58 (d d, 1 H, J 二 13· 0, 7· 0Hz ), 4.93-4.76 (m, 3H),4.68(t, 1 H, J-5. 0Hz ) , 4. 44 ( d , 1 H, J=5.0Hz ), 4. 17 (b r s, 1 H) , 4.02-3.82 (m, 3 H),、 1T .4 • l ·. This paper size applies to Chinese National Standard (CNS) Λ4ΙΜΙ 2 丨 公 #) Printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 491848 A7 B7 V. Description of the invention (^) 2 Η), 5. 01 (brs, 1 H), 4. 87 (brs, 1 H), 4. 43 (d, 1 H, J = 4.0 Hz), 4.30 (brs, 1 H), 4. 03-3. 80 (ni, 3 II), 2. 94 (brd, 1 H, J = 12.0 Hz), 2. 09-1 · 86 (m, 1 H), 1. 79-1 · 61 (m, 1 H ), 1.43 (s, 9H) (5) 8.78 g of the compound obtained in (4) was added to 100 ml of methanol, 330 bg of sodium borohydride was added slowly and ice-cooled, and after stirring for 2 hours, acetone was added to concentrate under reduced pressure. Water and ethyl acetate were added. ester. The organic layer was separated, dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. Ethyl acetate and n-hexane were added to obtain 4-[(lR #, 5R *, 8S *)-8- (third butanecarbonylamino group). ) -2-Hydroxy-6-azabispyridyl [3.3.0] oct-6-yl] -2,5-difluoro-3-hydroxymethylbenzoate 4.23 g. The filtrate was subjected to silica gel column chromatography (chloroform: methanol = 100: 1) to obtain 1.3 g of the above compound. Melting point: 1 3 9-1 4 2 ° CIR (KB r) cm -1: 3331, 1681 MS (m / z): 429 (MH +) 1H —NMR (CDC 1 3) ά: 7.58 (dd, 1 H , J 2 13. 0, 7.0 Hz), 4.93-4.76 (m, 3H), 4.68 (t, 1 H, J-5. 0Hz), 4. 44 (d, 1 H, J = 5.0Hz), 4. 17 (brs, 1 H), 4.02-3.82 (m, 3 H),
3. 93 (s, 3H) , 3·17 (d, 1 H, J 二 10.0Hz) , 2.35 ( t, 1 H, J = 5.0Hz ) , 2.01-1.65 (m, 2 H) , 1.45 (s, 9 H) (6) 於二氣甲烷250a g加(5)所得之化合物6.2克及三乙 胺3.12克,冰冷而加甲磺醛氯2.0克,在室溫携拌一夜, 加水及氯仿,分取有機層,以無水硫酸鎂乾燥,減壓蒸 除溶劑,在矽膠柱層析(正己烷:乙酸乙酯=4: 1),得 -7 0 - 本紙張尺度適用中國國家標準(CNS ) A4規格(21〇X297公釐) 丨 *-----£--: (請先閱讀背面之注意事項再填寫本頁) •裝· 、11 491848 A7 __B7_ 五、發明説明(Μ ) 4-〔(lR* ,5R* ,8S* )-8-(第三丁氣羰胺基)-2-垮-6- 吖雙環〔3·3·0〕辛-6-基〕-3-氯甲基-2,5-二氟苯甲酸 甲酯5 . 81克。 IR(淨)ci·1 : 3376,2979,1718 MS (ιώ/ζ) : 447 (ΜΗ+ ) ^-NMR (CDC13 ) 5 :7. 63 (dd, 1 H, J = 13· Ο, 7· OHz ), 4.80 (b r d, 1 H, J =7· 0Hz ) , 4· 71 ( d,2 H,J =2· 0Hz ), 4.66 (b r s, 1 H) , 4.46 (d, 1 H, J=5.0Hz ) , 4·20 (b r s, 1 H) , 4.02-3.83 (m, 3 H) , 3. 93 ( s , 3 H) , 3.13 (dd, 1 H, J-10.0, 2.0Hz ) , 2.00-L68 (m, 2 H) , 1.45 (s, 9 H) (7)於四氫呋喃2fl0ial溶解(6)所得之化合物5.81克及 三乙胺1.46克,加10%Pd-C 3 0 0 ag,在40°C吸收理論量 氫後,濾除觸媒,減壓蒸除溶劑,加水及乙酸乙酯。分 取有機層,以無水硫酸鎂乾燥,減壓蒸除溶劑,得4-〔 (1R* ,5ΙΤ ,8S* )-8-(第三丁氣羰胺基)-2-枵-6-吖雙 環〔3.3.0〕辛-6-基〕-2,5-二氟-3-甲基苯甲酸甲酯5.6 克。 IR(淨)cm 一1 : 2977,1715 經濟部中央標準局員工消費合作社印製 (請先閲讀背面之注意事項再填寫本頁) MS (m/z) : 413 (MH+ ) , / !H~NMR (CDCla ) δ :7. 46(dd, 1 Η, J = 13· 0,7· 0Hz ), 4.75 (b r s, 1 Η) , 4.58 ( t, 1 Η, J-5. Ollz ) , 4.45 (d, I Η, J=5. ΟΗζ ) , 4.18 (b r s, 1 Η) , 3.99-3.81 (m, 2 Η), 3· 91 ( s , 3 Η) , 3· 04 ( d d , 1 Η, J = 1〇· 〇, 2· ΟΗζ ) , 2· 22 ( d , 3Η, J 二 2·0Ηζ ),1.92-1.55 (m, 2Η) , 1.47 (s, 9Η) -7 1- 本紙張尺度適用中國國家標準(CNS ) Α4規格(210Χ297公釐) 491848 A7 B7 五、發明説明() (8) 於(7)所得化合物5·6克加乙醇70·1及IN NaOH水40通1 ,在室溫攪拌2日後,減壓蒸除乙醇,加水而在冰冷下 以10%乙酸水使呈弱酸性。濾集結晶,得4-CUR11 ,5R* ,8S* )-8-(第三丁氣羰胺基)U§-6-吖雙環〔3.3.0〕 辛-6-基〕-2,5-二氟-3-甲基苯甲酸3.7克。3.93 (s, 3H), 3.17 (d, 1 H, J 20.0Hz), 2.35 (t, 1 H, J = 5.0Hz), 2.01-1.65 (m, 2 H), 1.45 (s (9H) (6) Add 250g of digas methane to 6.2g of the compound obtained in (5) and 3.12g of triethylamine, add 2.0g of methanesulfonyl chloride in ice-cold, and stir at room temperature overnight, add water and chloroform, Separate the organic layer, dry over anhydrous magnesium sulfate, evaporate the solvent under reduced pressure, and perform column chromatography on silica gel (n-hexane: ethyl acetate = 4: 1) to get -7 0-This paper is in accordance with Chinese National Standards (CNS) A4 specifications (21〇X297 mm) 丨 * ----- £-: (Please read the precautions on the back before filling out this page) • Equipment · 11 491848 A7 __B7_ V. Description of the invention (Μ) 4- [(LR *, 5R *, 8S *)-8- (Third-butanecarbonylamino) -2-pent-6-azabicyclo [3 · 3 · 0] oct-6-yl] -3-chloroform Methyl-2,5-difluorobenzoate 5.81 g. IR (net) ci · 1: 3376, 2979, 1718 MS (ιώ / ζ): 447 (ΜΗ +) ^ -NMR (CDC13) 5: 7.63 (dd, 1 H, J = 13. Ο, 7 · OHz), 4.80 (brd, 1 H, J = 7.0 Hz), 4.71 (d, 2 H, J = 2.0 Hz), 4.66 (brs, 1 H), 4.46 (d, 1 H, J = 5.0Hz), 4.20 (brs, 1 H), 4.02-3.83 (m, 3 H), 3. 93 (s, 3 H), 3.13 (dd, 1 H, J-10.0, 2.0Hz), 2.00 -L68 (m, 2 H), 1.45 (s, 9 H) (7) 5.81 g of compound obtained by dissolving (6) in tetrahydrofuran 2fl0ial and 1.46 g of triethylamine, add 10% Pd-C 3 0 0 ag, in After the theoretical amount of hydrogen was absorbed at 40 ° C, the catalyst was filtered off, the solvent was distilled off under reduced pressure, and water and ethyl acetate were added. The organic layer was fractionated, dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure to obtain 4-[(1R *, 5ΙΤ, 8S *)-8- (third butanecarbonylamino) -2- 枵 -6-acryl. 5.6 g of bicyclo [3.3.0] octyl-6-yl] -2,5-difluoro-3-methylbenzoate. IR (net) cm-1: 2977,1715 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs (please read the notes on the back before filling this page) MS (m / z): 413 (MH +), /! H ~ NMR (CDCla) δ: 7.46 (dd, 1 Η, J = 13.0, 7.0 Hz), 4.75 (brs, 1 Η), 4.58 (t, 1 Η, J-5. Ollz), 4.45 ( d, I Η, J = 5. ΟΗζ), 4.18 (brs, 1 Η), 3.99-3.81 (m, 2 Η), 3.91 (s, 3 Η), 3.04 (dd, 1 Η, J = 1〇 · 〇, 2 · ΟΗζ), 2 · 22 (d, 3Η, J 2 · 0Ηζ), 1.92-1.55 (m, 2Η), 1.47 (s, 9Η) -7 1- This paper size applies to China National Standard (CNS) A4 specification (210 × 297 mm) 491848 A7 B7 V. Description of the invention () (8) 5.6 g of compound obtained in (7) plus ethanol 70 · 1 and IN NaOH water 40 pass 1 at room temperature After stirring for 2 days, ethanol was distilled off under reduced pressure, and water was added to make it weakly acidic with 10% acetic acid water under ice-cooling. The crystals were collected by filtration to obtain 4-CUR11, 5R *, 8S *) -8- (Third butanecarbonylamino) U§-6-Azabicyclo [3.3.0] oct-6-yl] -2,5- 3.7 g of difluoro-3-methylbenzoic acid.
融點:1 0 8 - 1 1 0 eC I R (KB r) cm -1 : 3370, 2979, 1698 MS (m/z) : 399 (MH+ ) ^-NMR (CDCla ) δ :7.50(dd, 1 H, J = 13. 0, 7. 〇Hz ), 4.91-4.52 (br, 2 H) , 4.45 (d, 1 H, J=5.〇Hz), 4.18 (br s, 1 H) , 4.05-3.79 (m, 3 H) , 3.30-3.00 (br d, 1H, J=10.0Hz) , 2·24 (d, 3H, J=2.0Hz ),1.98-1.56 (m, 2H), 1.47 ( s, 9 H) (9) 將(8)所得之化合物2.94克及1,:T -羰基二眯唑1.38 克溶在四氫呋喃4Dal,在50°C攪拌一夜後,冰冷而注入 將丙二酸乙酯鉀鹽1.77克,氯化鎂1.2克及三乙胺2.65克 溶在乙酸乙酯40ail而在室溫攪拌一夜之溶液。在室溫一 夜及5G°C 2小時之攪拌後,加冰水,以10%鹽酸水酸化。 經濟部中央標準局員工消費合作社印製 (請先閲讀背面之注意事項再填寫本頁) 用乙酸乙酯萃取而以無水硫酸鎂乾燥,減壓蒸除溶劑, 加異丙醚,濾集結晶,得4-〔(llT ,5R" ,8S_ )-8-(第 三丁氣羰胺基)-2-呜-6-吖雙璟〔3.3.0〕辛-6-基〕-2, 5-二氟-3-甲苄醛基乙酸乙酯2.24克。將濾液在矽膠柱 層析(氣仿),再得上逑化合物〇·25克。Melting point: 1 0 8-1 1 0 eC IR (KB r) cm -1: 3370, 2979, 1698 MS (m / z): 399 (MH +) ^ -NMR (CDCla) δ: 7.50 (dd, 1 H , J = 13. 0, 7. 〇Hz), 4.91-4.52 (br, 2 H), 4.45 (d, 1 H, J = 5.〇Hz), 4.18 (br s, 1 H), 4.05-3.79 (m, 3 H), 3.30-3.00 (br d, 1H, J = 10.0Hz), 2.24 (d, 3H, J = 2.0Hz), 1.98-1.56 (m, 2H), 1.47 (s, 9 H) (9) Dissolve 2.94 g of the compound obtained in (8) and 1.38 g of 1,: T-carbonyldioxazole in tetrahydrofuran 4Dal, stir it at 50 ° C overnight, and inject it with ice-cold potassium potassium malonate A solution of 1.77 g, 1.2 g of magnesium chloride and 2.65 g of triethylamine dissolved in ethyl acetate 40ail and stirred overnight at room temperature. After stirring at room temperature overnight and 5G ° C for 2 hours, ice water was added and acidified with 10% hydrochloric acid. Printed by the Employees' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs (please read the precautions on the back before filling this page) Extraction with ethyl acetate and drying over anhydrous magnesium sulfate, evaporation of the solvent under reduced pressure, addition of isopropyl ether, and filtration of the crystals, Obtain 4-[(llT, 5R ", 8S _)-8- (Third-butanecarbonylamino) -2-o-6-azepine [3.3.0] oct-6-yl] -2, 5- Difluoro-3-methylbenzaldehyde ethyl acetate 2.24 g. The filtrate was chromatographed on a silica gel column (aeroform) to obtain 0.25 g of the amidine compound.
融點:1 3 1 - 1 3 4 °C -72- 本紙張尸、度4«中* W家樣準(CNS ) A4規格(210X297公釐) 491848 A7 B7 _ 五、發明説明(V ) I R (KB r ) cm -1 : 3366, 1682, 1526 MS (m/z) : 469 (MH+ ) (10) 混合(9)所得之化合物2.24克,正甲酸乙酯1·〇7克 及乙酐1.23克,攪拌加熱150°C 2小時後,減壓濃縮,加 氯仿2Gb1,冰冷下加環丙胺0.3克,在室溫攪拌一夜後, 加熱50 °C而攪拌3小時。減壓濃縮後,加乙酸乙酯及水 。分取有機層,以無水硫酸鎂乾燥,減壓蒸除溶在 矽膠柱層析(氣仿:甲醇= 20: 1),得2-〔(lR* ,51Τ ,8S* )-8-(第三丁氣羰胺基吖雙環〔3·3·0〕 辛-6-基〕-2,5-二氟-3-甲苄醯基〕-3-璟丙胺基丙烯酸 乙酯2 · 9克。Melting point: 1 3 1-1 3 4 ° C -72- Paper body, degree 4 «Medium * W family sample standard (CNS) A4 specification (210X297 mm) 491848 A7 B7 _ V. Description of the invention (V) IR (KB r) cm -1: 3366, 1682, 1526 MS (m / z): 469 (MH +) (10) 2.24 g of compound obtained in (9), 1.07 g of ethyl n-formate and 1.23 of acetic anhydride G, stirred and heated at 150 ° C for 2 hours, concentrated under reduced pressure, added chloroform 2Gb1, and added 0.3 g of cyclopropylamine under ice cooling. After stirring at room temperature overnight, it was heated at 50 ° C for 3 hours. After concentration under reduced pressure, ethyl acetate and water were added. The organic layer was separated, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure to dissolve in a silica gel column chromatography (aerosol: methanol = 20: 1) to obtain 2-[(lR *, 51T, 8S *)-8- ( Tributylcarbonylaminoacylbicyclo [3 · 3 · 0] oct-6-yl] -2,5-difluoro-3-methylbenzylfluorenyl] -3-fluorenylaminoacrylic acid ethyl ester 2.9 g.
融點:7Z-7 5V IR (KBr) cm 一1 :3452, 2977, 1700, 1623 MS (m/z) : 536 (MH+ ) (11) 將(10)所得之化合物2. 9克及碩酸鉀1.5克投入二 鸣烷4 0 b 1 ,加熱9 (Γ C而攪拌一夜。減壓濃縮後,加水及 氯仿。分取有機層,以無水硫酸鎂乾燥,減壓蒸除溶劑 ,在矽膠柱層析(氯仿:甲醇=100: 1),得7-〔(1R·, 經濟部中央標準局員工消費合作社印製 (請先閲讀背面之注意事項再填寫本頁) 5R* ,8S* )-8-(第三丁氣羰胺基)-2-垮-6-丨丫雙璟〔3.3.0〕 辛-6-基〕-1-環丙基-6-氣-1,4 -二氣-8-甲基-4-氣Bf淋 -3-羧酸乙酯2 . 12克。 融點:1 1 5 - 1 1 8 X:(分解) -73- 本紙張尺度適用中國國家標準(CNS ) Α4規格(210Χ 297公釐) 經濟部中央標準局員工消費合作社印製 491848 A 7 B7 五、發明説明(W) I R (KB r ) cm -1 :3509, 2976, 1700, 1615 MS (m/z) : 516 (MH+ ) !H-NMR (CDC 1 a ) ά : 8.67 (s, 1 H) , 7.95 (d, 1 H, J =14· 0Hz) , 4· 75 ( b r s, 1 H) , 4.70 ( t, 1 H, J-5.0Hz ), 4. 48 (d, 1 H, J=5. 0Hz ), 4. 40 (q, 2 H, J =7. 0Hz ), 4.23 (b r s, 1 H) , 4.07-3.81 (m, 4 H) , 3· 08 ( d d, 1 H, J 二 10.0, 2.0Hz ) , 2.63 (s, 3 H) , 2.00-1.58 (m, 2 H) , 1.47 (s, 9H), 1.42( t, 3 H, J =7.0Hz ), 1.38-0.70 (m, 4 H) (12)將(11)所得之化合物2.1克投入乙醇50m1及10% 鹽酸水20b 1之混液中,加熱8G*C而攪拌4小時後,減壓 濃縮,加水而以10% NaOH中和。加氣仿後,分取有機 層,以無水硫酸鎂乾燥,減壓蒸除溶劑,加二氯甲烷及 乙酸乙酯,徐徐蒸除二氣甲烷。濾集結晶,以乙醚洗淨 ,得目的之 7-〔(lR* ,5R· ,8S* )-8-胺基-2-^-6-吖 雙環〔3.3.0〕辛-6-基〕-1-璟丙基-6-氟-1,4 -二氫- 8-甲基-4-氧ί奎啉-3-羧酸900nge 融點:1 1 4 - 1 1 7 °C 實施例58 仿實施例3得如下化合物。 7-〔(lR* ,5R* ,8S* )-8 -胺基- -吖雙環〔3·3·0〕 辛-6-基〕-1-(2,4-二氟苯基)-6-氟-5-羥基-1,4-二氫 -4-氣-1 ,8-暸啶-3-羧酸 融點:258-263 °C (分解) 實施例59 -74- 本紙張尺度適用中國國家標準(CNS Mil蟢(21OX 297公釐) (請先閲讀背面之注意事項再填寫本頁)Melting point: 7Z-7 5V IR (KBr) cm -1: 3452, 2977, 1700, 1623 MS (m / z): 536 (MH +) (11) 2.9 g of the compound obtained in (10) and ferric acid Put 1.5 g of potassium into dioxane 4 0 b 1, heat 9 ° C and stir overnight. After concentrating under reduced pressure, add water and chloroform. Separate the organic layer, dry over anhydrous magnesium sulfate, evaporate the solvent under reduced pressure, and place in a silica gel column. Chromatography (chloroform: methanol = 100: 1), get 7-[(1R ·, printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs (please read the precautions on the back before filling out this page) 5R *, 8S *)- 8- (Third Butane Carboxamido) -2-Ban-6- 丨 Yamidine [3.3.0] Octan-6-yl] -1-Cyclopropyl-6-Ga-1,4 -Digas -8-Methyl-4-Gas Bf leaching-3-carboxylic acid ethyl ester 2. 12 g. Melting point: 1 1 5-1 1 8 X: (decomposition) -73- This paper size applies to Chinese national standards (CNS ) Α4 size (210 × 297 mm) Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs 491848 A 7 B7 V. Description of the invention (W) IR (KB r) cm -1: 3509, 2976, 1700, 1615 MS (m / z): 516 (MH +)! H-NMR (CDC 1 a) ά: 8.67 (s, 1 H), 7.95 (d, 1 H, J = 14 · 0Hz), 4.75 (brs, 1 H), 4.70 (t, 1 H, J-5.0Hz), 4. 48 (d, 1 H, J = 5.0 Hz), 4. 40 (q, 2 H, J = 7. 0Hz), 4.23 (brs, 1 H), 4.07- 3.81 (m, 4 H), 3.08 (dd, 1 H, J 2 10.0, 2.0Hz), 2.63 (s, 3 H), 2.00-1.58 (m, 2 H), 1.47 (s, 9H), 1.42 (t, 3 H, J = 7.0 Hz), 1.38-0.70 (m, 4 H) (12) Put 2.1 g of the compound obtained in (11) into a mixture of ethanol 50 m 1 and 10% hydrochloric acid water 20 b 1, and heat 8G * C and stirred for 4 hours, concentrated under reduced pressure, added water and neutralized with 10% NaOH. After aerated imitation, the organic layer was separated, dried over anhydrous magnesium sulfate, the solvent was distilled off under reduced pressure, and dichloromethane and ethyl acetate were added. Ester, slowly distilling off methane gas. The crystals were collected by filtration, and washed with diethyl ether to obtain the target 7-[(lR *, 5R ·, 8S *)-8-amino-2-^-6-azabicyclo [3.3 .0] octyl-6-yl] -1-fluorenyl-6-fluoro-1,4-dihydro-8-methyl-4-oxoquinoline-3-carboxylic acid 900nge Melting point: 1 1 4 -1 1 7 ° C Example 58 The following compound was obtained by simulating Example 3. 7-[(lR *, 5R *, 8S *)-8-Amino-Acridinebicyclo [3 · 3 · 0] oct-6-yl] -1- (2,4-difluorophenyl) -6 -Fluoro-5-hydroxy-1,4-dihydro-4-gas-1,8-pyridine-3-carboxylic acid Melting point: 258-263 ° C (decomposition) Example 59 -74- Applicable to this paper size Chinese National Standard (CNS Mil 蟢 (21OX 297 mm) (Please read the notes on the back before filling this page)
491848 A7 B7五、發明説明(W ) 仿實施例1,得下列化合物。 5-胺基-7-〔(lR· ,5IT ,8S*卜8-胺基-2-鸣-6-吖雙環 〔3·3·0〕辛-6-基〕-1-璟丙基-8-乙氣基-6-氣-1,4 -二 氫-4-氣睹啉-3-羧酸 融點:2 1 7 - 2 2 0 °C 實施例60 仿實施例3 ,得下列化合物。 5-胺基-7-〔(lR* ,5R* ,8S* )-8-胺基-2-枵-6-吖雙 環〔3.3.0〕辛-6-基〕-1-(2,4 -二氟苯基)-6 -氣-1,4-二氫-4-氧-1,8 -瞭陡-3-竣酸 融點:2 6 7 - 2 7 0 °C (分解) 實施例N:錠劑之製法 丨...ih._|^_丨»1II (請先閱讀背面之注意事項再填寫本頁) 實施例1之化合物 2 5 0克 玉米澱粉 54克 羧甲基纖維素鈣 40克 微晶纖維素 50克 硬脂酸鎂 6克 訂 經濟部中央標準局員工消費合作社印製 將以上各成分與乙醇一起混合,而依常法造粒及打錠 ,得每H 2 0 0fflg之錠劑2 0 0 0錠。 産業上之利用可能性 本發明化合物(I)可當作人及動物之抗菌劑,另二環 胺化合物(II)可供為化合物(I)之直接合成中間體。 -75- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐)491848 A7 B7 V. Description of the invention (W) Following Example 1, the following compounds were obtained. 5-Amino-7-[(lR ·, 5IT, 8S *, 8-Amino-2-Ming-6-Azabicyclo [3 · 3 · 0] oct-6-yl] -1-fluorenyl- 8-Ethyl-6-Ga-1,4-dihydro-4-Ga-Phenolin-3-carboxylic acid Melting point: 2 1 7-2 2 0 ° C Example 60 The following compounds were obtained by imitating Example 3 5-amino-7-[(lR *, 5R *, 8S *)-8-amino-2-fluoren-6-acylbicyclo [3.3.0] oct-6-yl] -1- (2, 4-difluorophenyl) -6-gas-1,4-dihydro-4-oxo-1,8-lean-3-unacid melting point: 2 6 7-2 7 0 ° C (decomposition) Implementation Example N: Method for preparing lozenges 丨 ... ih._ | ^ _ 丨 »1II (Please read the precautions on the back before filling this page) The compound of Example 1 250 grams of corn starch 54 grams of carboxymethyl fiber 40 grams of calcium calcium, 50 grams of microcrystalline cellulose, 6 grams of magnesium stearate, printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs, and mixed the above ingredients with ethanol. 0 0 0 0 0 lg of tablets 2 0 0 tablets. Industrial applicability The compound (I) of the present invention can be used as an antibacterial agent for humans and animals, and the bicyclic amine compound (II) can be used as a direct compound (I). Synthetic intermediate. -75- Paper size Applicable to China National Standard (CNS) A4 specification (210X297 mm)
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TW086112167A TW491848B (en) | 1997-08-25 | 1997-08-25 | Pyridone carboxylic acid derivatives and the synthetic intermediate thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TW086112167A TW491848B (en) | 1997-08-25 | 1997-08-25 | Pyridone carboxylic acid derivatives and the synthetic intermediate thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW491848B true TW491848B (en) | 2002-06-21 |
Family
ID=21626926
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW086112167A TW491848B (en) | 1997-08-25 | 1997-08-25 | Pyridone carboxylic acid derivatives and the synthetic intermediate thereof |
Country Status (1)
| Country | Link |
|---|---|
| TW (1) | TW491848B (en) |
-
1997
- 1997-08-25 TW TW086112167A patent/TW491848B/en active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102482271B1 (en) | Macrocycles as modulators of cystic fibrosis transmembrane conductance modulators, pharmaceutical compositions thereof, uses thereof in the treatment of cystic fibrosis, and methods for their preparation | |
| US4665079A (en) | Antibacterial agents | |
| KR101864561B1 (en) | JAK inhibitors | |
| US4638067A (en) | Antibacterial agents | |
| JP3235539B2 (en) | Antibacterial agent | |
| JPH04210961A (en) | Intermediate useful for producing nitrogeneous polycyclic compound | |
| WO2014078372A1 (en) | Pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors | |
| US4777175A (en) | Antibacterial agents | |
| CN104203239A (en) | Compounds for treating spinal muscular atrophy | |
| WO1997011068A1 (en) | Novel pyridonecarboxylic acid derivatives or their salts and antibacterial agent comprising the same as the active ingredient | |
| JP7074758B2 (en) | Pyrazolo [3,4-b] pyridine and imidazole [1,5-b] pyridazine as PDE1 inhibitors | |
| US4771054A (en) | Antibacterial agents | |
| AU2022412827B2 (en) | Heterocyclic compound having anti-tumor activity and use thereof | |
| JP2021523875A (en) | Pyrazine-2 (1H) -one compound as an FGFR inhibitor | |
| JP3448305B2 (en) | Novel pyridonecarboxylic acid derivative or salt thereof and drug containing the same as active ingredient | |
| JPH08501063A (en) | 7-Substituted-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid compounds and related compounds useful as antibacterial agents | |
| EP0202763A1 (en) | 5,6-Difluoronaphthyridines and 5,6,8-trifluoro-quinolines as antibacterial agents | |
| CN116600808A (en) | Tetrahydronaphthyridine derivative serving as KRAS mutant G12C inhibitor, and preparation method and application thereof | |
| US6969716B2 (en) | 5-phenyl[1,2,4]triazines as ligands for GABA-A α2/α3 receptors for treating anxiety or depression | |
| CN113149996B (en) | Polycyclic amide derivative as CDK9 inhibitor, and preparation method and application thereof | |
| WO1998002431A1 (en) | cis-SUBSTITUTED AMINOCYCLOPROPANE DERIVATIVES | |
| TW491848B (en) | Pyridone carboxylic acid derivatives and the synthetic intermediate thereof | |
| CA3233509A1 (en) | Modulators of trpml, their compositions and methods of use | |
| JPS61189281A (en) | Pyridonecarboxylic acid derivatives, their esters and their salts | |
| CN110272416A (en) | Pyrazolo [3,4-c] pyridine -7- amine derivative and its preparation method and application |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GD4A | Issue of patent certificate for granted invention patent |